Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7" "Cell type enhanced" "Detected in many" "Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 7.6;U-937: 6.2" HPA040470 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.2 4.2 14.8 1.4 18.3 22.6 0.2 26.3 32.0 0.1 1.2 0.5 4.7 0.1 0.5 0.3 0.2 0.3 1.4 18.6 12.8 1.9 2.0 0.3 2.4 22.2 18.2 0.0 1.1 11.3 4.2 0.6 18.9 0.3 0.3 45.8 0.3 18.0 2.3 0.1 2.4 0.1 13.8 1.1 0.6 20.7 25.0 0.6 0.4 1.4 1.0 0.2 0.1 14.3 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 6.2 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.7 1.6 0.0 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.3 14.8 18.3 26.3 32.0 18.6 12.8 22.2 18.2 18.9 13.8 25.0 14.3 0.6 25.6 29.2 229.2 1.4 1.9 1.5 0.0 2.2 65.2 2.1 0.4 0.0 1.5 16.1 1.8 229.4 0.3 3.3 0.6 7.9 0.6 43.7 0.3 0.1 3.9 2.4 110.5 70.6 0.2 0.1 4.2 0.0 0.2 10.1 0.2 1.8 8.4 0.1 21.9 110.6 1.8 0.0 1.0 15.9 7.9 0.3 6.4 0.0 15.9 0.9 24.5 0.0 41.7 9.8 0.3 1.6 1.9 0.8 1.1 1.8 0.4 8.1 130.0 0.0 2.3 1.1 45.3 1.7 0.1 1.3 0.3 15.3 0.1 0.4 1.3 ACY3 "ACY-3, HCBP1, MGC9740" ENSG00000132744 "Aminoacylase 3" Q96HD9 11 67642555-67650730 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2" "Group enriched" "Detected in many" 8 "Proximal enterocytes: 255.7;Proximal tubular cells: 437.6" "Cancer enhanced" "Detected in many" "renal cancer: 24.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 34.1" "Group enriched" "Detected in many" 5 "dendritic cells: 8.7;monocytes: 34.1" "Cell line enhanced" "Detected in some" "CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8" "Low region specificity" "Detected in all" "HPA039219, HPA048187" Enhanced NA NA 13000 "Cluster 51: Monocytes - Innate immune response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA039219: AB_10671872, HPA048187: AB_2680306" "unprognostic (8.37e-3)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (1.43e-1)" "unprognostic (7.37e-4)" "unprognostic (2.44e-3)" "unprognostic (1.15e-1)" "unprognostic (3.21e-1)" "unprognostic (2.63e-3)" "unprognostic (1.07e-1)" "unprognostic (8.24e-2)" "unprognostic (2.68e-2)" "unprognostic (1.48e-3)" 0.1 0.1 4.0 4.2 3.0 1.4 0.9 3.6 3.5 10.5 2.0 6.7 77.7 0.5 0.8 0.8 0.9 1.9 0.0 4.1 5.0 58.2 33.8 0.2 7.0 5.0 3.5 0.2 22.2 0.4 0.3 0.2 4.3 0.6 4.5 0.0 2.4 0.4 0.0 0.2 70.8 0.3 5.7 1.4 11.9 0.1 5.1 1.9 0.1 0.0 8.9 0.3 0.1 4.6 0.2 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.6 15.3 57.7 0.6 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.1 2.1 2.5 0.0 15.3 0.0 1.8 0.0 9.8 0.0 0.0 0.0 0.1 0.3 1.3 0.1 0.0 0.1 2.8 0.2 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 6.4 0.5 0.0 0.7 0.0 0.2 7.6 0.7 1.3 0.4 0.2 3.8 1.4 1.3 0.9 0.0 3.9 34.1 8.7 0.0 1.9 4.0 3.0 3.6 3.5 4.1 5.0 5.0 3.5 4.3 5.7 5.1 4.6 0.1 0.0 1.7 0.0 4.7 0.0 0.1 0.7 0.0 0.0 1.6 2.2 0.5 8.6 1.6 22.0 0.0 0.2 0.1 9.2 31.3 4.1 0.0 0.5 0.2 0.1 1.2 0.0 0.0 10.4 0.3 0.1 19.4 0.9 0.0 0.0 0.0 25.3 2.2 0.0 0.0 40.8 0.0 0.6 0.9 0.0 0.0 3.0 5.4 10.3 0.4 0.0 0.0 0.0 0.0 5.7 10.6 0.0 3.3 0.5 255.7 437.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.7 0.1 14.7 0.9 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294069-24359014 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 357.5;stomach 1: 110.3" "Cell type enhanced" "Detected in many" "B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 71.6;naive B-cell: 87.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 27.8;OE19: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.2 2.2 5.9 24.7 4.6 9.3 3.9 7.1 5.0 16.1 4.0 14.3 8.8 6.9 357.5 2.8 12.3 40.2 1.0 5.8 8.8 5.1 1.2 3.9 26.7 12.0 9.3 2.3 3.5 1.1 18.5 3.7 11.7 5.3 12.1 1.3 15.9 5.7 0.3 3.3 24.7 2.9 9.8 19.9 110.3 0.7 10.1 5.1 1.9 0.4 32.3 11.3 1.7 18.6 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.1 27.8 0.3 0.8 0.0 0.9 0.1 0.0 0.8 0.1 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.7 0.7 8.8 0.1 0.1 0.0 0.4 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.2 2.5 0.1 2.1 1.0 0.2 42.4 2.5 18.5 0.0 0.6 0.0 71.6 0.1 0.0 21.0 87.0 0.1 0.0 4.3 2.7 0.2 1.1 0.1 2.5 5.9 4.6 7.1 5.0 5.8 8.8 12.0 9.3 11.7 9.8 10.1 18.6 1.5 3.2 6.0 0.7 240.9 0.9 3.0 36.9 0.0 0.1 2.3 2.2 2.0 28.6 62.9 3.7 0.0 0.4 9.9 0.7 0.0 7.9 1.3 7.6 1.0 3.7 0.0 8.2 4.3 3.5 8.7 3.9 141.7 18.4 2.5 0.0 0.0 0.0 9.4 0.0 2.7 0.4 28.5 12.3 30.9 1.8 0.6 46.4 5.4 233.3 7.8 0.1 23.7 3.5 1.6 55.7 0.1 0.4 43.3 1.5 0.6 4.4 13.1 0.1 6.6 0.0 1.1 0.4 0.2 0.7 0.6 0.5 9.0 6.4 1.3 7.6 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 219.9" "Cell type enhanced" "Detected in many" "dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Region enhanced" "Detected in many" "cerebral cortex: 219.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" Yes NA "Cluster 35: T-regs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 6.3 2.5 85.4 10.0 69.0 14.5 1.8 0.6 219.9 0.8 0.0 2.2 2.9 2.0 0.3 2.3 1.0 4.3 23.5 162.1 0.0 0.8 1.1 3.4 16.9 0.0 0.0 1.5 3.7 1.8 7.5 2.5 0.0 1.9 1.5 4.6 2.3 0.8 15.1 3.2 5.8 1.0 0.0 11.4 3.3 1.0 0.0 15.0 2.5 9.9 11.3 3.2 1.0 38.7 7.3 10.5 19.8 5.8 0.0 0.0 11.3 4.8 0.9 0.1 0.5 1.2 6.6 18.4 1.5 0.0 3.6 4.4 0.1 0.2 0.0 20.3 3.1 20.5 1.6 3.4 0.1 21.2 40.3 0.0 0.0 0.1 0.1 8.4 0.0 21.3 0.0 39.8 0.0 12.6 37.4 13.5 3.2 2.3 10.6 15.5 98.8 13.4 0.0 6.0 5.6 20.5 2.6 3.6 4.3 0.1 2.6 14.8 11.2 5.5 9.0 10.5 3.6 16.8 10.9 9.4 9.8 13.9 9.4 3.8 0.5 0.6 2.7 0.8 2.9 1.2 2.8 3.0 0.8 0.8 1.1 1.7 3.8 1.4 0.4 0.8 4.2 1.1 85.4 69.0 0.6 219.9 162.1 0.0 0.0 0.0 0.0 0.0 0.0 38.7 3.6 3.2 1.1 0.0 5.7 0.0 0.3 0.0 0.0 10.0 0.8 0.5 5.8 1.5 0.6 0.0 0.0 0.1 16.4 0.2 0.0 0.1 0.4 0.1 0.7 4.2 0.0 2.1 22.2 0.0 0.2 0.9 2.0 0.2 2.5 0.0 1.1 0.1 1.3 8.4 12.3 0.5 0.0 2.2 1.1 1.1 0.0 3.0 0.0 1.9 3.9 0.5 17.5 5.0 1.2 0.1 0.1 0.7 11.4 0.3 0.3 0.1 0.0 2.3 32.9 2.2 16.2 0.8 0.4 0.2 0.4 0.0 16.4 0.3 0.2 0.0 ANGPTL6 "AGF, ARP5" ENSG00000130812 "Angiopoietin like 6" Q8NI99 19 10092338-10102796 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 30.2" "Cell type enhanced" "Detected in some" "B-cells: 4.1;Hepatic stellate cells: 5.7;Hepatocytes: 8.2;Smooth muscle cells: 15.8;Spermatogonia: 6.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HMC-1: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "Secreted to blood" NA NA 450000 23000000 "Cluster 24: B-cells - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 3: HMC-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "unprognostic (1.28e-1)" "unprognostic (2.18e-6)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-2)" "unprognostic (5.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.99e-2)" "unprognostic (1.23e-2)" "unprognostic (1.85e-1)" "unprognostic (2.26e-10)" "unprognostic (8.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-2)" "unprognostic (1.32e-1)" 0.3 0.3 0.8 2.1 0.7 2.8 0.3 0.8 1.1 0.2 0.4 0.6 0.7 0.1 0.2 0.3 0.7 0.4 0.2 0.7 0.8 0.5 30.2 0.5 3.3 1.7 1.1 0.3 1.1 0.1 0.4 2.2 1.3 0.2 0.4 0.1 0.2 0.0 0.0 0.3 3.5 0.2 1.2 3.4 1.6 1.6 1.0 0.8 0.3 0.0 3.3 0.5 0.2 1.7 0.3 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.2 0.0 0.1 7.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 2.0 0.2 0.2 0.0 0.5 58.9 0.0 0.2 0.1 0.1 0.3 0.0 0.6 0.4 0.3 0.0 0.0 1.3 4.7 0.2 0.4 1.1 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.5 0.0 0.0 5.0 0.0 0.1 0.1 0.0 0.0 5.1 1.4 2.9 0.2 0.7 0.7 0.0 0.3 0.0 0.6 0.4 0.4 0.7 0.4 0.4 0.1 0.9 0.2 0.4 0.0 0.4 0.2 0.1 0.5 0.2 0.8 0.7 0.8 1.1 0.7 0.8 1.7 1.1 1.3 1.2 1.0 1.7 0.3 0.0 0.0 0.0 4.1 0.3 0.1 0.4 0.0 0.1 0.4 0.3 0.4 2.8 0.3 0.0 0.0 0.2 1.7 0.1 1.9 0.3 0.3 0.0 0.3 0.2 0.0 0.4 0.9 0.0 0.2 2.5 0.5 0.1 0.0 0.1 5.7 8.2 2.3 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 2.1 0.0 0.2 0.5 0.2 0.2 0.0 0.1 15.8 0.5 6.3 0.0 0.0 0.3 1.0 0.9 0.1 0.1 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039233-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.8;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" "Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5" "Group enriched" "Detected in all" 6 "B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3" "Cell line enhanced" "Detected in many" "HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: AB_2681500" "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 4.7 1.3 3.2 12.1 3.2 19.8 3.9 3.0 3.8 3.5 3.5 2.5 3.3 2.4 1.7 1.8 3.3 3.5 2.9 2.8 2.9 2.0 1.3 4.6 26.1 3.4 3.3 1.2 0.8 0.6 1.1 3.2 3.2 2.7 2.7 0.1 1.7 1.2 2.5 2.1 8.2 2.1 3.5 15.8 3.3 1.5 3.3 25.2 2.7 3.0 17.2 3.2 3.8 4.0 2.1 2.1 1.6 1.2 2.6 8.0 0.4 0.5 0.3 0.5 0.6 3.9 1.9 6.8 6.5 1.6 2.2 0.8 5.0 0.5 0.5 13.3 4.0 2.2 5.9 1.8 4.1 2.6 0.8 27.7 0.2 2.4 0.2 0.1 16.2 33.1 1.5 8.9 2.1 3.1 30.0 4.1 0.0 1.7 14.8 30.9 3.6 3.9 0.7 1.1 5.7 0.0 2.7 0.7 0.7 0.2 0.7 4.9 9.9 0.5 0.0 0.8 2.5 4.4 6.7 3.3 3.6 117.7 1.4 5.6 3.5 1.7 53.9 2.5 63.5 34.3 56.1 59.9 3.5 32.9 96.3 72.1 3.2 24.8 8.1 5.2 66.5 26.6 3.2 3.2 3.0 3.8 2.8 2.9 3.4 3.3 3.2 3.5 3.3 4.0 32.2 0.0 9.9 0.0 23.8 3.7 1.4 0.3 2.2 0.1 1.9 2.2 1.3 4.3 1.5 0.0 0.0 0.4 36.4 0.5 0.0 0.1 4.0 1.1 5.0 24.8 1.8 8.2 0.0 0.0 1.1 7.2 1.5 0.8 15.2 4.1 38.2 1.4 8.7 0.0 0.0 0.1 2.0 18.2 5.6 1.5 1.5 7.5 7.2 0.0 7.1 0.2 47.4 0.0 0.0 0.1 0.0 0.4 7.8 1.2 1.0 0.4 2.0 0.0 0.0 3.4 3.7 0.7 1.6 1.2 2.3 0.4 66.0 0.3 0.5 1.4 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39055972 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.9" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 2.2 6.3 2.2 9.2 2.1 3.3 2.5 2.2 2.7 4.0 3.4 3.5 3.7 4.1 6.3 2.4 8.3 3.5 5.5 2.0 2.2 3.4 2.9 3.4 15.7 3.1 2.6 8.8 3.0 5.2 3.4 2.2 2.8 4.8 2.8 1.1 4.9 5.2 0.6 1.6 3.8 4.5 2.3 11.9 4.8 8.2 2.5 5.3 3.0 1.3 14.5 4.5 3.2 2.9 4.9 4.2 1.8 6.2 4.9 7.1 2.2 4.2 6.9 8.8 14.0 3.9 9.1 12.9 4.1 8.9 7.7 6.5 1.7 6.0 3.8 11.7 5.3 16.5 0.5 2.5 8.6 3.6 7.0 9.5 3.0 5.0 1.5 5.1 8.5 3.5 1.3 19.9 4.8 3.9 4.0 2.7 0.8 0.5 0.7 6.1 0.7 2.5 8.1 6.6 0.9 1.5 4.7 1.2 2.5 3.5 4.7 1.9 2.3 2.0 5.0 0.4 2.0 3.4 1.7 0.5 5.6 1.9 3.1 3.2 4.7 9.4 8.5 9.1 9.8 27.7 5.6 9.0 6.0 34.2 3.4 5.6 3.1 14.6 14.5 4.6 8.4 7.4 2.2 2.1 2.2 2.7 2.0 2.2 3.1 2.6 2.8 2.3 2.5 2.9 1.6 0.0 0.5 0.0 9.8 0.9 4.9 6.3 2.2 0.0 2.1 2.2 5.9 8.6 4.2 0.0 0.0 2.0 7.6 0.8 1.9 7.4 2.4 4.8 3.8 2.6 1.2 2.1 0.1 3.9 1.4 2.9 2.6 3.6 2.5 11.0 3.6 1.6 5.9 0.0 0.0 2.2 4.1 2.2 1.4 5.2 5.0 2.8 5.4 2.8 5.3 2.2 8.2 0.5 0.0 4.8 3.6 6.4 9.6 4.5 0.5 5.3 4.6 0.2 0.0 1.0 2.6 0.3 0.4 1.6 0.9 1.6 5.4 7.8 1.5 5.9 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077067-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 45.9" "Cell type enhanced" "Detected in many" "dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 5.5 8.1 3.3 21.7 3.2 15.9 8.6 3.4 4.6 7.7 2.9 7.6 5.5 10.3 10.4 6.1 21.1 11.1 4.3 3.0 4.0 4.1 5.7 14.5 45.9 3.9 3.7 22.7 1.7 4.8 3.5 5.0 3.9 7.8 9.4 1.4 8.5 22.4 1.2 1.6 9.6 9.6 4.0 28.2 10.0 20.1 3.4 25.9 5.8 2.7 35.1 15.7 6.4 4.5 4.5 0.1 0.0 0.0 5.0 9.7 0.3 1.0 16.8 19.9 30.0 1.6 22.6 38.3 0.5 7.3 11.6 0.1 0.2 1.3 6.0 31.8 0.1 23.1 0.0 0.2 21.8 7.1 10.1 14.3 0.5 10.9 2.4 0.0 2.4 1.2 1.9 44.2 3.1 0.0 7.6 7.7 0.6 0.0 1.7 15.3 0.0 25.8 0.0 19.6 0.0 0.0 0.5 0.0 2.0 1.7 0.0 13.2 0.0 2.8 0.2 0.0 0.0 0.0 3.5 0.5 3.2 6.9 5.0 30.7 42.3 28.7 363.8 98.1 207.6 84.9 108.8 281.7 52.4 66.1 34.3 160.2 34.8 232.2 123.0 28.1 92.3 297.8 3.3 3.2 3.4 4.6 3.0 4.0 3.9 3.7 3.9 4.0 3.4 4.5 8.4 3.2 8.9 1.0 55.7 1.8 15.5 27.0 4.6 0.4 3.0 6.6 3.7 7.2 14.4 0.0 2.1 3.9 145.4 0.6 5.9 11.7 47.2 5.7 6.4 8.9 6.0 8.6 0.1 2.3 1.1 10.0 2.0 3.9 12.6 62.5 11.4 0.9 30.6 0.0 0.1 1.9 10.2 20.4 9.8 13.7 19.0 21.3 7.2 3.7 69.1 8.1 251.3 0.5 0.0 2.2 1.8 9.1 69.5 16.0 0.1 2.1 12.1 1.2 19.7 4.7 10.1 1.3 1.6 2.0 1.3 1.0 120.5 20.3 1.5 18.0 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 72.8" "Cell type enhanced" "Detected in many" "B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 657.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favorable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 11.1 5.2 5.2 38.8 5.4 37.4 8.0 5.6 7.9 6.0 5.1 7.2 6.2 6.7 22.7 4.3 4.7 11.7 6.7 5.2 5.6 7.1 10.1 21.3 71.4 7.6 6.0 16.7 2.1 2.3 3.5 10.7 6.7 5.0 9.6 0.6 5.1 3.8 3.2 6.2 23.3 8.3 7.1 72.8 8.8 2.5 7.0 27.3 5.1 8.4 67.3 11.9 4.7 8.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 20.8 0.5 0.0 0.1 2.5 0.0 20.5 0.0 2.3 0.0 66.7 0.0 0.0 1.0 14.8 256.1 0.2 2.4 0.4 8.1 0.0 0.0 22.2 0.4 23.6 0.0 0.0 17.2 47.3 1.2 0.2 0.0 18.7 4.3 0.8 0.0 5.4 4.1 0.6 0.2 0.0 1.4 1.4 0.0 12.3 3.5 0.1 0.9 0.1 0.5 50.8 29.0 16.8 0.2 33.3 0.3 234.8 60.8 528.7 171.3 75.9 107.0 156.4 76.2 150.0 37.4 100.8 54.2 95.2 657.3 170.6 94.8 52.3 102.0 132.0 5.2 5.4 5.6 7.9 5.2 5.6 7.6 6.0 6.7 7.1 7.0 8.4 14.1 3.2 15.0 0.3 88.7 5.6 12.4 2.9 5.7 0.8 0.7 6.1 1.4 1.5 2.0 0.0 0.0 0.5 35.1 0.1 1.9 0.1 1.8 0.7 0.6 16.6 3.0 11.6 15.5 0.2 0.4 3.5 2.0 0.4 210.8 0.1 15.4 1.0 48.6 0.0 0.9 0.5 2.0 27.3 12.8 3.6 1.5 22.6 1.8 88.1 40.9 0.5 103.0 0.5 0.9 0.0 0.1 2.6 34.7 1.2 0.0 0.2 5.2 0.2 6.6 0.8 2.1 0.6 1.3 2.5 1.4 0.3 53.7 1.8 0.2 2.5 ARHGAP4 "C1, KIAA0131, p115, RhoGAP4, SrGAP4" ENSG00000089820 "Rho GTPase activating protein 4" P98171 X 153907367-153934999 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 119.1;lymphoid tissue: 120.9" "Cell type enhanced" "Detected in many" "B-cells: 65.3;dendritic cells: 70.0;Hofbauer cells: 86.6;Kupffer cells: 77.2;Macrophages: 76.0;NK-cells: 70.0;T-cells: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 103.0;HL-60: 76.7;Karpas-707: 90.8;MOLT-4: 93.0;RPMI-8226: 180.7;THP-1: 83.7;U-698: 90.4;U-937: 79.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA000301, HPA001012, HPA001083" Enhanced Supported Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 57: B-cells - Immune response" Cytosol "HPA000301: , HPA001012: AB_1078201, HPA001083: AB_1078199" "unprognostic (3.54e-2)" "prognostic favorable (3.94e-5)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.79e-2)" "unprognostic (9.42e-2)" "prognostic favorable (3.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.39e-1)" "unprognostic (3.27e-1)" "unprognostic (1.37e-1)" "unprognostic (7.81e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (8.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 20.0 12.5 5.2 52.2 5.4 119.1 13.4 6.9 6.5 9.9 15.0 18.6 14.2 9.7 3.1 7.0 12.9 14.4 10.3 5.7 6.3 22.6 8.6 36.2 73.8 10.9 8.3 5.4 5.9 1.7 8.6 21.2 9.3 11.1 6.9 1.2 9.2 3.8 4.3 5.0 49.7 6.5 8.2 120.9 12.6 7.2 8.5 42.7 10.9 1.5 33.7 11.6 9.2 10.0 1.5 0.6 1.0 5.9 0.2 0.0 2.5 1.0 0.4 0.1 0.2 0.4 42.8 103.0 5.9 0.1 0.8 1.2 4.6 0.2 0.0 27.8 3.4 44.4 0.5 1.7 3.6 76.7 59.7 0.2 0.4 0.0 0.3 0.5 9.1 22.4 0.5 90.8 0.5 4.6 93.0 1.5 3.7 0.4 0.3 44.6 12.0 180.7 0.4 0.7 8.4 12.1 0.9 2.1 0.9 1.2 19.0 83.7 1.9 0.3 1.3 0.9 0.5 60.1 55.8 90.4 0.7 79.9 0.2 10.9 26.1 35.4 26.2 42.4 18.6 18.0 18.8 21.1 25.5 16.9 17.4 17.4 22.4 16.0 59.4 31.6 23.5 26.1 5.2 5.4 6.9 6.5 5.7 6.3 10.9 8.3 9.3 8.2 8.5 10.0 16.0 9.6 22.7 2.6 65.3 3.4 0.6 0.2 0.0 13.7 2.4 6.1 48.3 1.5 2.7 18.4 4.2 1.9 70.0 9.5 5.9 0.9 0.1 2.4 1.4 13.0 4.8 11.3 2.1 0.6 1.9 3.5 7.1 1.5 34.2 7.7 4.2 0.5 86.6 3.3 1.4 6.6 0.0 77.2 31.5 0.2 0.9 76.0 10.6 19.7 42.5 1.9 70.0 2.0 0.7 0.2 0.5 0.0 32.9 0.5 3.0 0.8 8.7 4.6 0.0 7.1 2.6 0.7 5.2 1.6 1.7 1.4 69.5 1.1 5.0 0.4 ARHGAP9 "10C, MGC1295" ENSG00000123329 "Rho GTPase activating protein 9" Q9BRR9 12 57472264-57488814 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 119.7;lymphoid tissue: 100.7" "Cell type enhanced" "Detected in many" "dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 388.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA078822 Approved "Plasma membrane,Cell Junctions" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Cell Junctions" "HPA078822: " "unprognostic (1.02e-2)" "unprognostic (4.01e-3)" "unprognostic (1.91e-2)" "prognostic favorable (6.61e-5)" "unprognostic (1.24e-1)" "unprognostic (2.38e-3)" "unprognostic (4.79e-2)" "unprognostic (5.56e-3)" "unprognostic (1.28e-2)" "unprognostic (2.80e-1)" "unprognostic (3.05e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.90e-9)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" 10.8 4.2 4.2 34.3 6.1 119.7 4.1 8.1 11.1 2.6 4.7 7.7 8.2 3.4 1.6 4.6 7.4 10.5 3.9 4.4 5.3 5.1 7.5 22.0 56.9 7.8 5.8 1.6 3.5 0.6 2.2 5.2 8.8 4.3 10.7 0.5 4.7 1.8 1.3 2.2 37.6 5.9 5.6 100.7 8.8 19.3 6.1 34.9 4.5 6.4 60.7 9.5 3.6 6.4 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.4 0.5 0.1 0.2 0.1 0.0 14.3 0.3 0.3 0.0 0.2 0.4 0.0 0.0 0.7 0.0 27.6 0.1 0.0 1.1 16.4 116.2 0.7 0.0 0.0 0.3 0.2 0.0 14.3 0.5 7.9 0.0 0.0 22.5 22.1 1.0 0.0 0.0 9.1 10.2 4.6 0.0 0.1 3.9 3.0 0.0 0.0 0.4 0.5 0.0 34.9 0.9 0.2 0.3 0.1 0.1 9.2 7.2 13.3 0.3 27.3 0.5 51.9 86.1 243.4 43.3 89.2 30.0 35.9 47.3 39.6 72.1 44.0 61.9 46.0 388.9 68.2 71.0 97.4 63.6 70.8 4.2 6.1 8.1 11.1 4.4 5.3 7.8 5.8 8.8 5.6 6.1 6.4 2.2 0.0 14.2 1.0 49.1 1.5 0.2 0.0 1.8 0.2 1.6 2.9 2.1 1.5 1.3 0.0 2.1 0.4 171.0 0.6 0.0 0.2 96.8 0.6 0.8 1.5 0.0 11.6 3.7 0.0 0.6 2.4 4.6 0.8 12.0 0.0 3.6 1.2 43.5 0.0 1.9 0.5 0.0 39.0 19.7 44.8 1.8 35.1 0.0 8.4 34.8 0.0 123.6 0.0 0.2 0.2 0.1 0.0 50.8 0.2 0.0 0.3 2.2 0.7 0.0 0.6 1.2 89.0 17.5 0.4 1.4 0.3 108.2 0.3 0.4 0.1 ARL4C "ARL7, LAK" ENSG00000188042 "ADP ribosylation factor like GTPase 4C" P56559 2 234493041-234497081 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.0" "Cell type enhanced" "Detected in many" "dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028927 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" Cytosol "HPA028927: AB_10602387" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-3)" "prognostic unfavorable (2.90e-7)" "unprognostic (8.01e-3)" "unprognostic (3.35e-2)" "unprognostic (9.26e-2)" "unprognostic (2.68e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-2)" "unprognostic (3.17e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.69e-8)" "unprognostic (8.57e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.99e-5)" 15.1 10.6 15.4 31.7 14.6 65.0 17.3 17.8 18.6 11.4 45.3 9.1 6.6 5.8 9.5 23.2 11.9 31.8 5.1 13.1 21.9 12.2 12.8 16.1 55.3 21.9 17.1 2.1 5.5 10.8 7.4 16.5 21.3 10.3 11.2 9.7 21.6 5.4 1.5 24.1 13.2 5.9 12.8 51.0 13.6 1.2 18.5 74.0 3.7 1.7 32.1 25.5 18.0 13.8 32.3 97.4 12.0 1.6 10.4 3.0 31.6 3.2 13.8 3.8 6.6 45.4 60.4 0.1 8.0 7.7 109.0 23.5 12.0 66.4 4.1 30.4 4.2 0.0 0.6 0.6 10.7 0.1 2.8 6.4 42.2 36.6 21.2 149.4 6.4 78.4 0.4 102.4 16.4 4.4 93.7 0.3 12.6 22.5 21.9 0.3 54.1 18.0 284.8 35.2 44.1 8.1 1.1 7.1 4.7 18.2 0.9 1.9 14.8 60.0 23.2 168.2 61.6 51.1 19.7 1.6 101.9 0.1 32.0 79.8 1.2 27.4 86.7 1.6 85.6 18.1 60.0 69.5 10.3 18.3 53.5 59.1 2.2 61.2 0.9 55.2 83.8 30.0 15.4 14.6 17.8 18.6 13.1 21.9 21.9 17.1 21.3 12.8 18.5 13.8 12.3 73.7 15.9 8.8 63.6 124.8 120.7 18.4 145.1 156.6 40.4 64.6 10.9 67.2 27.0 14.7 8.4 30.0 610.9 2.3 0.0 19.6 7.8 73.9 19.2 23.4 1.8 6.1 15.5 5.7 5.4 23.7 19.9 186.3 27.8 1.1 11.0 3.4 31.4 107.7 103.0 2.5 0.0 208.4 474.5 6.5 0.3 182.1 42.7 6.5 41.8 32.2 437.7 6.0 2.5 16.5 0.1 0.0 132.6 60.4 0.1 0.9 4.7 13.1 0.0 7.0 19.3 0.7 1.9 65.4 42.9 14.6 349.8 0.4 1.2 46.6 ARMH1 "C1orf228, MGC33556, NCRNA00082, p40" ENSG00000198520 "Armadillo like helical domain containing 1" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.2;testis: 11.7" "Cell type enhanced" "Detected in some" "B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.4 1.1 1.7 0.2 2.2 2.2 0.7 1.1 2.6 0.8 4.5 0.5 0.2 1.7 3.5 0.5 8.2 0.7 0.2 2.3 1.3 0.9 4.2 1.0 0.6 2.6 4.0 2.6 0.5 1.9 3.3 0.3 2.1 0.8 0.3 4.2 0.7 0.6 0.1 0.8 0.3 0.3 1.8 0.3 0.7 11.7 1.9 0.4 0.6 0.0 0.3 0.3 0.3 2.2 0.2 0.3 1.8 0.1 0.5 2.1 0.5 0.0 0.2 0.5 0.3 0.4 3.8 0.2 0.2 0.8 0.9 0.5 0.0 0.0 0.0 1.0 0.2 0.9 2.6 0.6 0.2 6.9 4.1 1.7 0.2 0.7 0.0 1.3 0.2 0.3 0.1 0.7 0.2 0.0 4.9 7.5 0.1 0.5 0.0 2.7 0.1 2.2 0.7 0.0 1.2 0.8 0.0 1.2 0.9 1.2 0.3 3.6 0.0 0.3 0.3 0.3 0.0 0.3 0.1 0.2 0.3 9.9 0.4 8.7 2.1 6.1 0.2 0.7 0.1 0.6 1.1 0.8 1.0 0.9 1.6 1.5 1.0 0.4 0.0 4.8 0.0 1.4 1.7 2.2 1.1 2.6 2.3 1.3 2.6 4.0 2.1 1.8 1.9 2.2 0.5 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 3.7 0.0 0.4 1.3 0.0 1.9 0.7 0.0 13.1 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.7 0.0 6.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 5.2 0.9 0.0 0.0 ARRDC5 ENSG00000205784 "Arrestin domain containing 5" A6NEK1 19 4890437-4902896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 17.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 292.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 18 "REH: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 14: REH - Unknown function" "Cluster 34: Spermatids - Unknown function" "unprognostic (2.85e-2)" "unprognostic (3.83e-5)" "unprognostic (2.53e-1)" "unprognostic (7.22e-5)" "unprognostic (1.70e-1)" "unprognostic (7.16e-5)" "unprognostic (1.65e-2)" "unprognostic (1.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.03e-2)" "unprognostic (8.76e-2)" "unprognostic (6.45e-2)" "unprognostic (7.18e-8)" "unprognostic (1.76e-1)" "unprognostic (3.07e-1)" "unprognostic (1.95e-1)" "unprognostic (3.79e-2)" 0.1 0.1 0.4 0.6 0.4 1.6 0.1 0.2 0.7 0.1 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.3 0.4 0.1 0.1 0.5 1.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.4 2.1 0.2 17.0 0.8 1.6 0.1 0.0 0.6 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 1.1 0.3 0.6 1.0 0.2 0.8 0.5 0.7 1.0 1.1 0.0 0.6 0.1 1.4 0.5 0.3 0.4 0.4 0.2 0.7 0.3 0.4 0.7 0.5 0.5 0.4 0.8 0.9 0.0 0.0 0.0 0.3 2.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 8.4 0.1 0.0 0.0 292.2 0.3 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.3 1.0 0.0 0.4 0.0 0.0 3.5 0.6 61.0 1.2 2.2 0.0 13.1 3.0 0.0 15.5 0.0 0.3 0.1 0.0 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 5.9 1.0 0.0 0.1 0.0 4.1 0.0 0.0 0.4 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711487-44718851 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Immunity "Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 31919.3;NK-cells: 24726.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1790000000 2100000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 3160.2 3214.7 697.6 5686.5 705.1 7839.2 2606.9 711.8 1145.0 2539.9 789.6 5139.0 5180.7 2192.2 1735.6 2283.9 1648.3 4948.8 2327.2 651.0 769.9 2462.6 6206.2 6159.2 9311.8 889.5 763.2 1945.7 1310.9 1940.5 318.4 3502.0 815.3 2345.0 5593.5 139.3 5657.1 1784.5 931.7 3015.6 5693.3 2545.3 838.3 7896.1 4878.2 615.6 771.9 4217.4 2340.8 2026.5 5333.4 5753.1 549.4 909.5 1735.4 378.9 226.0 633.6 4348.7 4719.4 1662.5 2045.5 4961.9 3609.7 6561.4 425.3 5417.9 554.8 2567.9 1948.8 2410.2 2537.0 497.2 878.7 1226.2 4762.2 435.9 2956.9 2263.6 600.3 3609.3 2074.5 3328.6 2735.9 609.8 1075.7 1044.4 2442.6 1884.1 965.4 611.9 3649.1 2195.5 476.9 1518.4 3213.8 206.5 629.8 1014.3 2240.2 1926.6 4789.2 2425.5 3486.4 254.1 179.1 1288.4 1571.2 1338.5 394.3 655.3 6180.6 2548.7 4531.4 676.5 5389.2 2193.3 4771.7 7118.6 1683.1 5384.6 3783.6 2567.3 48105.4 18117.1 33178.9 20639.1 17775.0 20836.8 15768.0 23783.0 22245.1 9978.8 11988.4 17122.9 22791.8 50453.6 18779.6 19034.9 12052.6 29659.1 56957.2 697.6 705.1 711.8 1145.0 651.0 769.9 889.5 763.2 815.3 838.3 771.9 909.5 12048.3 3387.8 3505.1 28.7 8472.8 7843.7 3197.1 8420.8 1628.8 33.3 2399.5 2015.2 1068.8 3593.1 5347.4 2100.3 27.1 1354.6 14028.8 8753.6 1038.9 13898.6 43.1 2073.7 2414.0 8385.6 2266.0 2087.2 7.3 9034.5 4397.5 3691.1 1981.7 2282.2 3029.5 1270.6 6835.7 3832.6 11985.7 5.0 22.0 5982.6 8701.4 12536.8 14507.0 158.8 3018.0 10687.9 6744.8 368.2 31919.3 322.0 24726.3 95.0 129.2 10115.7 7085.6 1688.8 11026.6 5300.4 18327.7 3122.5 8367.9 52.5 4016.7 2055.2 4107.1 64.2 72.1 1541.4 8619.8 804.8 14266.2 3229.8 3063.4 8248.6 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "BAF chromatin remodeling complex subunit BCL11B" Q9C0K0 14 99169287-99272197 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9" "Group enriched" "Detected in many" 8 "gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0" "Lineage enriched" "Detected in single" 14 "T-cells: 4.6" "Group enriched" "Detected in some" 6 "JURKAT: 38.3;MOLT-4: 47.3" "Region enhanced" "Detected in many" "basal ganglia: 64.3" "Region enhanced" "Detected in many" "basal ganglia: 30.0" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favorable (7.48e-4)" 0.4 0.3 8.0 5.1 21.2 4.9 1.1 0.0 17.2 0.9 0.0 1.2 2.0 0.2 0.5 4.3 0.3 0.9 0.1 18.9 1.1 0.3 0.4 1.1 10.2 0.3 0.8 0.2 0.1 0.0 0.2 0.1 0.0 0.5 1.4 0.0 1.7 0.3 0.2 15.0 3.5 0.2 1.5 4.4 1.9 0.5 2.0 36.6 0.8 0.0 7.5 1.3 2.9 3.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 1.7 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.0 0.0 38.3 0.0 4.1 0.0 2.8 47.3 0.8 0.5 3.6 0.0 7.0 0.0 0.0 0.0 2.6 3.7 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.7 0.2 0.0 2.6 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.1 2.0 0.0 1.8 0.0 2.8 2.4 0.0 0.0 4.6 3.1 0.0 0.3 0.0 0.0 2.0 0.8 8.0 21.2 0.0 17.2 18.9 1.1 0.3 0.8 0.0 1.5 2.0 3.9 1.3 3.2 0.0 1.3 6.4 62.8 1.6 6.3 73.4 0.4 4.3 4.4 3.8 4.3 1.3 0.0 0.0 0.1 44.2 3.8 1.9 0.2 0.2 0.2 0.2 1.2 1.2 5.3 57.5 0.5 0.0 3.3 2.0 0.3 5.1 0.2 3.3 0.3 0.3 0.0 105.7 4.9 2.0 1.0 11.4 0.4 0.6 4.0 5.4 1.0 4.9 0.0 51.5 32.2 2.0 1.1 5.4 0.0 24.4 0.6 10.1 0.5 0.3 0.1 0.0 0.5 1.9 1.6 5.8 42.7 71.3 0.0 133.4 0.1 9.7 0.6 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133400056-133475222 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "T-reg: 13.4" "Lineage enriched" "Detected in single" 43 "T-cells: 13.4" "Group enriched" "Detected in some" 6 "Daudi: 2.4;U-698: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.1 5.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.6 0.0 1.0 0.1 0.1 0.0 BIN2 BRAP-1 ENSG00000110934 "Bridging integrator 2" Q9UBW5 12 51281038-51324668 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 101.3;lymphoid tissue: 48.7" "Cell type enhanced" "Detected in many" "dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038666, HPA038667" Enhanced Enhanced "Plasma membrane" NA NA 19000000 "Cluster 38: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "HPA038666: AB_2676139, HPA038667: AB_2676140" "unprognostic (8.44e-3)" "prognostic favorable (1.33e-4)" "unprognostic (2.48e-1)" "prognostic favorable (6.34e-4)" "unprognostic (4.63e-1)" "unprognostic (2.00e-3)" "unprognostic (1.21e-1)" "unprognostic (3.59e-2)" "unprognostic (3.72e-2)" "unprognostic (7.47e-2)" "unprognostic (5.71e-2)" "unprognostic (3.29e-1)" "unprognostic (1.65e-3)" "unprognostic (4.03e-1)" "unprognostic (3.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-1)" 7.1 3.7 3.6 32.5 3.5 101.3 3.3 3.6 4.8 3.6 4.2 8.9 6.2 2.1 1.0 3.2 3.1 9.2 2.3 3.2 3.8 3.0 7.3 16.4 41.9 5.9 4.7 1.7 1.3 1.0 1.1 19.5 5.1 2.1 9.2 0.4 3.4 2.0 1.5 1.3 10.7 6.4 4.4 48.7 7.4 7.9 6.4 48.6 2.2 4.3 36.4 10.1 2.0 6.2 0.1 0.1 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 38.3 0.1 82.6 0.0 0.0 0.0 34.7 134.9 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.1 59.1 0.0 0.5 24.2 140.8 0.1 0.1 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.2 117.4 0.1 0.0 0.1 0.1 0.1 31.5 0.1 8.0 0.1 76.8 0.0 663.7 199.8 245.9 281.0 311.8 227.7 49.2 188.9 237.2 107.2 74.0 145.4 193.5 380.1 235.6 411.7 39.7 267.1 479.5 3.6 3.5 3.6 4.8 3.2 3.8 5.9 4.7 5.1 4.4 6.4 6.2 1.5 3.2 17.6 1.3 54.0 0.6 0.1 0.0 0.0 0.1 1.3 1.5 0.6 1.5 2.6 1.8 0.0 103.9 213.6 4.5 17.6 0.1 26.5 0.1 0.2 3.5 1.2 16.2 0.7 0.0 172.1 2.7 3.1 0.2 56.3 0.1 8.2 1.2 56.9 0.0 0.6 8.5 0.0 73.0 22.3 25.7 0.6 111.2 1.8 44.0 77.6 0.0 598.3 2.0 0.6 0.0 4.6 0.4 51.3 0.1 0.1 1.6 3.7 0.1 0.0 1.0 0.9 39.6 11.3 0.4 0.6 158.6 165.7 0.1 5.4 0.1 BTN2A2 "BT2.2, BTF2, BTN2.2" ENSG00000124508 "Butyrophilin subfamily 2 member A2" Q8WVV5 6 26383096-26394874 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 30.3;Plasma cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 72.8;U-266/70: 58.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA051504 Uncertain Approved Mitochondria NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 57: B-cells - Immune response" Mitochondria "HPA051504: AB_2681510" "prognostic favorable (1.01e-4)" "unprognostic (4.93e-3)" "unprognostic (1.37e-2)" "unprognostic (6.78e-2)" "unprognostic (9.26e-2)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.04e-3)" "unprognostic (1.01e-1)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (1.93e-1)" "unprognostic (1.73e-2)" "unprognostic (3.45e-1)" "unprognostic (6.54e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" 7.2 13.5 5.4 21.9 6.9 4.3 8.7 14.4 6.0 7.9 21.2 8.0 7.2 10.2 7.5 5.1 8.4 8.5 4.9 6.8 5.9 7.5 6.1 16.2 32.1 7.5 6.9 10.4 5.2 17.5 5.7 4.0 7.8 8.3 10.5 2.9 12.1 6.8 2.8 11.0 11.3 10.9 6.5 21.8 10.4 6.1 6.2 15.2 7.5 4.2 36.6 8.2 6.9 6.9 10.6 6.6 13.2 14.2 4.4 6.8 0.9 11.4 29.7 17.4 30.0 4.2 4.1 9.6 12.1 20.5 14.1 9.5 10.7 8.7 23.1 29.9 17.9 15.0 13.2 8.4 9.1 3.4 5.1 14.5 2.7 33.5 11.3 20.7 16.3 18.5 12.3 72.8 7.9 4.6 12.1 4.4 5.0 0.4 6.6 28.1 18.7 29.8 12.7 5.9 12.6 17.6 7.4 2.8 31.1 7.5 13.5 6.6 19.5 6.4 7.3 5.6 17.7 58.9 38.8 16.9 6.4 13.4 16.3 2.1 13.7 2.4 6.1 14.6 5.8 24.1 5.0 5.7 23.9 29.4 4.1 5.1 12.4 8.7 6.3 9.7 10.3 7.9 5.4 6.9 14.4 6.0 6.8 5.9 7.5 6.9 7.8 6.5 6.2 6.9 8.1 9.6 12.6 0.0 30.3 3.8 7.3 6.5 6.2 0.6 5.2 5.1 2.5 2.8 8.5 3.7 0.0 2.3 15.0 0.6 0.0 8.6 0.4 8.8 4.5 13.1 1.8 3.6 0.0 5.6 0.8 5.0 3.6 7.5 19.6 9.6 6.1 3.8 8.4 0.0 0.0 7.8 12.2 16.0 24.2 0.6 6.5 17.1 7.2 0.0 15.4 14.3 7.2 0.0 0.0 8.3 0.8 4.9 30.7 6.4 2.6 2.3 10.2 0.7 0.0 5.0 4.4 0.3 1.5 4.5 4.5 1.0 10.0 10.6 2.1 4.2 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415208 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 59.1;NK-cells: 73.2;Plasma cells: 47.6;T-cells: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA012565 Approved Uncertain Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavorable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favorable (4.81e-4)" 19.2 20.7 10.2 44.8 11.1 29.6 20.1 9.8 10.5 21.2 10.3 24.8 28.5 28.0 16.0 11.9 22.5 30.5 12.1 9.1 12.1 12.8 18.9 41.4 63.4 16.4 10.9 35.1 13.1 13.1 13.7 19.2 12.5 16.5 28.8 3.6 23.9 13.5 12.8 24.9 35.1 21.3 12.2 84.0 31.3 5.0 11.4 33.1 11.5 14.5 52.6 20.0 17.4 12.0 7.4 6.2 9.3 9.5 25.9 27.5 1.2 6.2 24.1 13.5 39.4 0.3 16.7 19.7 20.4 11.2 20.9 5.1 3.0 9.7 8.2 19.5 6.4 10.4 8.5 4.7 11.8 9.5 9.3 15.0 5.6 11.8 5.4 20.4 19.3 31.0 2.5 25.3 5.5 0.6 17.6 6.6 1.0 3.3 2.1 24.2 4.0 45.2 8.3 9.4 4.9 9.8 3.4 7.1 13.5 1.4 6.5 4.0 4.8 10.3 2.6 3.1 5.9 41.8 45.9 7.3 15.6 21.4 8.4 53.8 11.1 28.8 44.7 11.7 40.4 18.8 27.8 42.3 9.1 10.5 24.1 32.0 23.9 40.5 12.9 4.3 36.0 28.0 10.2 11.1 9.8 10.5 9.1 12.1 16.4 10.9 12.5 12.2 11.4 12.0 24.8 16.0 6.5 0.0 27.1 4.2 3.9 3.5 2.2 4.3 8.6 8.1 4.2 11.5 8.5 5.5 0.0 5.5 59.1 8.2 0.0 7.4 0.1 5.5 10.4 18.0 4.8 13.3 0.0 3.2 4.3 9.9 9.2 10.3 25.9 14.0 11.7 3.9 7.2 0.0 0.0 17.3 2.0 19.2 6.1 0.8 3.7 15.4 1.8 0.0 13.7 1.9 73.2 0.0 0.0 2.2 6.3 2.6 47.6 5.4 15.9 1.3 6.7 0.4 0.0 6.7 5.5 0.0 0.1 3.6 3.3 1.5 50.1 8.4 7.4 5.0 C12orf42 FLJ25323 ENSG00000179088 "Chromosome 12 open reading frame 42" Q96LP6 12 103237591-103495978 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 17.2" "Group enriched" "Detected in some" 13 "Early spermatids: 398.6;Late spermatids: 372.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.1;naive B-cell: 5.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "unprognostic (9.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.96e-2)" "unprognostic (1.05e-2)" "unprognostic (2.66e-1)" "unprognostic (9.83e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (8.96e-4)" "unprognostic (4.89e-2)" "unprognostic (2.20e-3)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-2)" "unprognostic (3.30e-1)" 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 17.2 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.1 1.3 1.6 0.2 5.3 1.4 1.5 0.0 0.0 0.0 1.1 2.2 1.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.5 27.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 398.6 0.0 0.0 0.2 0.0 0.0 8.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.2 372.8 2.8 0.9 0.0 12.2 0.3 0.0 0.0 24.6 0.7 0.0 1.1 1.5 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 10.7 2.3 0.0 0.0 0.0 3.3 0.0 0.0 0.1 CAMK4 "CaMK-GR, CaMKIV" ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 70.4;lymphoid tissue: 55.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 70.9;Early spermatids: 306.2;Excitatory neurons: 212.2;Inhibitory neurons: 131.8;Late spermatids: 108.4;Oligodendrocyte precursor cells: 133.2;T-cells: 83.3" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "basal ganglia: 30.6;cerebellum: 70.4" "Group enriched" "Detected in many" 4 "MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3" "Lineage enriched" "Detected in many" 23 "T-cells: 33.1" "Cell line enhanced" "Detected in many" "HDLM-2: 88.9;JURKAT: 61.3;MOLT-4: 27.9;SH-SY5Y: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 0.4 3.8 5.0 4.4 30.6 3.1 0.4 70.4 8.2 0.9 0.0 1.3 1.4 0.6 0.3 0.7 0.3 1.5 0.1 7.6 0.0 0.7 1.4 1.1 8.1 0.0 0.4 0.6 0.4 0.0 0.6 0.2 1.4 3.4 1.4 4.7 0.4 1.4 0.1 0.1 2.3 0.8 0.0 2.6 1.5 9.4 0.8 55.4 0.2 0.0 5.2 1.7 0.4 0.0 0.0 0.0 3.1 2.1 0.6 2.3 0.0 0.8 6.8 8.0 7.8 0.0 0.1 0.0 4.0 0.4 5.4 0.3 6.8 0.8 5.8 88.9 5.2 1.3 2.8 0.0 0.2 0.6 0.3 0.3 0.0 16.8 1.7 4.9 1.4 61.3 0.0 3.3 0.4 0.0 27.9 0.0 4.1 0.0 0.2 4.0 5.0 0.2 2.9 0.1 18.8 33.5 1.2 0.0 5.6 0.2 0.1 0.5 0.1 16.3 9.5 0.1 14.7 2.6 0.3 0.0 8.0 0.0 6.3 0.1 0.0 0.0 4.8 0.0 24.3 1.3 17.3 13.5 0.0 0.3 33.1 18.5 0.9 1.4 0.0 0.1 21.3 5.5 5.0 30.6 70.4 8.2 7.6 0.0 0.0 0.4 1.4 0.0 0.8 0.0 1.8 0.0 1.1 57.8 9.4 1.1 0.3 1.3 8.6 70.9 0.6 0.6 5.3 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.1 306.2 0.2 1.6 1.1 0.0 0.0 212.2 0.0 0.2 4.6 3.6 0.4 4.5 0.3 0.7 0.3 0.2 0.0 131.8 0.8 0.0 1.3 2.1 108.4 4.1 2.0 0.0 12.2 2.7 2.8 1.0 133.2 5.4 1.2 0.0 1.5 11.5 0.5 0.0 0.1 0.1 4.3 0.0 0.6 3.8 30.3 6.2 2.4 1.0 0.0 83.3 0.1 0.0 0.3 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 126.0;lymphoid tissue: 91.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2" "Region enhanced" "Detected in all" "olfactory bulb: 18.4" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 20.4 10.5 8.7 59.1 8.8 36.3 21.9 9.3 14.6 11.9 9.8 47.7 124.6 8.7 12.0 27.2 12.3 27.4 12.2 8.5 9.6 13.3 21.6 48.3 52.1 11.2 9.4 11.7 6.4 2.7 5.0 30.0 11.1 13.0 49.7 1.1 20.8 12.5 6.2 30.9 126.0 20.8 10.7 91.0 22.5 2.4 10.7 23.2 7.8 7.3 35.5 35.7 19.4 11.9 1.3 0.3 0.0 5.3 5.8 12.1 1.0 5.7 112.7 14.0 38.5 0.2 0.7 18.7 2.3 6.6 25.7 8.1 0.0 53.8 3.3 12.3 0.0 0.9 0.7 1.3 58.2 22.1 0.2 20.9 37.4 11.4 30.3 36.2 6.1 0.3 0.2 0.0 3.4 0.0 0.6 30.7 0.0 0.1 0.3 18.1 0.4 14.9 0.3 8.9 0.4 0.4 16.9 1.1 26.2 0.1 1.2 50.1 7.2 12.8 0.6 1.2 1.6 0.1 5.4 0.1 8.1 136.2 2.7 83.8 246.1 134.9 132.9 359.9 178.5 40.2 92.7 115.8 220.2 35.5 50.2 82.7 220.0 63.0 383.0 7.7 129.0 213.3 8.7 8.8 9.3 14.6 8.5 9.6 11.2 9.4 11.1 10.7 10.7 11.9 26.3 19.2 30.0 0.0 27.2 26.0 42.5 91.5 14.2 0.1 5.8 23.0 2.9 8.6 37.7 11.0 0.0 2.1 34.1 33.1 1.9 23.3 0.2 5.8 2.5 24.0 6.0 10.3 0.2 12.9 1.3 17.8 11.7 3.4 15.8 0.2 22.9 3.1 96.5 0.0 0.0 50.6 14.2 125.3 120.7 1.3 3.4 136.6 5.4 12.2 185.6 0.1 64.9 0.0 0.1 5.3 73.4 3.4 20.0 8.7 116.0 2.2 28.4 0.2 0.0 1.0 8.1 0.0 0.1 17.9 22.3 1.1 58.4 3.3 90.5 43.6 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 33.9" "Cell type enhanced" "Detected in many" "dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 37.0" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favorable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 4.5 1.4 5.9 19.4 23.9 31.2 6.9 3.2 7.1 4.0 2.5 9.4 13.3 3.1 1.6 12.5 12.2 6.2 4.0 3.6 3.9 6.8 3.6 9.7 33.9 5.6 6.7 1.0 8.3 5.3 5.2 2.4 4.6 9.4 7.0 1.0 10.1 3.9 2.3 7.0 11.7 2.3 4.3 21.7 12.4 8.0 7.8 20.4 2.5 2.7 20.4 8.1 7.6 3.2 8.5 6.9 7.5 9.5 0.0 0.0 34.9 0.0 0.0 0.0 0.0 6.8 13.4 45.1 6.1 0.0 0.4 0.4 11.3 6.4 0.0 28.8 4.7 10.0 4.8 9.9 0.7 23.0 8.4 0.0 11.4 0.0 0.0 0.7 8.6 55.6 11.2 50.1 0.1 24.9 24.2 29.6 7.1 6.2 11.5 19.5 0.2 14.2 2.6 10.2 53.6 11.6 4.6 16.9 4.6 5.6 10.2 20.7 2.6 0.0 0.2 0.1 0.1 58.5 76.2 22.8 0.0 20.1 0.1 7.8 3.3 1.3 9.4 1.9 8.8 2.5 6.0 9.2 1.8 2.1 3.8 5.8 2.3 4.0 3.0 2.0 10.7 4.1 5.9 23.9 3.2 7.1 3.6 3.9 5.6 6.7 4.6 4.3 7.8 3.2 26.6 3.2 28.8 7.8 54.1 9.3 15.9 19.0 27.9 0.0 15.3 7.6 19.8 10.0 22.1 14.7 0.0 3.6 80.1 29.6 0.0 4.4 9.6 62.6 1.4 17.3 23.9 20.6 7.1 5.9 2.2 4.2 20.4 12.1 2.5 1.3 20.3 1.6 6.3 0.0 2.5 15.3 22.4 21.0 12.4 18.7 4.1 18.9 1.8 9.4 20.1 8.0 142.2 8.0 5.2 7.8 18.2 3.0 93.2 16.8 13.1 13.2 112.5 0.1 0.0 2.9 4.4 4.7 17.4 31.2 9.5 1.8 89.2 3.3 19.4 19.8 CCL4 "Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4" ENSG00000275302 "C-C motif chemokine ligand 4" P13236 17 36103827-36105621 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 192.9" "Cell type enhanced" "Detected in many" "dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 414.7" "Group enriched" "Detected in all" 6 "granulocytes: 135.0;T-cells: 414.7" "Group enriched" "Detected in some" 6 "U-266/70: 51.6;U-266/84: 13.3" CAB007805 Approved "Secreted to blood" NA NA 144000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB007805: AB_598177" "unprognostic (6.03e-2)" "unprognostic (2.48e-2)" "prognostic favorable (3.54e-4)" "prognostic favorable (1.97e-5)" "unprognostic (2.06e-1)" "unprognostic (7.02e-2)" "unprognostic (9.08e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-1)" "unprognostic (8.57e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (3.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-2)" 38.9 28.0 2.0 32.0 2.0 192.9 10.5 3.4 5.5 16.0 4.1 9.9 7.6 10.3 6.4 15.0 8.2 45.1 4.4 2.0 1.9 6.8 84.2 33.9 34.3 3.2 2.9 5.0 15.6 12.0 2.5 17.8 2.8 7.6 11.1 0.1 5.1 3.4 1.0 0.9 11.4 18.0 2.5 65.3 10.3 2.7 2.1 24.1 5.9 4.5 15.4 56.4 4.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 51.6 13.3 0.2 0.2 0.1 0.0 14.4 3.4 135.0 414.7 4.8 101.6 8.4 46.0 240.6 2.3 17.7 13.8 181.7 55.8 42.8 11.1 2.6 0.5 138.9 2.0 2.0 3.4 5.5 2.0 1.9 3.2 2.9 2.8 2.5 2.1 3.3 52.3 0.0 54.5 0.0 135.9 15.6 1.9 0.3 24.5 1.5 26.3 49.3 11.2 14.3 7.2 0.0 0.0 9.7 3753.7 1.2 0.0 0.4 20.8 3.7 4.7 77.6 1.2 60.9 0.0 0.4 11.3 18.9 118.3 5.5 60.8 0.2 21.4 10.5 849.7 1.7 0.0 1.5 0.0 429.4 428.0 32.6 0.9 1168.2 51.6 3.7 10.5 1.1 1232.8 0.0 0.0 0.2 0.1 0.4 974.5 0.8 0.4 2.8 5.8 5.2 0.0 3.9 20.9 0.4 0.4 11.0 14.5 25.9 1948.3 0.0 0.9 1.6 CD1C CD1 ENSG00000158481 "CD1c molecule" P29017 1 158289923-158294774 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 130.4" "Cell type enriched" "Detected in some" 6 "Langerhans cells: 551.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory B-cell: 84.1;myeloid DC: 324.9" "Group enriched" "Detected in many" 8 "B-cells: 84.1;dendritic cells: 324.9" "Group enriched" "Detected in some" 10 "JURKAT: 14.8;MOLT-4: 49.4" HPA068359 Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA 200000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus, Vesicles" "Endoplasmic reticulum" "HPA068359: " "unprognostic (2.55e-3)" "prognostic favorable (1.79e-5)" "unprognostic (1.75e-5)" "unprognostic (3.09e-5)" "unprognostic (3.12e-2)" "unprognostic (8.13e-3)" "unprognostic (2.01e-1)" "unprognostic (3.80e-3)" "unprognostic (7.11e-3)" "unprognostic (1.87e-1)" "unprognostic (7.41e-2)" "unprognostic (1.93e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (8.05e-2)" "unprognostic (1.99e-1)" 2.7 0.8 0.0 17.3 0.0 1.1 5.0 0.0 0.2 2.3 0.0 3.4 2.0 2.4 0.6 4.5 1.8 7.7 2.0 0.0 0.0 1.2 4.1 6.5 26.2 0.0 0.0 0.9 0.7 0.6 0.2 0.1 0.0 1.8 9.4 0.0 2.8 1.3 1.0 12.2 12.0 3.1 0.0 23.0 3.7 0.9 0.0 130.4 0.7 1.1 38.2 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 49.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 0.6 26.8 0.1 0.1 24.7 0.3 84.1 0.1 0.0 324.9 49.1 0.2 0.0 1.1 4.1 3.7 1.5 0.5 15.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.2 0.0 26.6 13.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.1 0.0 0.1 1.5 0.0 0.8 0.0 0.0 0.1 1.4 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 7.1 551.4 4.5 0.0 91.2 19.6 0.0 11.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.5 0.0 0.0 0.2 0.4 0.1 0.3 0.0 7.4 0.0 1.9 0.0 0.0 0.0 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754430-116769229 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 249.8" "Group enriched" "Detected in many" 6 "dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 6 "gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2" "Group enriched" "Detected in all" 10 "NK-cells: 1108.0;T-cells: 714.1" "Group enriched" "Detected in some" 25 "HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002430, HPA003883" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 4.6 4.6 0.6 51.3 0.7 11.4 7.6 0.6 1.0 5.8 0.8 13.9 17.2 3.7 2.8 8.4 4.2 16.8 2.6 0.5 0.8 2.5 7.8 21.0 119.6 1.7 0.7 2.8 2.9 0.9 0.7 1.0 1.1 5.2 16.0 0.0 8.6 2.3 1.4 3.5 28.4 4.4 1.0 44.1 24.1 1.8 1.0 249.8 3.8 1.7 79.1 20.8 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 224.1 0.0 0.4 0.0 0.0 0.0 0.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 145.8 0.1 0.5 0.0 0.0 166.9 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.8 0.4 0.0 11.3 5.2 1.6 421.8 3.7 403.1 3.8 610.2 714.1 95.4 2.5 316.3 486.2 14.1 1108.0 2.8 21.0 655.2 565.1 0.6 0.7 0.6 1.0 0.5 0.8 1.7 0.7 1.1 1.0 1.0 1.1 5.0 3.2 17.5 0.0 12.3 5.0 0.4 0.0 2.2 0.0 4.0 4.7 2.1 0.0 2.5 3.7 0.0 0.1 158.3 0.2 0.0 0.5 23.5 1.1 1.0 2.9 3.0 24.0 0.0 0.0 0.0 2.5 10.7 0.9 5.1 0.0 8.2 1.5 0.6 0.0 0.0 0.0 0.0 10.9 16.6 7.8 0.6 19.1 1.8 1.0 15.5 0.0 178.2 0.0 0.0 0.0 0.0 0.4 42.3 0.1 0.0 1.7 0.0 0.0 0.0 2.9 4.1 0.3 0.2 0.4 3.7 0.0 476.8 0.0 0.5 0.2 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 20.2;parathyroid gland: 62.4" "Cell type enhanced" "Detected in many" "dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3" "Group enriched" "Detected in many" 11 "NK-cells: 29.7;T-cells: 36.6" "Group enriched" "Detected in some" 6 "HEL: 100.0;HMC-1: 42.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 20000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.1 0.6 1.1 5.7 6.4 4.4 1.5 1.5 2.4 1.1 0.0 1.8 2.3 1.3 0.5 1.6 1.3 3.0 0.5 0.7 2.0 1.5 4.2 4.2 9.7 3.1 3.3 0.9 0.5 62.4 0.6 0.5 3.2 1.0 2.4 1.4 1.5 0.4 0.7 0.3 3.1 1.6 2.2 20.2 3.2 1.2 5.5 6.4 0.7 0.6 7.1 3.1 0.4 3.2 0.0 0.1 0.3 0.3 0.0 0.0 0.1 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.4 0.2 5.3 0.1 100.0 0.3 0.1 0.0 0.7 42.6 0.0 1.1 0.2 0.6 0.2 0.0 0.9 0.3 9.3 0.4 0.0 0.8 0.4 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.8 0.3 0.1 0.2 11.5 0.4 0.0 0.3 0.2 0.5 0.3 0.1 1.2 36.6 1.0 13.4 0.8 28.8 22.5 2.9 0.1 15.8 17.3 1.6 29.7 1.3 0.1 11.3 13.2 1.1 6.4 1.5 2.4 0.7 2.0 3.1 3.3 3.2 2.2 5.5 3.2 0.6 3.2 3.6 3.3 3.2 0.0 0.3 0.0 0.0 3.4 0.5 0.8 2.5 0.0 0.7 0.0 0.0 0.1 52.1 0.2 0.0 0.0 8.4 0.9 1.7 1.0 0.0 3.2 4.6 0.4 0.0 1.3 3.1 0.5 13.9 1.3 3.3 0.4 1.6 0.0 3.1 0.1 0.0 16.7 2.7 8.2 0.9 24.4 0.0 22.5 14.7 0.8 90.6 2.0 26.6 0.2 0.1 0.7 13.4 0.3 0.0 0.3 1.5 3.6 0.0 1.8 0.6 0.4 0.8 0.0 0.4 0.0 43.2 0.5 0.1 0.2 CD27 "S152, TNFRSF7, Tp55" ENSG00000139193 "CD27 molecule" P26842 12 6444955-6451718 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 147.8" "Group enriched" "Detected in many" 11 "B-cells: 119.4;Melanocytes: 97.8;Plasma cells: 352.1;T-cells: 109.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in all" "T-reg: 640.4" "Group enriched" "Detected in all" 7 "B-cells: 293.4;T-cells: 640.4" "Group enriched" "Detected in some" 107 "Daudi: 238.2;U-698: 141.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002420, HPA038936" Enhanced NA NA 100000 "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB002420: AB_563539, HPA038936: AB_2676278" "unprognostic (2.75e-3)" "prognostic favorable (3.77e-5)" "unprognostic (8.87e-3)" "prognostic favorable (2.90e-4)" "unprognostic (2.35e-1)" "prognostic favorable (6.65e-7)" "unprognostic (3.56e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.50e-4)" "unprognostic (1.31e-3)" "unprognostic (4.32e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.80e-1)" "unprognostic (3.15e-1)" "unprognostic (1.28e-1)" "unprognostic (7.35e-2)" 2.1 2.6 0.3 59.0 0.5 10.6 4.3 0.0 0.5 2.4 0.1 18.0 22.5 1.7 1.0 10.2 1.9 11.0 3.9 0.1 0.1 1.3 2.0 8.2 147.8 0.5 0.2 3.0 1.4 0.0 0.3 0.4 0.8 2.5 11.6 0.4 12.3 1.4 0.6 1.9 34.5 1.6 0.2 73.8 16.6 0.9 0.4 44.7 6.5 0.7 106.3 19.0 1.4 1.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 238.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.8 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.5 0.1 0.0 0.0 0.0 141.7 0.3 0.1 0.0 6.2 1.6 1.4 117.2 1.3 201.2 293.4 283.5 262.6 1.0 114.8 382.8 281.1 6.2 65.0 1.6 2.4 640.4 182.4 0.3 0.5 0.0 0.5 0.1 0.1 0.5 0.2 0.8 0.2 0.4 1.0 1.1 0.0 4.9 0.3 119.4 2.3 0.1 0.0 0.6 1.1 1.1 1.3 0.1 0.0 0.6 0.0 0.0 0.1 7.0 0.3 0.0 0.2 0.0 0.2 0.3 0.9 1.2 8.4 0.2 0.0 0.0 1.5 3.1 0.3 1.3 0.0 2.5 1.5 0.3 0.0 0.3 0.1 0.0 3.2 4.4 0.3 0.3 3.0 97.8 0.0 5.7 0.4 14.4 1.0 1.0 0.0 0.1 0.4 352.1 0.2 0.0 0.9 0.8 1.4 0.0 0.7 1.3 0.1 0.1 0.6 3.1 0.3 109.5 0.0 2.4 0.0 CD28 ENSG00000178562 "CD28 molecule" P10747 2 203706475-203738912 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 30.8;placenta: 14.8" "Group enriched" "Detected in some" 5 "Hofbauer cells: 34.1;T-cells: 52.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 101.9" "Lineage enriched" "Detected in many" 7 "T-cells: 101.9" "Group enriched" "Detected in some" 14 "Karpas-707: 360.6;RPMI-8226: 173.2;U-266/70: 294.1;U-266/84: 283.7" "Region enhanced" "Detected in single" "olfactory bulb: 1.0" "Not detected" "Not detected" HPA070003 Enhanced NA NA "Cluster 13: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA070003: AB_2686226" "unprognostic (5.54e-2)" "unprognostic (2.16e-4)" "unprognostic (1.90e-3)" "unprognostic (2.49e-3)" "unprognostic (3.44e-2)" "unprognostic (6.07e-5)" "unprognostic (9.09e-2)" "unprognostic (4.66e-2)" "unprognostic (3.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-1)" "unprognostic (1.68e-1)" "unprognostic (5.78e-5)" "unprognostic (4.77e-2)" "unprognostic (2.93e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-2)" 4.0 0.3 0.0 14.9 0.1 3.3 0.8 0.1 0.1 1.1 0.9 1.7 1.1 0.7 0.3 0.9 0.5 4.1 0.6 0.1 0.1 0.5 1.3 1.9 28.0 0.1 0.0 0.3 0.5 0.2 0.1 14.8 0.1 1.0 1.9 0.1 0.6 0.8 0.3 0.3 3.0 1.4 0.1 7.2 2.5 0.7 0.2 30.8 0.5 0.1 18.6 4.6 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.7 2.0 0.0 360.6 0.2 0.0 19.9 0.0 0.1 0.0 0.0 0.1 0.3 173.2 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.3 294.1 283.7 2.9 0.3 0.1 0.0 1.7 0.6 1.0 8.3 0.5 50.6 0.3 54.5 26.1 0.1 0.3 48.1 18.6 13.8 0.2 0.5 0.2 101.9 14.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.5 0.0 1.3 0.0 2.4 2.9 0.1 0.0 0.6 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 3.2 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.3 1.0 2.0 0.1 1.3 0.0 0.0 0.1 34.1 0.0 0.0 0.0 0.0 0.8 5.3 0.2 0.0 4.4 0.0 1.0 1.5 0.0 2.1 0.0 0.1 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.2 1.6 0.1 52.6 0.0 0.0 0.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466399-74484794 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 95.2" "Cell type enhanced" "Detected in some" "dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 10.6 7.5 6.7 31.1 7.1 24.4 4.6 7.1 31.1 2.8 7.5 9.2 11.3 3.5 1.8 3.5 3.1 14.2 4.7 6.9 7.8 3.5 14.6 18.1 27.0 11.4 8.6 1.5 3.2 1.4 3.6 13.9 13.2 4.0 8.6 1.0 4.0 2.5 1.6 4.5 13.5 11.7 9.2 95.2 4.9 1.2 12.1 14.1 2.3 2.7 11.7 9.5 2.6 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 5.5 104.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.5 45.9 0.0 0.0 0.0 0.2 0.0 88.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 17.1 0.0 845.6 170.3 481.9 226.4 374.2 48.3 18.9 45.5 67.5 159.2 6.4 16.7 52.5 560.5 456.5 387.6 149.7 3.1 197.0 6.7 7.1 7.1 31.1 6.9 7.8 11.4 8.6 13.2 9.2 12.1 12.5 1.0 0.0 7.4 0.3 7.8 0.9 0.1 0.2 0.0 0.0 0.6 1.8 0.6 1.5 0.7 0.0 0.0 0.7 103.5 0.1 0.0 0.1 0.0 0.6 0.2 2.5 0.0 5.7 0.1 0.0 1.2 0.8 0.5 0.7 59.5 0.0 2.2 1.3 114.0 0.0 0.3 0.2 0.0 97.6 24.0 0.4 0.0 90.9 3.6 5.6 36.6 0.0 225.6 1.0 0.0 0.0 0.1 0.0 14.5 0.1 0.0 0.4 0.6 0.1 6.6 0.6 0.5 0.0 0.4 0.2 0.6 1.5 33.2 0.0 0.2 0.2 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531475 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 7.8;brain: 16.3;lymphoid tissue: 8.2" "Group enriched" "Detected in some" 4 "dendritic cells: 7.1;Hofbauer cells: 6.2;Kupffer cells: 8.7;Langerhans cells: 6.5;Macrophages: 16.6;monocytes: 13.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 5 "cerebral cortex: 16.3" "Immune cell enhanced" "Detected in many" "eosinophil: 75.9" "Group enriched" "Detected in many" 53 "dendritic cells: 25.0;granulocytes: 75.9;monocytes: 31.7" "Group enriched" "Detected in some" 6 "HL-60: 1.7;NB-4: 2.4;THP-1: 1.9;U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060449 Approved "Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 1.7 0.4 0.1 8.2 0.2 7.8 0.7 0.1 16.3 0.4 0.6 0.7 0.7 0.3 0.0 0.3 0.3 2.1 0.2 0.1 0.2 0.2 0.8 1.7 0.8 0.3 0.3 0.1 0.9 0.1 0.2 0.9 3.1 0.4 0.9 0.0 0.3 0.1 0.3 0.1 1.6 1.8 0.2 3.7 0.6 0.3 1.3 0.6 0.2 0.1 0.9 2.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 1.1 0.0 1.5 31.7 75.9 0.1 13.6 0.3 0.0 0.0 0.0 25.0 0.0 0.0 0.2 33.3 0.8 1.9 15.6 0.0 11.8 0.1 0.2 0.1 16.3 0.1 0.2 0.3 0.3 3.1 0.2 1.3 0.4 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.6 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.4 0.2 6.2 0.0 0.0 0.0 0.0 8.7 6.5 0.2 0.0 16.6 0.0 0.0 13.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7" "Cell type enhanced" "Detected in many" "B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 16.6 7.0 7.5 100.2 7.4 155.2 6.5 9.4 13.7 4.2 5.9 13.9 8.2 3.7 0.7 7.3 5.8 13.9 5.2 6.3 11.4 7.6 6.4 46.9 215.0 17.0 12.0 1.7 3.2 1.8 3.4 15.1 16.5 6.9 3.8 0.3 11.5 2.8 1.9 4.1 116.3 3.9 16.7 235.7 14.8 7.4 15.6 57.5 8.3 2.4 88.0 19.1 5.2 28.7 0.2 0.6 1.5 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 306.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 49.5 0.2 53.1 0.0 0.5 0.0 9.4 290.0 0.0 0.0 0.0 0.0 0.2 0.0 18.5 2.6 16.3 0.0 0.0 0.4 5.8 0.2 0.0 0.0 2.9 0.3 110.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 109.0 0.8 0.3 1.0 0.2 0.0 0.3 0.1 69.4 0.2 81.4 0.1 550.2 658.2 829.6 353.2 601.6 357.4 1511.6 426.3 376.2 449.7 1722.2 435.3 368.6 903.8 321.8 747.8 586.3 467.1 816.2 7.5 7.4 9.4 13.7 6.3 11.4 17.0 12.0 16.5 16.7 15.6 28.7 7.1 9.6 14.3 0.3 1643.9 11.7 1.3 0.1 4.6 12.1 4.6 12.1 1.6 2.8 2.5 1.8 6.2 1.9 489.6 2.2 0.0 0.5 94.2 1.2 1.9 9.7 1.2 67.7 0.1 0.0 2.3 6.9 11.7 1.5 264.6 0.3 11.4 4.1 345.3 0.0 0.2 1.7 0.0 272.0 358.4 221.3 2.8 319.7 28.4 21.5 365.0 1.1 394.4 0.0 0.1 0.0 8.0 0.7 119.8 1.1 0.6 2.9 0.9 6.3 0.0 3.2 5.7 1.1 1.3 2.6 11.8 2.9 390.3 0.9 1.9 1.1 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 94.7" "Group enriched" "Detected in many" 11 "dendritic cells: 139.6;T-cells: 294.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 21 "gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0" "Lineage enriched" "Detected in many" 26 "T-cells: 241.7" "Group enriched" "Detected in some" 52 "JURKAT: 70.9;MOLT-4: 193.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 0.7 0.8 0.6 10.5 0.8 1.3 1.0 1.1 0.8 0.7 1.1 2.3 3.3 0.5 0.6 1.4 0.9 2.5 0.5 0.5 0.4 0.6 1.6 2.8 27.9 0.9 0.6 0.4 0.5 0.2 0.0 0.3 0.8 0.9 2.7 0.4 1.6 0.3 10.5 0.9 4.6 0.6 0.3 11.5 4.1 0.4 0.8 94.7 0.6 0.3 20.4 3.0 0.4 1.9 0.2 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 70.9 2.5 0.3 0.0 0.6 193.8 1.3 0.2 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.5 0.2 0.0 1.1 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.7 0.3 0.2 0.2 0.1 9.2 1.2 1.2 229.0 0.6 135.6 0.8 187.3 197.3 0.6 0.9 192.6 241.7 6.4 1.4 1.2 1.5 200.0 90.4 0.6 0.8 1.1 0.8 0.5 0.4 0.9 0.6 0.8 0.3 0.8 1.9 3.2 3.2 6.9 0.0 7.8 2.3 0.1 0.0 1.8 0.2 2.0 2.9 0.8 1.5 1.9 0.0 0.0 0.1 139.6 0.4 0.0 0.3 1.0 0.4 0.4 1.4 0.0 3.4 0.1 0.0 0.0 2.3 13.7 0.4 6.3 0.0 4.2 1.7 0.1 0.0 0.1 0.2 0.0 3.8 5.8 1.4 0.0 7.7 5.4 1.0 8.1 0.0 14.4 0.0 0.3 0.0 0.1 0.0 18.5 0.0 0.0 0.6 0.7 0.8 0.0 1.3 1.6 0.2 0.4 0.6 2.4 0.3 294.0 0.1 0.3 0.0 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609979-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 65.0" "Cell type enhanced" "Detected in many" "B-cells: 95.6;dendritic cells: 18.3;Hofbauer cells: 18.7;Kupffer cells: 25.6;Macrophages: 21.1;NK-cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "memory B-cell: 232.9;naive B-cell: 413.5" "Lineage enriched" "Detected in all" 20 "B-cells: 413.5" "Cell line enhanced" "Detected in some" "Daudi: 21.4;Karpas-707: 14.5;REH: 7.8;U-698: 44.4" "Region enriched" "Detected in single" 7 "basal ganglia: 4.1" "Low region specificity" "Detected in single" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: AB_2679039" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 4.5 2.3 1.9 20.6 2.0 6.7 1.7 2.0 3.3 1.4 4.2 1.9 1.3 1.0 4.8 0.6 1.2 4.1 0.7 1.8 1.8 2.2 6.0 2.8 65.0 2.8 1.8 0.8 2.2 1.1 2.5 3.3 2.4 1.5 1.3 0.4 1.6 0.7 0.6 2.0 8.4 1.6 1.9 53.6 2.6 0.8 3.3 6.9 2.4 0.0 50.2 4.2 0.9 2.3 0.1 0.0 0.6 0.5 0.9 5.2 0.1 0.3 0.1 0.4 0.7 0.0 0.2 21.4 0.1 0.3 0.1 0.0 0.0 0.1 0.5 1.8 0.4 0.6 0.2 0.0 0.5 0.3 4.1 1.5 0.0 0.2 0.4 0.9 0.0 4.9 0.0 14.5 1.1 0.0 0.3 2.7 0.2 0.0 0.1 7.8 0.0 5.5 0.0 0.0 0.3 0.5 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.7 0.2 0.2 0.0 0.3 0.3 44.4 0.8 0.5 0.0 0.6 2.0 0.3 3.1 3.5 4.3 232.9 1.5 2.2 20.2 413.5 0.7 2.4 1.4 10.6 0.5 11.0 1.7 14.8 1.9 2.0 2.0 3.3 1.8 1.8 2.8 1.8 2.4 1.9 3.3 2.3 0.7 0.0 0.6 5.9 95.6 1.0 0.5 0.9 0.6 0.0 1.3 1.3 1.1 1.5 0.4 3.7 0.0 0.2 18.3 0.7 0.0 0.8 0.2 0.4 0.6 0.9 1.8 2.7 1.0 0.7 0.3 0.9 1.1 0.4 0.0 0.8 0.7 0.2 18.7 0.0 1.2 0.2 0.0 25.6 14.6 0.3 0.9 21.1 0.0 0.0 3.0 0.6 19.6 2.0 4.4 1.1 0.0 0.4 2.7 0.5 0.6 0.7 1.3 0.7 0.0 0.5 0.9 1.1 1.7 0.2 1.1 0.3 5.9 0.5 0.4 0.4 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194537-84219621 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 313.8;skin 1: 214.0" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "NK-cell: 7.5" "Lineage enriched" "Detected in single" 12 "NK-cells: 7.5" "Cell line enhanced" "Detected in some" "HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3" "Region enriched" "Detected in many" 21 "olfactory bulb: 333.0" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" NA NA 55000 "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.2 1.9 7.4 1.0 18.3 0.4 4.5 2.3 8.7 5.3 46.2 29.2 0.1 0.6 4.4 10.7 0.5 0.4 1.2 6.6 7.5 0.4 0.5 0.2 0.9 13.4 2.3 1.1 0.1 0.0 3.0 0.2 13.9 1.4 53.2 313.8 1.5 4.2 1.0 214.0 12.2 1.2 0.1 7.0 0.2 0.3 3.2 3.3 0.2 0.0 1.1 0.1 3.5 3.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 10.2 2.0 0.0 0.0 5.2 6.3 0.0 0.0 0.2 0.0 0.2 0.0 2.2 0.0 0.7 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.5 4.4 0.0 0.0 0.0 0.0 1.4 16.3 0.0 3.4 0.8 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.1 7.4 18.3 2.3 8.7 6.6 7.5 13.4 2.3 13.9 0.1 3.2 3.5 0.0 0.0 0.5 1.3 0.1 51.2 0.3 1.4 3.4 24.1 0.0 0.1 1.8 0.0 0.7 0.0 379.5 0.0 2.1 47.9 0.0 0.1 0.0 2.7 0.7 1.8 12.7 0.0 4.9 0.0 0.0 0.6 0.0 3.1 0.0 3.7 0.4 0.4 0.0 5.0 7.7 46.9 0.0 0.3 5.2 0.2 0.0 0.1 3.6 1.0 0.0 26.3 1.0 7.5 4.4 0.0 31.2 0.0 0.7 0.3 23.0 0.2 0.1 240.4 0.0 0.2 0.3 0.6 0.3 3.0 67.5 0.0 3.0 0.3 52.9 0.2 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "CEA cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.5;lymphoid tissue: 10.2" "Cell type enriched" "Detected in some" 10 "Granulosa cells: 150.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8" HPA043411 Uncertain NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favorable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.3 0.7 1.4 2.2 0.8 17.5 0.8 0.8 1.3 2.2 0.6 0.8 0.6 2.6 0.3 0.4 0.7 0.5 0.5 0.8 2.8 0.7 1.2 3.8 5.3 1.9 2.7 0.4 0.2 0.1 0.4 1.5 2.2 0.6 0.6 0.0 0.5 3.6 0.1 0.2 2.6 0.5 1.8 10.2 0.9 1.1 3.9 2.2 0.6 0.1 3.5 0.8 0.3 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.8 1.0 1.0 0.0 5.8 0.0 0.1 6.0 27.3 29.7 11.7 20.1 10.8 25.6 20.8 6.9 15.1 21.3 21.0 30.2 19.2 7.0 12.4 26.6 17.9 1.4 0.8 0.8 1.3 0.8 2.8 1.9 2.7 2.2 1.8 3.9 1.2 1.5 0.0 0.0 0.3 5.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.6 1.8 0.0 0.1 7.2 0.0 0.0 0.0 5.4 7.3 0.1 2.0 0.0 5.7 0.1 0.0 0.1 0.3 0.0 2.2 4.5 150.8 10.0 0.3 9.4 0.0 0.7 0.0 0.0 9.0 0.6 10.3 0.0 6.2 1.8 15.0 1.0 0.0 9.2 0.0 0.1 0.0 0.0 0.4 10.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.6 0.0 0.0 0.3 8.8 0.0 0.0 0.0 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699553 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.5" "Cell type enhanced" "Detected in many" "B-cells: 128.6;dendritic cells: 112.0;Early spermatids: 95.5;monocytes: 81.6;NK-cells: 131.8;T-cells: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2" "Group enriched" "Detected in all" 11 "B-cells: 127.5;T-cells: 223.0" "Group enriched" "Detected in many" 4 "Daudi: 67.9;HDLM-2: 53.3;Karpas-707: 31.0;U-698: 105.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 6.1 1.8 3.6 16.7 3.5 16.0 5.6 3.3 4.9 6.4 3.1 4.8 3.3 4.5 11.8 3.2 5.3 5.5 5.3 3.2 3.7 3.9 2.9 8.6 53.5 4.0 3.4 6.0 2.4 0.8 2.3 2.6 3.9 7.3 3.9 2.2 6.5 4.5 2.9 3.7 20.3 2.0 3.5 26.6 5.5 9.5 4.1 31.6 4.5 1.3 41.7 5.7 4.6 4.2 1.2 2.5 3.5 0.3 0.5 1.4 4.0 1.7 2.5 0.6 2.1 1.9 2.1 67.9 0.3 1.8 1.0 0.7 1.2 0.2 1.1 53.3 0.9 2.1 1.6 2.9 5.7 1.7 1.7 2.3 1.7 0.5 2.1 8.0 0.1 1.2 0.5 31.0 1.5 4.5 0.7 5.9 3.2 0.2 0.4 14.9 1.6 2.2 3.4 3.6 0.6 1.3 0.9 2.8 3.0 6.6 0.6 1.8 0.6 1.3 1.8 1.0 1.2 4.4 1.1 105.8 2.8 3.1 2.1 6.8 2.1 1.5 188.1 1.4 114.5 95.0 183.3 208.7 2.3 127.5 192.3 223.0 6.0 16.5 1.3 1.6 175.2 109.8 3.6 3.5 3.3 4.9 3.2 3.7 4.0 3.4 3.9 3.5 4.1 4.2 8.9 6.4 20.7 11.8 128.6 4.1 39.7 2.1 1.8 1.3 6.5 6.1 9.6 4.3 7.1 1.8 4.2 10.4 112.0 0.8 7.9 3.0 95.5 3.6 6.9 13.0 0.0 21.5 6.3 1.9 6.0 12.2 4.6 6.2 20.2 18.1 12.5 2.3 9.2 5.0 6.8 2.5 0.0 20.9 17.8 28.3 8.4 19.4 1.8 56.2 81.6 3.2 131.8 27.6 4.4 2.8 2.0 9.8 71.5 17.2 0.5 2.1 7.4 2.3 19.7 26.2 8.7 5.7 6.3 1.9 4.8 4.8 215.1 7.4 3.5 24.3 CLEC9A "CD370, DNGR-1, HEEE9341, UNQ9341" ENSG00000197992 "C-type lectin domain containing 9A" Q6UXN8 12 10030678-10066031 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.5" "Group enriched" "Detected in some" 5 "Langerhans cells: 30.2;Macrophages: 19.5;Microglial cells: 15.9;Spermatocytes: 9.4" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 96 "myeloid DC: 22.0;neutrophil: 7.9" "Group enriched" "Detected in many" 96 "dendritic cells: 22.0;granulocytes: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 41: Macrophages - Immune response" "unprognostic (1.13e-3)" "unprognostic (1.21e-2)" "unprognostic (5.00e-3)" "unprognostic (7.85e-3)" "unprognostic (1.28e-2)" "unprognostic (1.56e-5)" "unprognostic (6.58e-4)" "unprognostic (4.73e-3)" "unprognostic (9.65e-2)" "unprognostic (7.45e-3)" "unprognostic (8.15e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (7.93e-2)" "unprognostic (3.45e-5)" "unprognostic (2.17e-1)" 0.3 0.2 1.3 1.5 1.4 0.5 0.6 2.0 1.8 0.3 1.1 0.7 0.8 0.5 0.2 0.2 0.2 0.9 0.2 1.6 2.1 0.3 0.8 0.6 7.5 2.7 1.8 0.7 0.3 0.2 0.3 0.2 2.1 0.6 0.6 0.1 1.1 0.4 0.1 0.3 1.5 0.7 2.2 4.8 0.4 3.0 1.9 4.9 0.2 0.2 2.2 1.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 7.9 0.1 0.0 0.0 0.0 0.4 1.3 1.4 2.0 1.8 1.6 2.1 2.7 1.8 2.1 2.2 1.9 2.6 0.8 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.2 30.2 1.8 0.0 19.5 0.0 15.9 2.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684768 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.2" "Cell type enriched" "Detected in many" 5 "Ionocytes: 73.2" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 4.1;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035671, HPA035672" Uncertain Uncertain Vesicles NA NA "Cluster 35: T-regs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.3 0.2 0.5 0.9 0.4 0.4 0.6 1.5 0.7 0.2 0.5 0.3 0.6 0.4 1.2 0.4 0.2 0.5 0.2 0.5 0.5 6.2 0.9 0.6 3.0 0.4 0.2 0.4 0.1 0.1 1.3 1.0 0.5 0.4 0.4 0.3 0.5 0.3 0.2 0.8 0.9 0.1 0.1 1.5 1.1 0.8 0.5 1.4 0.3 0.0 2.0 0.3 0.0 0.9 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.2 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 2.2 0.1 0.5 0.1 0.2 0.2 0.1 0.1 1.4 0.4 0.1 2.6 1.1 0.1 0.1 0.4 2.0 0.0 0.6 1.8 0.2 0.5 0.4 1.5 0.7 0.5 0.5 0.4 0.2 0.5 0.1 0.5 0.9 0.1 3.2 3.0 1.0 12.9 0.8 0.8 0.0 0.0 1.3 0.3 0.3 0.7 0.0 0.9 0.0 2.1 0.3 4.6 0.1 13.7 0.0 5.3 0.7 0.2 0.4 0.0 5.3 1.7 0.0 2.2 0.5 0.5 0.9 11.4 0.2 0.7 0.3 0.3 0.0 1.6 0.2 73.2 1.9 5.5 5.4 0.3 3.5 1.8 1.9 0.5 0.4 0.0 1.0 0.7 0.1 0.0 2.2 1.1 0.7 0.0 0.2 0.2 1.0 0.0 1.1 0.5 1.9 0.8 0.0 0.4 0.1 6.0 1.3 0.0 0.7 COTL1 CLP ENSG00000103187 "Coactosin like F-actin binding protein 1" Q14019 16 84565596-84618078 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Chaperone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 273.2;lymphoid tissue: 374.3" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1402.6;Hofbauer cells: 595.3;Kupffer cells: 1015.5;Langerhans cells: 1146.3;Macrophages: 1046.2;monocytes: 949.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 2441.1;eosinophil: 3418.8;intermediate monocyte: 4072.1;myeloid DC: 2395.7;neutrophil: 1758.0;non-classical monocyte: 4579.3" "Group enriched" "Detected in all" 5 "dendritic cells: 2395.7;granulocytes: 3418.8;monocytes: 4579.3" "Cell line enhanced" "Detected in all" "WM-115: 1271.3" "Low region specificity" "Detected in all" "HPA008918, CAB062328" Enhanced Supported Cytosol NA NA 10000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 17: WM-115 - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "CAB062328: AB_2084785, HPA008918: AB_2668176" "unprognostic (2.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (3.21e-3)" "unprognostic (8.95e-2)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (7.70e-2)" "unprognostic (5.99e-2)" "unprognostic (5.43e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (5.48e-2)" "unprognostic (7.73e-2)" "unprognostic (3.35e-3)" 87.8 36.8 65.8 296.0 82.1 273.2 54.2 80.6 67.4 31.7 57.7 68.7 90.4 46.7 12.1 32.4 49.5 75.2 25.1 68.8 82.8 140.5 44.6 110.6 374.3 87.5 80.5 24.1 30.3 32.4 47.4 78.0 86.6 44.5 66.0 44.4 24.9 28.5 10.9 20.4 104.8 66.6 78.0 330.5 126.5 20.5 101.5 88.6 38.0 12.2 263.5 118.4 28.3 86.4 546.3 445.0 994.2 1058.1 111.5 305.0 299.5 462.0 295.8 355.8 136.6 609.1 818.7 149.6 137.6 349.7 211.7 266.8 61.3 364.1 355.1 1.1 77.9 281.9 87.7 162.7 314.0 320.1 1069.3 245.6 57.6 344.2 305.0 222.2 172.2 326.4 26.5 60.5 215.3 88.3 99.1 191.7 123.1 178.5 448.8 10.4 33.7 9.3 529.2 227.5 156.7 7.9 430.7 101.9 238.8 116.9 77.1 256.7 445.9 509.0 290.2 165.8 341.4 11.5 58.1 123.7 397.7 154.1 1271.3 740.1 2441.1 3418.8 69.9 4072.1 92.5 546.6 441.0 417.2 2395.7 279.2 192.6 229.6 1758.0 667.2 4579.3 123.7 685.2 2954.6 65.8 82.1 80.6 67.4 68.8 82.8 87.5 80.5 86.6 78.0 101.5 86.4 44.0 3.2 12.2 20.5 331.8 63.5 116.5 7.5 27.3 10.4 22.2 32.9 5.1 17.2 6.2 77.3 244.0 136.4 104.5 47.0 39.2 73.0 6.8 17.6 74.5 94.4 145.6 78.4 6.8 34.5 1402.6 59.9 181.0 29.8 141.8 126.0 189.2 6.6 595.3 25.2 14.1 77.8 2.0 1015.5 1146.3 10.8 8.1 1046.2 96.0 39.4 949.1 31.5 74.2 27.6 2.1 108.2 19.8 16.1 130.1 165.3 52.8 305.3 4.5 43.2 6.6 15.4 75.7 5.1 39.5 9.2 38.2 172.8 354.9 11.9 140.2 179.6 CSF2RA "alphaGMR, CD116, CSF2R" ENSG00000198223 "Colony stimulating factor 2 receptor subunit alpha" P15509 X 1268800-1310381 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 248.5;Extravillous trophoblasts: 124.6;Langerhans cells: 365.1;Macrophages: 114.5;monocytes: 575.2;Syncytiotrophoblasts: 312.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 320.2" "Group enriched" "Detected in all" 30 "dendritic cells: 170.7;granulocytes: 320.2;monocytes: 161.1" "Group enriched" "Detected in some" 7 "BEWO: 194.0;HMC-1: 58.3;SK-MEL-30: 142.0" "Low region specificity" "Detected in single" CAB016148 Uncertain "Secreted to blood" NA NA 13000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 3: Monocytes - Immune response regulation" "CAB016148: AB_626868" "unprognostic (4.19e-2)" "prognostic favorable (2.38e-5)" "unprognostic (5.47e-2)" "unprognostic (4.33e-2)" "unprognostic (4.88e-2)" "prognostic favorable (2.81e-4)" "unprognostic (8.24e-2)" "unprognostic (2.17e-1)" "unprognostic (5.55e-2)" "unprognostic (8.48e-2)" "unprognostic (8.89e-2)" "unprognostic (3.80e-1)" "unprognostic (2.89e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (5.53e-4)" "unprognostic (3.60e-1)" "unprognostic (9.44e-2)" 10.0 5.5 4.2 25.4 4.4 21.7 6.8 5.2 4.8 5.1 5.4 5.8 5.8 2.5 1.7 5.3 4.1 12.6 2.5 4.0 5.4 2.3 4.6 14.2 20.9 8.5 6.6 1.8 3.3 3.1 1.4 64.4 8.3 2.5 7.4 0.7 3.0 3.0 0.6 4.0 6.6 7.1 7.2 14.9 5.0 1.1 9.0 9.4 1.6 2.0 23.5 12.7 1.5 11.9 0.3 11.5 0.5 0.0 0.0 0.0 194.0 0.3 0.5 0.4 0.1 4.2 1.0 0.2 12.6 0.0 10.3 0.2 0.1 0.0 0.0 3.9 0.1 0.2 8.0 0.1 0.0 4.6 58.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.4 18.8 1.6 1.8 0.4 0.2 0.5 0.3 0.0 0.5 0.1 0.3 3.7 0.1 142.0 15.1 9.4 16.8 0.0 0.2 5.5 0.1 0.0 0.1 0.1 0.6 0.0 18.5 0.1 17.4 161.1 200.3 0.4 94.9 1.0 2.3 0.3 0.3 170.7 0.6 0.4 0.3 320.2 7.3 48.7 164.0 1.1 65.5 4.2 4.4 5.2 4.8 4.0 5.4 8.5 6.6 8.3 7.2 9.0 11.9 1.2 0.0 7.3 1.3 5.5 7.8 0.9 0.1 0.6 0.6 6.3 2.5 1.2 2.8 3.6 1.8 0.0 248.5 38.3 0.0 0.0 0.3 0.6 7.8 1.2 5.3 0.0 1.3 1.4 1.8 124.6 3.4 0.0 14.7 10.1 0.5 0.7 0.1 75.5 0.0 1.7 0.0 2.0 74.8 365.1 0.3 0.9 114.5 8.8 66.5 575.2 0.3 0.0 1.5 0.9 0.2 0.0 0.4 1.0 0.5 0.0 0.1 2.7 1.5 6.6 1.8 1.4 0.2 0.4 0.0 5.3 312.5 3.3 0.1 0.0 2.5 CXCL10 "C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10" ENSG00000169245 "C-X-C motif chemokine ligand 10" P02778 4 76021118-76023497 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 95.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 52.7;Glandular and luminal cells: 23.5;Kupffer cells: 41.1;Langerhans cells: 21.4;Macrophages: 45.7;Plasma cells: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9" "Lineage enriched" "Detected in many" 15 "monocytes: 52.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.1;BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;GAMG: 5.1;RPMI-8226: 4.3;RT4: 2.4;THP-1: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 253000 "Cluster 51: Monocytes - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 41: Macrophages - Immune response" "unprognostic (1.94e-1)" "unprognostic (5.32e-2)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-1)" "unprognostic (7.59e-2)" "prognostic favorable (1.12e-5)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-2)" 4.0 5.9 1.4 95.5 1.5 1.2 20.7 0.9 2.6 13.2 1.2 10.7 11.2 7.1 0.7 8.0 4.1 10.6 4.4 1.2 1.0 7.8 29.0 35.1 68.0 7.4 1.2 3.0 0.9 17.1 2.1 10.3 10.8 43.9 15.9 0.4 20.1 1.8 1.2 2.0 11.2 15.8 3.4 20.3 19.2 3.0 2.6 35.2 3.7 1.1 17.3 45.1 3.7 1.5 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.1 2.2 2.2 0.2 0.1 2.0 0.2 0.0 5.1 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 4.3 0.1 2.4 0.0 0.0 0.0 0.4 1.3 0.0 0.1 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.0 0.0 21.5 0.0 0.0 52.4 0.0 1.4 0.3 0.0 3.5 0.1 0.0 0.0 1.1 0.0 36.9 0.0 0.0 7.6 1.4 1.5 0.9 2.6 1.2 1.0 7.4 1.2 10.8 3.4 2.6 1.5 3.8 0.0 2.2 0.0 2.2 0.9 9.4 52.7 0.6 0.0 2.6 7.0 0.3 1.5 2.8 0.0 0.0 0.1 0.0 2.7 0.0 5.9 2.6 12.5 10.9 8.0 0.0 0.0 0.0 0.0 0.0 6.9 3.1 23.5 1.3 0.0 0.0 0.1 17.3 0.0 0.0 1.0 10.2 41.1 21.4 4.0 0.3 45.7 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 11.4 6.4 2.6 1.3 0.0 0.0 1.3 12.4 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.9 1.4 CXCR3 "CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR" ENSG00000186810 "C-X-C motif chemokine receptor 3" P49682 X 71615916-71618511 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3" "Cell type enhanced" "Detected in some" "dendritic cells: 87.6;NK-cells: 15.5;Plasma cells: 36.5;Proximal enterocytes: 17.6;T-cells: 48.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 306.7" "Group enriched" "Detected in many" 5 "dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7" "Cell line enriched" "Detected in some" 15 "RPMI-8226: 47.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA045942 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA045942: AB_2679507" "unprognostic (4.84e-3)" "unprognostic (3.05e-3)" "unprognostic (1.61e-1)" "prognostic favorable (3.44e-6)" "unprognostic (3.93e-2)" "prognostic favorable (3.35e-4)" "unprognostic (1.01e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.90e-4)" "unprognostic (6.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.67e-6)" "unprognostic (4.67e-2)" "unprognostic (2.18e-1)" "unprognostic (2.91e-2)" "unprognostic (5.76e-2)" 0.6 0.8 0.1 5.9 0.1 7.2 0.5 0.2 0.3 0.5 0.0 1.6 5.4 0.4 0.0 0.6 0.5 1.4 0.4 0.2 0.0 0.5 0.5 3.3 16.3 0.2 0.0 0.4 0.5 0.0 0.1 0.1 0.0 0.4 1.0 0.0 1.8 0.3 0.1 0.6 6.4 0.4 0.0 7.5 2.9 0.3 0.1 3.0 0.9 0.1 5.3 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.1 0.0 0.4 0.3 0.2 80.4 0.2 40.9 45.3 90.3 124.7 8.4 9.9 5.5 51.6 1.9 198.9 0.2 306.7 89.4 35.3 0.1 0.1 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 13.9 0.3 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 87.6 3.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 3.2 0.0 0.2 0.0 0.3 3.1 0.3 1.3 0.0 0.7 0.3 0.3 0.0 0.0 1.8 0.0 0.8 6.1 0.0 0.0 4.0 1.8 0.0 2.1 0.0 15.5 0.0 0.0 0.2 5.3 0.0 36.5 0.0 17.6 0.5 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.6 0.1 48.3 1.5 3.1 0.1 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1" "Cell type enhanced" "Detected in many" "B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.2 1.0 1.4 21.4 1.3 21.2 1.0 1.5 1.7 0.9 1.5 3.0 4.9 0.9 0.0 1.9 1.3 2.8 1.1 1.4 1.5 1.6 2.1 5.8 32.1 2.4 1.8 0.3 1.3 0.1 0.8 1.8 2.2 1.6 1.2 0.0 3.0 0.5 0.8 1.4 14.4 1.2 1.8 35.1 5.2 0.4 2.8 20.5 1.7 0.3 14.9 3.0 1.3 2.6 0.2 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 22.5 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.0 0.0 15.1 0.0 1.6 0.0 7.5 44.7 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.3 9.4 0.1 0.0 14.7 11.5 0.0 0.5 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 13.8 0.1 0.0 0.0 0.0 0.0 0.4 2.0 10.6 0.1 31.3 0.0 18.3 19.9 32.8 40.1 32.4 35.0 23.8 28.6 35.0 19.5 18.7 35.7 32.1 27.8 23.8 35.0 11.2 35.6 37.1 1.4 1.3 1.5 1.7 1.4 1.5 2.4 1.8 2.2 1.8 2.8 2.6 0.3 3.2 3.0 0.0 27.5 0.4 0.1 0.0 1.2 0.0 0.6 0.6 1.3 2.8 0.0 1.8 0.0 0.2 30.1 0.5 1.9 0.4 0.7 1.5 0.2 0.4 0.0 5.7 0.4 0.0 0.2 0.7 1.5 0.3 15.9 0.5 1.1 0.7 14.6 0.0 0.5 0.9 0.0 11.6 9.2 0.6 0.0 13.8 3.6 2.8 10.9 0.0 35.0 0.0 0.5 0.3 0.4 0.0 13.5 0.2 2.9 6.2 1.6 0.0 0.0 0.0 0.3 0.3 1.2 1.6 0.1 0.3 34.5 0.7 1.0 0.1 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 101.5;lymphoid tissue: 198.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 49.0;Squamous epithelial cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 86.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 130.4;hTERT-HME1: 133.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 58: T-cells - T-cell receptor" Vesicles "Nucleoplasm, Mitochondria" "HPA041645: AB_2677595, HPA045462: AB_2679335" "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 12.7 12.8 7.6 50.0 9.8 31.9 11.0 6.6 9.2 22.9 7.0 25.6 51.2 13.1 9.9 101.5 11.4 15.8 8.5 7.2 5.2 7.9 3.7 18.6 95.5 5.2 5.0 10.9 14.6 12.0 6.9 14.9 5.3 24.8 26.9 2.8 35.5 9.6 2.3 84.7 64.8 14.1 4.8 53.8 12.4 12.3 5.0 198.1 10.5 4.2 101.8 28.4 39.0 6.8 22.2 13.2 9.3 12.4 22.4 29.0 2.8 47.2 47.8 18.2 13.5 6.9 35.2 13.5 11.1 31.5 6.2 38.7 10.3 130.4 21.4 14.4 2.5 21.1 26.8 3.6 19.1 6.7 20.9 25.1 68.4 25.2 133.9 60.6 37.9 78.8 2.4 18.7 49.4 2.3 54.3 8.6 2.0 18.1 15.5 23.8 2.9 2.0 43.7 60.9 1.6 5.6 15.5 0.9 1.7 23.8 9.3 6.4 34.0 12.0 8.4 2.8 1.7 2.9 1.2 32.4 13.8 17.5 3.4 17.0 7.4 15.3 18.5 5.2 35.5 20.4 70.6 33.0 10.5 16.2 86.9 51.5 13.3 14.1 3.5 10.5 86.7 36.2 7.6 9.8 6.6 9.2 7.2 5.2 5.2 5.0 5.3 4.8 5.0 6.8 4.5 3.2 6.5 1.6 25.7 15.0 9.7 21.1 26.7 1.2 4.0 4.6 2.9 4.3 19.1 5.5 0.0 16.3 12.2 35.4 0.0 5.1 9.4 1.9 6.5 5.3 2.4 11.2 11.2 9.4 4.3 8.2 15.3 3.0 7.0 2.4 4.2 0.2 4.2 0.0 5.2 7.7 2.0 6.9 21.6 7.0 3.7 14.0 0.0 5.6 15.7 2.6 10.3 9.0 0.8 25.3 14.4 3.0 14.8 8.2 49.0 0.3 5.2 0.5 6.6 1.5 4.2 6.6 4.2 40.4 13.9 26.4 37.4 1.6 9.7 20.1 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042468 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.1;lymphoid tissue: 32.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1806.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "HPA058106: AB_2683606" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.5 8.2 22.6 18.8 49.2 10.2 3.8 33.7 33.4 8.7 9.7 6.3 4.1 3.2 1.1 3.2 2.4 6.3 1.6 28.7 35.1 3.2 5.5 7.6 27.8 45.5 38.4 17.7 1.7 2.0 1.0 2.3 48.9 1.6 6.5 5.7 2.5 1.7 1.2 5.0 12.5 4.3 32.0 29.8 6.7 2.2 37.9 32.1 2.7 0.8 19.9 6.4 4.4 83.1 0.0 21.4 6.7 0.0 8.5 17.9 0.0 45.5 36.8 21.3 15.8 0.0 0.0 0.6 0.1 28.9 73.4 0.5 0.0 0.1 16.9 52.7 0.0 0.6 4.5 0.0 0.3 4.4 2.1 4.3 0.4 31.0 12.0 8.3 21.4 7.0 0.1 42.1 36.4 2.1 8.0 6.1 2.6 0.0 5.0 10.5 9.8 6.2 1.1 0.1 0.4 5.5 0.0 0.0 4.8 1.2 1.4 20.0 48.2 22.8 5.7 10.9 15.6 0.0 0.0 0.0 32.2 29.6 10.1 3.0 3.3 0.2 6.5 9.2 6.6 7.2 10.9 9.1 6.9 4.5 10.5 9.3 0.1 14.3 11.8 2.8 8.4 4.5 22.6 49.2 33.7 33.4 28.7 35.1 45.5 38.4 48.9 32.0 37.9 83.1 3.7 3.2 9.1 4.2 47.1 4.7 0.6 0.3 8.0 7.9 0.8 4.3 1.2 0.0 2.5 5.5 0.0 0.3 39.5 0.8 1.9 0.1 3.2 0.2 2.3 3.2 2.4 5.5 8.0 0.0 0.2 4.9 5.1 0.5 36.7 64.0 2.5 1.4 30.6 97.6 244.2 3.8 0.0 54.2 39.7 2.8 0.6 51.0 8.8 201.4 38.3 1.2 38.1 400.6 1806.0 0.2 0.3 0.0 43.5 0.5 0.2 0.3 2.6 1.8 13.1 2.5 18.9 0.3 1.1 2.1 4.1 0.8 75.1 31.4 2.5 0.7 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 45.0;lymphoid tissue: 64.8" "Cell type enhanced" "Detected in many" "Microglial cells: 506.8;monocytes: 134.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003218, HPA073349" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695, HPA073349: " "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favorable (6.89e-6)" 11.0 13.3 4.3 35.7 4.4 42.2 7.3 5.2 3.9 4.3 45.0 7.3 7.3 3.0 2.9 7.2 4.3 14.6 2.0 4.0 5.9 16.5 6.1 19.7 51.1 8.8 7.6 2.0 4.2 7.7 2.6 15.3 9.1 5.1 7.3 4.5 4.6 2.8 1.0 3.0 15.4 6.2 9.3 45.6 9.5 7.5 8.8 64.8 4.9 2.5 49.6 14.8 3.3 12.8 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 1.6 1.4 52.9 3.9 0.0 0.0 2.3 0.8 0.3 0.0 18.2 2.3 0.1 0.0 0.2 0.0 53.3 7.1 0.2 9.3 0.0 0.2 0.0 0.0 0.0 11.8 25.9 0.0 3.2 50.1 83.7 0.2 0.2 0.7 61.9 0.1 21.3 0.2 54.3 0.1 0.0 0.0 0.6 3.6 1.0 1.4 158.0 10.2 0.0 0.4 0.7 0.1 10.3 0.1 0.0 0.1 33.3 0.9 65.1 56.9 73.5 12.2 52.0 10.2 25.2 15.7 13.8 53.0 23.2 11.3 11.1 173.6 24.1 84.2 13.8 15.6 22.6 4.3 4.4 5.2 3.9 4.0 5.9 8.8 7.6 9.1 9.3 8.8 12.8 5.0 9.6 33.5 2.3 112.6 6.4 2.5 1.2 45.5 3.6 12.3 10.8 2.3 18.6 4.9 7.3 77.2 70.9 101.9 1.5 1.9 1.0 33.4 1.9 0.7 9.8 8.4 35.1 1.9 6.5 4.3 5.3 12.8 3.2 24.6 12.7 2.9 2.6 58.4 0.0 4.2 12.9 2.0 115.0 49.4 14.8 3.1 107.7 8.8 506.8 134.3 1.1 74.2 4.5 2.2 1.4 24.9 0.4 94.6 1.5 1.2 12.8 8.0 4.2 13.1 30.2 20.6 22.1 13.3 9.4 3.8 42.7 111.6 1.1 1.3 3.4 EPSTI1 "BRESI1, MGC29634" ENSG00000133106 "Epithelial stromal interaction 1" Q96J88 13 42886388-42992271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 168.1;monocytes: 144.2;Proximal enterocytes: 156.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 99.6;HDLM-2: 74.2;RPMI-8226: 35.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017362 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" "HPA017362: AB_1848226" "unprognostic (2.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.80e-1)" "unprognostic (3.59e-2)" "unprognostic (2.35e-1)" "unprognostic (9.55e-2)" "unprognostic (2.31e-1)" "unprognostic (2.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.05e-3)" "unprognostic (8.13e-2)" 7.5 7.7 3.7 31.6 4.1 33.6 4.8 3.1 5.1 5.7 2.8 12.6 33.7 6.0 1.6 5.0 3.7 18.1 4.7 3.1 3.6 8.0 12.9 16.8 34.2 7.8 4.6 3.1 3.5 7.6 2.7 16.8 5.2 2.7 11.0 0.3 18.5 4.8 2.2 1.5 32.0 9.7 5.5 31.3 15.8 7.4 4.4 27.7 3.1 2.5 20.7 13.1 3.6 4.5 2.8 0.1 0.0 0.0 0.1 5.2 3.0 2.3 26.0 95.8 99.6 23.2 5.7 3.7 0.8 3.4 10.1 11.4 0.2 3.9 12.2 74.2 0.2 11.9 0.0 0.1 22.9 0.0 2.0 17.4 5.2 7.7 0.5 1.4 1.4 5.7 0.0 17.9 2.5 0.2 19.0 2.9 0.5 1.9 0.1 0.2 0.1 35.7 16.1 0.7 2.0 0.0 0.3 0.0 1.9 0.4 0.6 1.9 3.9 0.0 0.0 1.0 0.0 0.8 0.6 0.0 1.9 0.0 1.0 52.3 34.4 29.4 10.8 59.3 11.4 26.7 22.3 12.3 31.1 23.7 10.4 7.8 16.1 24.4 39.3 3.8 59.0 22.5 3.7 4.1 3.1 5.1 3.1 3.6 7.8 4.6 5.2 5.5 4.4 4.5 26.5 19.2 10.9 1.3 40.0 4.2 1.7 4.1 0.6 0.0 1.2 1.8 2.9 12.8 9.2 5.5 0.0 10.9 27.1 26.5 1.9 40.9 89.0 10.2 18.8 18.8 24.6 31.5 0.3 39.0 168.1 15.9 15.3 20.7 10.8 22.4 12.5 6.3 84.2 0.0 11.6 25.1 2.0 39.2 28.3 27.1 14.9 68.7 10.6 84.3 144.2 0.2 37.0 4.5 0.3 51.2 55.4 4.9 23.6 3.6 156.0 39.1 6.5 0.1 0.0 2.6 10.6 2.6 1.7 2.8 3.8 14.5 37.0 43.9 37.6 3.7 ERN1 "IRE1, IRE1P" ENSG00000178607 "Endoplasmic reticulum to nucleus signaling 1" O75460 17 64039080-64130819 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Transcription, Transcription regulation, Unfolded protein response" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 53.0;pancreas: 66.7" "Cell type enhanced" "Detected in many" "Plasma cells: 325.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 17.9" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0" "Cell line enhanced" "Detected in many" "Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009495, HPA027730" Supported NA Yes "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB009495: AB_2098712, HPA027730: AB_10602494" "unprognostic (2.52e-1)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (2.81e-2)" "unprognostic (9.14e-2)" "unprognostic (2.72e-2)" "unprognostic (4.55e-1)" "unprognostic (6.17e-2)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.65e-1)" "unprognostic (1.89e-1)" "unprognostic (1.36e-2)" "unprognostic (3.11e-2)" 9.5 53.0 1.5 5.4 1.7 13.4 7.5 2.6 3.2 22.6 2.1 7.7 6.3 10.1 6.4 9.5 14.3 6.2 6.1 1.6 2.4 5.6 23.5 16.5 5.8 1.7 1.0 16.9 66.7 4.3 19.5 5.6 1.3 9.9 4.5 8.8 15.7 7.1 6.8 11.3 10.6 5.6 1.0 15.8 16.2 2.8 1.6 6.8 10.2 2.4 6.6 8.3 11.7 1.7 4.0 4.0 2.2 4.8 4.8 4.4 9.8 4.1 9.7 2.8 1.3 2.5 2.3 6.6 3.2 2.8 3.5 3.6 1.9 4.5 6.1 1.6 1.5 6.0 3.2 2.4 19.6 3.2 2.1 3.8 8.1 6.4 21.5 3.5 5.0 4.7 4.2 74.6 2.8 3.9 4.5 1.0 0.6 3.6 3.2 4.2 4.2 40.2 1.1 5.5 7.1 3.5 4.3 6.1 5.7 3.5 3.8 5.9 5.9 2.5 4.1 6.4 2.7 77.4 23.9 4.8 4.0 2.1 4.2 17.9 0.9 0.4 4.9 0.4 9.0 0.2 3.3 4.1 0.4 0.3 0.9 0.9 4.9 2.5 0.3 7.7 0.8 1.0 1.5 1.7 2.6 3.2 1.6 2.4 1.7 1.0 1.3 1.0 1.6 1.7 31.9 0.0 36.1 7.2 27.8 22.0 54.3 8.3 15.4 4.0 35.0 29.7 8.6 11.5 8.6 12.9 6.2 8.1 106.4 10.0 1.9 12.6 2.3 26.1 49.1 18.3 79.7 11.2 8.6 27.3 8.8 42.2 52.0 79.4 8.2 11.8 13.9 26.8 8.0 3.3 6.1 8.2 8.2 15.7 71.3 1.7 4.7 60.4 74.7 12.2 10.2 3.5 28.8 6.0 4.6 17.9 7.3 6.0 325.8 44.7 7.9 4.4 6.1 26.5 0.0 19.0 25.7 4.0 4.1 27.7 45.0 54.9 88.2 12.0 9.6 60.1 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 291.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favorable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 38.8 31.3 130.5 91.9 135.1 50.1 58.1 105.0 185.5 44.4 66.3 46.6 29.2 64.8 49.5 30.6 63.7 42.0 53.0 136.9 108.8 42.6 90.3 63.2 159.0 103.1 110.1 51.6 40.8 19.7 98.6 29.1 106.1 52.1 24.2 204.6 41.2 32.0 33.2 41.0 69.9 62.0 92.5 107.7 43.3 31.6 115.5 179.4 37.9 28.8 126.2 43.1 32.8 121.2 15.2 14.2 107.1 30.3 22.4 58.5 59.7 18.9 26.5 14.2 18.7 0.8 11.4 30.9 24.9 19.2 10.5 0.4 49.0 36.3 16.8 30.4 32.6 51.9 11.5 8.4 18.0 16.2 116.7 31.6 18.9 9.1 35.8 29.3 38.3 117.3 25.5 2.3 15.7 22.7 291.7 89.6 19.7 13.1 21.8 65.4 58.7 5.5 17.2 0.6 120.8 73.1 14.3 22.0 7.2 24.6 17.7 47.4 27.7 11.2 16.5 66.9 12.8 55.3 44.1 87.9 14.9 27.1 19.7 2.3 2.6 27.4 20.2 13.9 15.1 9.6 22.6 19.2 4.3 13.2 26.3 24.4 0.6 18.0 16.5 0.8 41.4 10.6 130.5 135.1 105.0 185.5 136.9 108.8 103.1 110.1 106.1 92.5 115.5 121.2 26.4 28.9 42.3 45.1 155.2 20.8 22.2 10.8 12.0 125.4 70.4 50.5 4.7 22.8 14.2 12.9 402.4 22.6 215.3 1.0 31.3 12.9 4.2 40.1 51.9 47.5 8.4 31.1 119.9 14.0 12.0 30.5 20.4 26.2 17.1 45.1 39.3 102.2 144.8 77.4 121.1 3.7 8.2 82.5 76.6 12.0 24.8 92.5 26.6 100.2 42.0 89.1 591.2 86.0 66.1 11.6 2.9 49.7 53.3 17.4 2.6 14.2 41.9 438.0 6.6 29.8 33.9 14.1 28.4 8.7 31.4 14.6 373.3 13.5 3.8 15.9 FCHO1 KIAA0290 ENSG00000130475 "FCH and mu domain containing endocytic adaptor 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2" "Cell type enhanced" "Detected in many" "B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: AB_2684915" "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 1.8 24.9 14.7 33.7 20.2 1.5 21.7 32.6 1.0 8.6 2.5 3.2 1.3 1.4 1.1 1.5 4.2 0.8 24.1 25.6 1.4 2.2 3.7 24.3 27.5 28.6 1.7 0.7 1.1 3.9 1.1 29.7 1.0 2.2 3.4 1.3 0.8 0.6 22.2 8.1 1.7 19.9 15.5 3.4 4.4 29.2 17.6 1.0 0.8 17.4 3.0 1.0 59.5 0.9 11.9 7.5 5.2 0.2 0.2 7.5 1.1 0.3 0.3 0.5 1.5 1.4 62.4 17.1 0.5 1.4 2.3 3.7 2.3 0.2 27.6 2.1 4.9 1.4 6.4 0.6 15.7 10.2 0.1 0.3 0.0 0.4 0.4 1.6 30.2 24.9 28.9 0.0 17.4 36.2 27.8 3.6 14.7 28.7 30.2 0.2 43.3 0.2 1.2 1.3 2.5 0.3 5.9 0.9 0.9 6.0 15.4 1.3 0.1 4.1 0.9 0.4 18.2 9.0 33.4 0.9 38.5 0.5 13.2 9.6 10.1 7.0 14.3 6.0 12.4 7.9 6.3 14.5 12.3 7.4 6.1 37.8 6.4 11.5 15.3 7.6 7.4 24.9 33.7 21.7 32.6 24.1 25.6 27.5 28.6 29.7 19.9 29.2 59.5 0.4 0.0 1.5 0.7 16.8 0.0 0.4 0.2 0.6 7.8 2.0 4.3 0.9 2.8 0.4 1.8 0.0 2.9 19.1 2.0 0.0 0.5 1.5 0.8 0.2 2.4 1.2 2.5 15.0 0.0 4.6 2.5 1.5 1.0 9.5 2.9 2.5 0.0 6.8 0.0 13.0 1.7 0.0 8.7 14.3 0.7 2.5 11.0 1.8 6.5 12.3 0.1 13.4 3.0 46.9 2.1 0.5 8.6 4.5 0.3 0.1 0.1 0.7 0.8 0.0 0.2 0.6 0.9 5.5 0.2 0.6 0.8 9.8 12.2 1.8 0.3 FOXP3 "AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID" ENSG00000049768 "Forkhead box P3" Q9BZS1 X 49250438-49270477 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 7.2;lymphoid tissue: 7.4" "Cell type enhanced" "Detected in some" "granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 11 "T-reg: 53.3" "Lineage enriched" "Detected in single" 394 "T-cells: 53.3" "Cell line enhanced" "Detected in some" "HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026301, HPA045943" Enhanced Supported Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB026301: , HPA045943: AB_2679508" "unprognostic (2.46e-2)" "prognostic favorable (1.91e-4)" "unprognostic (4.95e-3)" "prognostic favorable (7.02e-4)" "unprognostic (2.55e-4)" "prognostic favorable (4.90e-4)" "unprognostic (2.42e-2)" "unprognostic (3.46e-1)" "unprognostic (1.04e-2)" "unprognostic (1.99e-3)" "unprognostic (8.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.73e-14)" "unprognostic (5.93e-2)" "unprognostic (4.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-1)" 0.2 0.2 0.9 7.4 0.7 1.3 0.7 1.5 0.8 0.4 0.0 0.6 0.7 0.2 7.2 1.2 0.2 1.6 0.2 0.8 0.6 0.3 2.4 0.9 6.1 0.7 0.7 0.4 0.2 0.4 0.5 0.1 0.8 0.6 0.7 0.7 1.1 0.8 0.3 2.3 1.9 0.3 0.5 2.4 1.6 1.3 0.8 7.2 0.6 0.1 5.2 2.8 0.3 0.7 0.1 0.3 0.2 0.9 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.8 0.2 0.6 0.3 0.5 0.6 0.3 0.8 0.0 0.1 2.9 0.5 0.2 0.3 0.2 0.4 0.3 0.4 0.1 0.8 0.9 1.7 0.0 0.0 0.9 0.9 0.7 0.0 5.2 0.1 0.3 0.8 0.1 0.7 0.4 0.3 0.2 0.2 0.2 0.6 0.5 4.7 0.5 2.0 0.5 1.5 0.8 0.8 0.3 1.4 0.5 0.1 0.4 1.1 0.4 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 4.7 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 53.3 1.3 0.9 0.7 1.5 0.8 0.8 0.6 0.7 0.7 0.8 0.5 0.8 0.7 0.1 0.0 0.6 0.3 0.4 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 1.3 0.1 0.0 1.4 0.1 3.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.0 0.4 0.0 5.3 0.2 0.0 0.0 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154302 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 273.1" "Cell type enhanced" "Detected in many" "dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2" "Cancer enhanced" "Detected in some" "glioma: 4.2;ovarian cancer: 3.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 52.1" "Group enriched" "Detected in many" 23 "B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7" "Cell line enhanced" "Detected in some" "HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1" HPA026916 Approved NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 2.1 0.4 119.1 1.7 140.3 0.6 1.1 45.1 273.1 5.8 37.8 2.7 0.6 1.9 0.0 0.4 0.9 0.4 0.7 153.8 75.1 0.4 1.1 1.1 2.8 124.3 83.1 1.0 0.2 0.0 2.1 0.1 129.5 1.0 0.2 1.6 0.5 0.3 2.7 1.3 2.0 0.2 70.1 2.8 1.0 1.3 101.6 0.2 0.5 0.1 1.5 0.8 3.1 185.5 0.6 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.0 0.2 1.8 0.0 0.2 0.3 0.1 0.2 0.6 0.0 0.1 0.0 5.3 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.5 2.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.2 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.1 0.0 0.0 0.0 15.0 0.0 9.5 19.0 23.7 17.2 0.1 14.6 7.5 13.8 0.6 52.1 0.1 1.3 7.5 4.9 119.1 140.3 45.1 273.1 153.8 75.1 124.3 83.1 129.5 70.1 101.6 185.5 1.1 0.0 1.3 7.2 8.0 2.0 0.1 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 1.8 0.0 0.0 14.0 0.0 0.0 0.0 0.1 0.0 1.0 0.9 0.0 0.4 42.0 0.2 0.1 1.1 0.0 0.0 1.3 0.1 0.7 0.2 0.1 1.7 12.9 0.0 0.0 0.0 4.4 0.2 1.2 0.7 3.6 9.4 0.2 1.5 0.0 3.5 6.2 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 6.6 0.7 1.1 3.1 5.0 0.1 1.1 0.3 19.2 0.0 0.0 0.0 GBP5 ENSG00000154451 "Guanylate binding protein 5" Q96PP8 1 89258950-89272804 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Antimicrobial, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.9;lymphoid tissue: 73.9" "Cell type enhanced" "Detected in many" "dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 243.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5" "Low region specificity" "Detected in many" HPA028656 Supported NA NA "Cluster 13: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "HPA028656: AB_10601471" "unprognostic (2.72e-2)" "unprognostic (1.82e-2)" "prognostic favorable (9.54e-4)" "prognostic favorable (3.73e-6)" "unprognostic (8.33e-2)" "unprognostic (8.68e-3)" "unprognostic (3.71e-2)" "unprognostic (6.43e-3)" "unprognostic (2.37e-3)" "prognostic favorable (1.24e-4)" "unprognostic (3.47e-2)" "unprognostic (4.16e-1)" "prognostic unfavorable (5.53e-8)" "unprognostic (2.75e-2)" "unprognostic (3.68e-2)" "unprognostic (1.66e-1)" "unprognostic (4.11e-2)" 3.7 3.3 0.4 73.9 0.5 34.9 4.6 0.4 1.7 3.1 1.5 6.9 5.8 2.3 1.4 2.6 3.1 11.5 2.0 0.4 0.5 2.0 11.1 19.1 54.4 2.9 0.7 2.7 1.1 0.7 1.0 2.8 1.2 2.3 8.0 0.2 4.8 1.2 0.7 1.0 9.0 6.1 0.5 42.7 9.2 4.0 0.8 12.4 2.3 0.9 23.3 12.7 1.4 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.7 1.2 1.2 0.0 0.1 0.1 6.5 5.3 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.9 0.6 3.0 0.3 0.0 0.0 10.0 1.4 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.6 1.3 0.1 0.0 0.0 4.0 0.1 0.5 0.5 0.0 2.2 20.7 0.5 0.1 0.2 31.5 0.0 0.9 15.3 1.1 97.5 38.0 150.4 4.8 63.1 89.3 6.7 6.0 23.2 35.8 97.9 53.4 44.9 0.7 243.8 38.4 0.4 0.5 0.4 1.7 0.4 0.5 2.9 0.7 1.2 0.5 0.8 0.7 2.1 6.4 5.1 0.0 12.4 0.0 0.2 0.5 0.6 0.0 0.4 0.4 0.7 1.5 4.2 0.0 4.2 0.1 39.2 0.1 0.0 0.0 0.4 3.7 0.4 2.8 0.0 0.8 0.0 1.1 0.0 1.5 2.0 3.9 10.8 0.2 4.6 0.6 4.0 0.0 0.7 0.0 0.0 18.9 1.4 0.2 0.0 17.1 0.0 2.8 10.4 2.9 75.2 0.0 0.0 1.3 0.0 0.0 22.9 0.4 0.0 0.3 8.0 0.4 0.0 0.9 0.9 0.1 2.9 0.9 0.0 0.1 72.9 11.0 0.1 0.1 GFI1 "GFI-1, GFI1A, ZNF163" ENSG00000162676 "Growth factor independent 1 transcriptional repressor" Q99684 1 92473043-92486925 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 53.7;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in some" "dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB011197 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB011197: AB_532302" "unprognostic (5.67e-4)" "unprognostic (8.67e-3)" "prognostic favorable (5.68e-5)" "unprognostic (4.88e-3)" "unprognostic (3.57e-2)" "unprognostic (5.86e-3)" "unprognostic (2.06e-1)" "unprognostic (3.87e-3)" "unprognostic (1.26e-3)" "unprognostic (4.47e-3)" "unprognostic (5.20e-2)" "unprognostic (1.72e-1)" "unprognostic (6.80e-6)" "unprognostic (2.63e-1)" "unprognostic (8.27e-2)" "unprognostic (3.97e-1)" "unprognostic (4.37e-2)" 1.0 0.5 0.1 5.1 0.2 53.7 0.9 0.1 0.1 0.6 0.3 3.6 4.7 0.6 0.5 0.5 0.7 1.9 0.3 0.1 0.1 0.5 1.0 2.8 6.9 0.3 0.1 0.5 9.4 0.2 0.5 0.2 0.2 0.8 4.5 0.0 1.0 0.3 0.2 0.3 5.7 0.4 0.2 7.0 3.2 0.9 0.2 31.2 0.9 0.0 4.4 1.7 0.6 0.2 1.4 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.1 0.1 1.0 10.3 0.1 0.7 0.0 0.5 0.4 1.2 0.0 0.2 0.0 2.5 1.6 0.2 5.3 0.1 61.9 47.5 0.0 0.0 0.1 0.1 0.3 0.1 17.1 0.4 15.3 0.1 2.1 39.5 64.7 0.0 0.1 0.2 7.8 2.7 3.4 0.0 0.7 0.1 0.1 0.3 0.1 0.3 0.1 0.0 127.7 0.0 0.0 1.5 0.1 0.2 22.2 1.6 4.0 0.0 261.3 0.0 0.0 0.0 0.4 2.1 0.0 1.0 0.0 0.9 1.4 0.0 0.0 0.3 1.9 0.0 0.1 0.0 0.8 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.2 0.2 0.2 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.9 0.0 0.1 1.1 0.2 0.0 0.1 1.4 0.0 0.1 0.0 0.1 12.4 0.0 0.8 0.2 0.2 0.0 0.8 0.0 0.0 0.1 0.0 11.3 0.0 0.1 0.4 0.0 0.0 8.6 0.0 0.7 0.1 0.1 0.0 0.0 0.1 0.2 0.5 3.9 0.0 0.0 0.0 16.4 0.1 0.4 0.0 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294539-99307399 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 112.7;lymphoid tissue: 84.5" "Group enriched" "Detected in many" 4 "Langerhans cells: 2572.5;Macrophages: 809.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 1050.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 23 "HDLM-2: 157.7;HL-60: 108.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033690, HPA075590" Approved NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "CAB033690: AB_2114269, HPA075590: " "unprognostic (3.28e-3)" "prognostic favorable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 26.2 12.8 1.9 84.5 2.1 112.7 11.2 2.2 3.5 12.6 7.1 14.8 8.0 6.6 2.4 15.2 6.5 40.5 13.1 1.8 5.5 3.8 17.1 20.1 67.7 8.1 3.0 3.5 4.6 3.8 5.1 27.8 5.2 9.4 21.3 2.0 5.2 3.9 2.0 5.9 23.6 21.9 3.9 35.1 15.7 1.5 3.5 31.8 15.2 4.1 75.6 52.3 5.3 7.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.2 0.8 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.4 157.7 0.0 1.4 0.4 0.0 0.0 108.6 0.3 0.0 0.0 1.5 0.0 0.0 0.0 5.7 2.6 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.8 0.3 0.7 0.0 1050.9 10.4 391.6 43.7 3.8 264.5 364.1 463.0 240.9 77.9 172.1 286.1 39.8 9.9 487.0 3.9 255.2 401.6 255.9 1.9 2.1 2.2 3.5 1.8 5.5 8.1 3.0 5.2 3.9 3.5 7.3 6.0 16.0 26.3 0.0 413.9 61.6 0.8 0.5 2.2 0.3 2.5 3.9 4.6 1.5 6.3 0.0 6.2 1.0 168.8 0.5 1.9 0.2 0.7 0.6 1.3 17.1 0.0 4.4 0.2 2.9 1.5 12.8 11.2 0.9 60.9 0.1 0.7 1.2 113.4 0.0 0.2 0.0 18.3 119.1 2572.5 2.8 0.3 809.4 145.9 46.9 248.7 0.1 1.0 0.5 0.3 1.0 0.0 0.0 85.5 0.4 0.0 0.8 3.8 0.9 6.6 2.1 9.1 0.4 0.2 1.3 53.4 1.8 245.2 0.0 0.3 0.6 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005135-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.6;lymphoid tissue: 9.6" "Cell type enhanced" "Detected in many" "dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5" "Not detected" "Not detected" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 2.0 1.1 0.5 9.1 0.6 12.6 0.9 0.5 0.8 1.1 0.6 1.2 1.6 0.7 0.4 0.9 0.7 2.8 0.6 0.4 1.0 0.8 2.7 4.3 8.8 1.9 1.0 0.3 0.4 0.4 0.4 1.7 1.6 0.8 1.5 0.1 0.7 0.5 0.2 0.3 2.4 2.3 1.0 9.6 1.6 0.6 1.2 4.2 0.4 0.5 6.6 3.4 0.5 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.2 7.5 9.0 0.3 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 39.0 19.8 43.6 33.8 28.4 62.4 9.3 16.9 26.2 13.0 8.1 8.6 19.4 15.2 49.1 32.1 5.9 9.0 24.5 0.5 0.6 0.5 0.8 0.4 1.0 1.9 1.0 1.6 1.0 1.2 2.3 2.9 3.2 21.6 0.3 77.8 4.2 0.5 0.0 0.0 0.2 1.9 3.2 0.4 7.2 1.3 0.0 0.0 0.2 256.1 0.5 0.0 0.0 9.1 0.2 0.4 2.1 0.0 6.6 0.0 0.0 0.3 2.3 6.6 0.5 317.8 0.0 3.9 1.4 62.8 0.0 0.0 0.6 0.0 112.5 73.1 1.4 0.6 88.6 3.6 4.7 90.9 0.0 319.3 0.0 0.1 0.0 0.0 0.0 25.6 0.2 0.1 0.3 0.7 0.2 0.0 0.9 2.0 0.1 0.1 0.7 5.3 0.4 192.8 0.9 0.4 0.2 GZMA "CTLA3, HFSP" ENSG00000145649 "Granzyme A" P12544 5 55102646-55110252 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 68.1" "Group enriched" "Detected in many" 24 "dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 15 "gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8" "Group enriched" "Detected in all" 42 "NK-cells: 718.8;T-cells: 941.4" "Cell line enhanced" "Detected in some" "HL-60: 4.0;JURKAT: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054134, HPA076751" Enhanced "Secreted to blood" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA054134: AB_2682395, HPA076751: " "prognostic favorable (7.27e-4)" "unprognostic (7.29e-3)" "unprognostic (1.50e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.96e-3)" "unprognostic (1.85e-3)" "unprognostic (8.30e-3)" "unprognostic (1.15e-2)" "unprognostic (5.15e-3)" "unprognostic (3.03e-2)" "unprognostic (1.77e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.26e-6)" "unprognostic (5.91e-2)" "unprognostic (5.57e-1)" "unprognostic (5.73e-3)" "unprognostic (3.33e-3)" 5.6 6.0 0.9 16.7 0.9 35.3 7.2 0.9 2.5 7.6 1.2 14.7 29.2 14.7 8.8 4.8 4.6 14.0 4.0 0.8 1.0 3.2 15.2 21.9 68.1 1.6 0.9 4.5 1.0 1.3 1.0 3.1 1.1 3.1 17.8 0.0 7.1 3.0 1.7 1.6 27.6 7.2 1.1 51.1 11.7 2.0 1.1 12.4 2.9 1.3 19.2 13.5 2.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.5 3.8 941.4 2.3 926.2 3.4 250.0 922.7 3.1 1.3 48.5 494.1 19.9 718.8 4.0 3.2 33.1 712.7 0.9 0.9 0.9 2.5 0.8 1.0 1.6 0.9 1.1 1.1 1.1 1.1 5.1 3.2 18.1 0.0 12.3 0.4 0.1 0.0 2.8 0.0 2.7 2.4 1.6 5.7 3.1 0.0 0.0 0.4 739.3 1.4 0.0 1.6 0.0 1.7 2.7 2.8 0.0 36.2 0.0 0.0 0.2 7.8 20.4 2.1 7.6 0.0 17.9 2.8 0.3 0.0 0.1 1.5 0.0 25.8 2.6 0.0 0.0 12.3 3.6 0.0 12.6 0.0 1543.8 0.0 0.1 0.0 3.9 0.0 40.8 0.1 2.8 3.3 2.9 0.0 0.0 2.6 2.6 0.0 0.1 1.1 1.4 0.7 709.4 0.0 1.8 0.0 GZMB "CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT" ENSG00000100453 "Granzyme B" P10144 14 24630954-24634267 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 68.2;lymphoid tissue: 37.1" "Group enriched" "Detected in many" 5 "dendritic cells: 2050.2;NK-cells: 1704.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 6765.2" "Lineage enriched" "Detected in all" 5 "dendritic cells: 6765.2" "Cell line enriched" "Detected in some" 6 "HMC-1: 22.0" "CAB000376, HPA003418" Enhanced "Secreted to blood" NA NA 2170 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB000376: AB_323716, HPA003418: AB_1079020" "prognostic favorable (7.27e-4)" "unprognostic (2.82e-3)" "unprognostic (8.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (2.07e-3)" "unprognostic (1.48e-3)" "unprognostic (4.43e-2)" "unprognostic (8.25e-2)" "unprognostic (3.70e-2)" "unprognostic (3.05e-3)" "unprognostic (4.26e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.10e-7)" "unprognostic (1.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-3)" 8.2 1.7 1.2 17.8 1.3 68.2 2.1 1.2 3.9 1.2 1.4 2.5 2.3 7.1 1.6 3.8 1.5 6.5 1.8 1.2 7.9 1.5 4.1 15.3 37.1 1.5 1.5 0.3 1.0 0.7 0.7 3.3 1.6 1.4 2.2 0.0 2.3 1.4 2.0 0.4 4.4 4.3 1.4 28.9 3.5 0.5 1.8 9.7 1.9 1.5 34.6 18.5 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.7 2.8 9.9 3.0 5.3 1338.5 4.0 16.0 7.0 95.2 641.6 6.3 3.1 29.1 607.5 43.1 507.8 6.0 6765.2 2.7 1607.1 1.2 1.3 1.2 3.9 1.2 7.9 1.5 1.5 1.6 1.4 1.8 1.3 4.3 6.4 36.0 0.0 15.9 2.8 0.3 0.0 0.0 0.0 0.9 0.8 1.1 4.3 7.4 0.0 0.0 0.4 2050.2 0.6 0.0 1.6 0.0 0.4 0.5 2.7 0.0 11.8 0.0 0.0 0.1 5.1 9.2 0.5 17.7 0.0 4.2 1.2 0.2 0.0 0.0 0.6 0.0 4.8 9.0 0.2 0.0 27.1 42.7 1.0 11.6 0.0 1704.4 0.0 0.1 0.1 2.3 0.0 86.8 0.2 0.6 3.1 4.4 0.0 0.0 1.3 1.3 0.0 0.1 0.4 4.1 0.3 373.8 0.0 0.6 0.1 HASPIN GSG2 ENSG00000177602 "Histone H3 associated protein kinase" Q8TF76 17 3723903-3726699 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA027422, HPA030698" Approved Supported Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA027422: AB_10601812, HPA030698: AB_2673575" "unprognostic (1.15e-2)" "unprognostic (2.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.14e-2)" "unprognostic (8.05e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (6.60e-2)" "unprognostic (1.77e-1)" "unprognostic (2.75e-3)" "unprognostic (3.82e-3)" "unprognostic (0.00e+0)" "unprognostic (5.65e-3)" "unprognostic (3.09e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" 0.2 0.1 0.0 1.8 0.2 6.0 0.4 0.0 0.1 0.2 0.2 1.1 1.5 0.2 0.1 1.3 0.3 0.2 0.1 0.0 0.0 0.1 0.1 1.4 4.2 0.1 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.3 1.0 0.0 0.4 0.0 0.6 0.7 1.8 0.4 0.0 1.7 0.9 7.3 0.2 5.3 0.3 0.1 5.1 0.3 0.5 0.2 11.3 12.2 11.1 12.5 0.7 1.4 9.3 10.2 7.8 19.7 19.3 9.6 4.6 27.7 5.7 5.7 7.9 18.0 20.1 9.9 18.7 0.1 16.7 13.8 9.9 5.8 0.5 8.1 13.7 0.9 0.8 14.9 9.2 2.4 9.1 21.6 12.4 23.7 10.1 5.9 16.4 4.8 9.8 8.7 8.3 16.8 13.9 7.4 3.0 7.8 4.4 6.5 8.9 6.1 3.5 9.6 6.1 7.5 4.7 8.7 9.9 9.8 18.1 4.5 5.4 13.4 5.1 11.5 10.7 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.2 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 HEATR9 "C17orf66, FLJ32830" ENSG00000270379 "HEAT repeat containing 9" A2RTY3 17 35854946-35868891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 10.1" "Group enriched" "Detected in some" 17 "Early spermatids: 88.4;Late spermatids: 36.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA023129 Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA023129: AB_1845599" "unprognostic (1.02e-1)" "unprognostic (2.63e-3)" "unprognostic (5.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (7.44e-4)" "unprognostic (1.30e-3)" "unprognostic (2.43e-2)" "unprognostic (2.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.61e-10)" "unprognostic (6.78e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (5.61e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 88.4 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.0 36.4 0.6 0.1 0.0 0.0 0.1 0.0 3.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 HLA-C "D6S204, HLA-JY3, PSORS1" ENSG00000204525 "Major histocompatibility complex, class I, C" P10321 6 31268749-31272130 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1445.7" "Cell type enhanced" "Detected in all" "NK-cells: 3899.1;Proximal enterocytes: 3582.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 760.0;EFO-21: 795.5;RPTEC TERT1: 462.7;U-266/70: 481.6;U-266/84: 401.0;U-698: 289.3" "Intracellular and membrane" NA NA 240000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (2.17e-1)" "unprognostic (3.38e-1)" "unprognostic (3.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.56e-1)" "unprognostic (2.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-3)" "unprognostic (3.23e-3)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (8.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.16e-2)" 538.6 417.5 0.7 274.6 2.4 122.3 507.4 0.8 0.9 464.4 1.5 594.3 1.6 434.8 259.5 277.6 411.7 103.9 424.3 0.3 1.1 561.0 485.7 1078.3 334.0 1.6 0.9 266.3 245.3 0.2 269.6 34.5 0.9 344.2 27.7 13.7 389.5 0.4 190.6 449.6 750.0 51.0 1.3 1445.7 419.4 62.3 1.2 2.4 382.9 0.3 0.7 372.7 377.5 0.8 760.0 1.1 0.0 0.0 120.1 94.1 1.7 3.1 0.9 1.1 2.3 0.9 0.0 0.4 795.5 190.8 208.7 0.5 0.0 188.1 0.0 1.4 170.4 0.8 8.1 0.1 0.8 0.5 0.5 80.5 0.2 0.5 0.0 272.4 0.0 92.5 0.4 0.0 0.0 0.0 7.8 4.8 0.5 0.0 0.8 1.9 0.3 1.9 462.7 0.0 0.9 1.5 0.2 0.1 2.2 0.3 0.3 3.3 0.6 196.4 65.8 2.3 2.5 481.6 401.0 289.3 0.3 8.2 0.2 1.9 2.8 2.3 0.7 0.8 0.6 0.4 0.4 0.6 0.4 0.4 0.4 0.5 2.8 0.8 0.3 0.1 0.9 46.1 0.7 2.4 0.8 0.9 0.3 1.1 1.6 0.9 0.9 1.3 1.2 0.8 1903.4 227.6 328.1 13.1 1576.5 729.1 757.8 1082.3 236.8 33.4 457.0 342.8 61.2 807.8 662.7 483.7 10.4 39.5 2429.1 1994.0 84.1 1966.4 25.6 233.7 343.8 1466.2 482.2 301.2 3.9 1511.3 1010.7 608.5 648.8 557.2 344.1 256.3 1390.0 469.2 1579.0 99.3 5.8 1375.7 923.7 2050.7 1492.7 32.1 507.3 1595.9 836.0 76.8 2570.1 207.3 3899.1 18.6 3.8 1272.7 2195.7 333.6 2482.6 1038.0 3582.3 232.5 548.5 24.0 1203.0 336.7 558.8 142.0 43.5 192.6 651.7 121.6 2212.1 786.8 1003.1 1160.6 HLA-DMB "D6S221E, RING7" ENSG00000242574 "Major histocompatibility complex, class II, DM beta" P28068 6 32934629-32941028 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.8;lymphoid tissue: 101.5" "Group enriched" "Detected in many" 4 "B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9" "Low region specificity" "Detected in all" "HPA012298, HPA077524" Supported Supported Vesicles NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Vesicles "HPA012298: AB_1853927, HPA077524: " "unprognostic (5.34e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.89e-5)" "unprognostic (3.07e-1)" "unprognostic (7.64e-3)" "unprognostic (4.00e-1)" "unprognostic (3.46e-3)" "unprognostic (6.99e-2)" "unprognostic (8.76e-2)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (6.82e-3)" "unprognostic (2.03e-1)" "unprognostic (4.14e-2)" "unprognostic (8.35e-2)" "unprognostic (5.60e-2)" 38.3 35.9 0.1 13.2 0.2 6.9 25.7 0.3 1.0 21.6 0.1 19.9 0.0 14.6 7.4 9.3 14.6 0.1 11.1 0.0 0.6 41.9 7.8 59.9 17.6 0.3 0.4 9.5 9.1 0.0 9.2 0.8 0.2 13.1 14.9 0.5 14.7 0.0 5.3 14.3 78.8 0.0 0.9 101.5 17.6 2.2 0.1 9.9 45.9 0.0 18.8 14.4 10.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 27.6 12.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 7.8 0.4 31.9 0.0 0.1 0.0 0.5 73.2 16.7 1.2 73.8 2.6 94.0 1.0 2.9 85.0 128.8 0.7 2.4 4.7 16.2 28.1 85.3 6.7 71.4 0.1 0.2 0.3 1.0 0.0 0.6 0.3 0.4 0.2 0.9 0.1 1.1 36.8 9.6 57.0 0.7 228.5 12.0 1.0 5.4 2.2 0.2 2.5 4.7 2.6 5.7 12.7 16.5 0.0 1.7 129.4 3.3 11.7 28.8 0.5 7.5 5.4 37.2 4.2 10.3 0.8 4.4 1.6 3.8 3.1 38.5 15.2 22.7 5.7 0.5 274.8 0.0 0.6 8.5 2.0 201.9 472.8 1.5 3.4 272.4 16.0 27.2 187.1 0.5 21.6 1.0 0.1 2.5 17.8 1.9 3.8 1.3 284.8 7.4 16.8 1.1 6.6 1.6 3.1 0.6 0.7 1.1 10.9 2.7 17.6 0.9 10.3 8.7 IFNG ENSG00000111537 "Interferon gamma" P01579 12 68154768-68159740 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense, Growth regulation" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 11.5;lymphoid tissue: 7.4" "Group enriched" "Detected in many" 12 "dendritic cells: 283.2;T-cells: 200.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 7 "T-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB010344 Approved "Secreted to blood" NA NA 1470 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 7: Non-specific - Mitochondria" "CAB010344: AB_2123447" "unprognostic (2.16e-4)" "unprognostic (1.93e-3)" "unprognostic (9.21e-2)" "unprognostic (1.04e-4)" "unprognostic (5.14e-1)" "unprognostic (3.96e-3)" "unprognostic (1.33e-1)" "unprognostic (3.17e-4)" "unprognostic (7.79e-2)" "unprognostic (7.97e-3)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (7.62e-9)" "unprognostic (3.54e-2)" "unprognostic (5.36e-1)" "unprognostic (6.32e-2)" "unprognostic (7.38e-3)" 0.7 0.7 0.1 3.5 0.2 11.5 0.3 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.5 0.2 0.0 0.0 0.3 1.5 1.8 7.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.9 0.2 0.0 0.0 0.3 0.2 0.0 1.3 0.4 0.1 0.1 0.5 0.3 0.0 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 2.4 6.6 0.0 0.4 0.5 3.7 0.1 0.9 0.0 0.0 0.1 0.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.0 0.0 0.0 3.1 3.2 1.3 0.0 0.0 0.0 4.8 5.5 0.2 1.5 0.0 0.0 0.0 0.0 283.2 0.1 0.0 0.0 0.2 1.0 1.1 1.3 0.0 0.4 0.0 0.0 0.0 1.5 6.1 1.1 0.0 0.0 1.4 1.2 0.1 0.0 0.0 0.5 0.0 4.4 5.5 0.0 0.0 10.4 7.2 0.0 0.0 0.0 19.6 0.0 0.1 0.0 1.1 0.0 10.9 0.2 0.0 0.3 0.0 0.0 0.0 1.0 2.9 0.0 0.0 0.8 4.0 0.0 200.1 0.0 0.2 0.2 IKZF1 "hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1" ENSG00000185811 "IKAROS family zinc finger 1" Q13422 7 50304068-50405101 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 173.0;lymphoid tissue: 112.5" "Cell type enhanced" "Detected in many" "B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009247, HPA035221, HPA035222" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525" "prognostic favorable (4.28e-4)" "prognostic favorable (2.02e-4)" "unprognostic (2.49e-3)" "unprognostic (2.41e-3)" "unprognostic (5.59e-1)" "prognostic favorable (8.63e-4)" "unprognostic (1.45e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-2)" "unprognostic (2.43e-1)" "unprognostic (6.63e-2)" "unprognostic (2.95e-1)" "unprognostic (1.69e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-2)" "unprognostic (6.77e-2)" "unprognostic (4.67e-2)" 5.0 3.2 3.5 53.0 3.4 173.0 4.4 4.0 3.9 3.6 3.3 7.6 7.0 2.5 2.3 4.8 2.2 7.7 1.5 3.0 4.0 1.4 4.9 11.6 87.1 7.7 5.2 1.6 0.8 0.8 0.6 3.6 7.5 2.3 6.8 0.2 4.6 1.9 1.0 2.0 15.6 4.0 7.3 48.6 12.0 1.7 8.7 112.5 2.1 1.2 73.8 9.6 1.8 10.3 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 258.6 0.2 52.1 0.0 0.0 0.0 84.5 220.4 0.0 0.0 0.0 0.0 0.0 0.0 128.9 72.4 15.4 0.0 0.0 184.3 80.9 2.4 0.0 0.0 192.3 0.3 39.6 0.0 0.0 1.6 2.0 0.8 1.0 0.8 0.4 0.2 112.1 0.2 0.0 1.9 0.2 0.4 80.8 49.4 342.7 0.5 89.5 0.5 21.2 14.2 25.0 35.4 43.9 29.1 46.7 36.3 35.0 15.1 40.7 48.2 35.7 20.2 24.3 43.3 23.4 32.6 26.4 3.5 3.4 4.0 3.9 3.0 4.0 7.7 5.2 7.5 7.3 8.7 10.3 2.8 3.2 12.2 0.7 120.5 2.8 0.1 0.0 0.0 0.0 2.8 1.9 1.5 2.8 1.8 1.8 0.0 0.4 221.4 0.3 0.0 0.4 3.8 0.5 0.4 2.6 0.0 89.8 0.2 0.0 0.4 2.5 4.6 0.6 23.4 0.2 3.9 2.0 30.6 0.0 0.3 0.0 0.0 64.3 61.0 5.3 0.0 72.1 19.6 91.8 106.6 0.0 150.4 1.0 0.3 0.1 0.4 0.0 128.9 0.1 0.0 1.0 1.5 0.1 0.0 1.5 1.6 0.1 2.1 0.5 2.7 0.7 182.8 0.1 0.1 0.1 IL2 "IL-2, TCGF" ENSG00000109471 "Interleukin 2" P60568 4 122451470-122456725 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Cytokine, Growth factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Melanocytes: 3.6;T-cells: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB010310 Uncertain "Secreted to blood" NA NA 20300 "Cluster 7: Non-specific - Mitochondria" "CAB010310: AB_649346" "unprognostic (8.87e-5)" "unprognostic (6.13e-3)" "unprognostic (1.38e-3)" "unprognostic (9.79e-3)" "unprognostic (2.56e-2)" "unprognostic (7.32e-2)" "unprognostic (2.06e-5)" "unprognostic (5.21e-3)" "unprognostic (8.01e-2)" 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 13.4 0.0 0.0 0.0 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402174-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 7.6;lymphoid tissue: 24.7" "Cell type enhanced" "Detected in some" "B-cells: 15.5;dendritic cells: 21.8;Langerhans cells: 11.4;NK-cells: 23.7;Plasma cells: 13.4;T-cells: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 25.9;HDLM-2: 110.8;Karpas-707: 49.3;RH-30: 37.2;RPMI-8226: 63.0;U-266/70: 24.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.5 0.4 1.4 11.9 1.0 7.6 0.2 1.1 2.6 0.2 0.9 0.8 0.6 0.3 0.2 0.3 0.2 1.1 0.7 0.9 2.3 0.9 0.4 2.9 24.7 2.1 2.3 0.2 0.3 0.0 0.5 0.8 3.3 0.4 0.9 1.1 0.6 0.1 0.3 0.8 2.1 0.7 1.2 5.5 1.5 1.1 1.2 14.4 0.6 0.0 18.8 2.2 0.2 1.6 0.1 0.2 0.3 0.2 0.0 1.3 0.8 0.8 0.1 0.1 2.2 0.2 0.2 25.9 0.2 2.1 1.4 0.1 0.0 0.1 0.1 110.8 0.1 5.4 0.2 0.7 3.4 0.2 1.5 3.8 0.0 6.8 0.1 0.7 0.0 0.6 0.3 49.3 3.8 0.2 0.1 0.5 0.9 0.1 0.0 0.4 37.2 63.0 0.0 0.1 0.2 0.2 0.1 0.1 2.7 0.2 0.1 1.3 2.8 1.9 0.7 0.6 0.2 24.7 9.4 5.9 5.2 1.4 0.2 0.5 0.4 0.1 13.4 8.3 4.9 1.8 8.6 14.2 2.3 14.2 9.2 9.3 0.9 9.5 27.0 1.1 10.8 7.3 1.4 1.0 1.1 2.6 0.9 2.3 2.1 2.3 3.3 1.2 1.2 1.6 0.2 0.0 1.3 0.0 15.5 0.4 0.1 0.0 0.0 2.0 0.2 0.1 1.9 0.0 0.0 0.0 4.2 0.1 21.8 0.1 0.0 0.0 6.5 0.1 0.2 0.9 0.0 0.0 0.4 0.0 0.1 0.3 1.5 0.2 0.0 0.0 1.1 0.2 8.2 0.0 0.5 0.0 0.0 5.0 11.4 5.7 0.0 3.6 1.8 2.8 1.8 0.2 23.7 0.5 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.0 0.5 0.0 0.8 0.8 0.2 0.0 0.0 0.9 0.1 25.1 0.1 0.1 0.1 INPP5D "hp51CN, SHIP, SHIP1" ENSG00000168918 "Inositol polyphosphate-5-phosphatase D" Q92835 2 233059967-233207903 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 50.8;lymphoid tissue: 99.4" "Cell type enhanced" "Detected in many" "B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016300, HPA070455" Enhanced Supported Cytosol No No 4400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB016300: AB_628250, HPA070455: AB_2686267" "unprognostic (5.29e-2)" "unprognostic (2.05e-3)" "unprognostic (1.99e-2)" "unprognostic (6.71e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (3.74e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (6.54e-2)" 15.5 5.8 6.7 19.8 7.3 32.7 11.4 7.6 6.5 9.2 6.7 9.5 3.7 6.3 2.8 7.5 9.2 6.0 8.2 6.0 8.5 9.5 6.5 25.2 34.1 10.8 9.4 3.2 3.1 1.2 6.9 8.4 11.2 11.8 4.7 0.3 26.3 2.9 3.9 7.9 50.8 3.5 9.3 99.4 6.3 3.5 10.4 14.5 7.8 1.7 31.9 9.8 8.4 10.3 0.1 0.1 0.6 0.0 0.0 0.2 4.8 0.1 0.2 0.1 0.0 0.0 1.2 17.9 0.0 0.0 0.0 0.1 0.0 44.7 0.1 15.4 0.2 94.6 0.1 9.0 0.7 28.7 94.8 1.6 87.1 0.3 9.6 0.3 12.7 2.6 0.4 8.0 0.4 0.0 13.2 89.4 2.9 0.0 0.1 27.5 0.1 6.5 0.1 5.5 0.1 0.1 0.0 1.7 0.0 11.1 0.0 62.9 10.7 0.0 1.5 0.0 0.0 0.2 5.2 26.7 0.1 36.5 0.2 13.2 10.8 11.4 16.0 15.8 10.9 14.0 7.1 12.0 12.3 12.6 5.8 8.4 10.3 12.5 20.0 6.1 10.5 17.9 6.7 7.3 7.6 6.5 6.0 8.5 10.8 9.4 11.2 9.3 10.4 10.3 18.1 3.2 15.5 3.3 94.5 1.7 1.6 5.4 9.1 0.5 3.2 5.8 3.6 4.3 5.2 3.7 0.0 0.6 95.8 1.1 0.0 0.5 13.0 0.8 0.3 20.8 0.0 35.7 2.6 0.5 0.8 1.7 2.0 0.5 15.2 0.1 15.0 2.2 29.2 0.0 1.1 0.2 0.0 65.6 17.1 13.4 0.0 51.5 0.0 181.8 51.4 0.0 193.6 4.0 1.8 0.4 2.5 1.2 34.0 0.6 0.1 0.4 5.7 0.0 0.0 2.0 1.7 0.5 1.0 3.1 1.1 1.1 60.6 0.1 0.5 1.5 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132440440-132508719 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 142.1" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 516.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 138.1;REH: 114.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: AB_2684945" "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 53.7 19.1 8.2 88.0 7.6 142.1 29.5 8.1 9.4 21.3 7.7 46.3 84.8 21.3 11.7 24.3 24.4 32.6 25.8 7.3 7.5 32.9 54.4 119.0 86.3 17.2 8.1 18.4 15.6 7.4 17.3 22.2 15.8 36.4 38.1 2.8 28.7 16.2 16.7 19.7 68.8 33.1 8.8 117.4 47.4 13.5 10.5 66.4 25.8 13.3 45.3 63.9 24.1 8.0 26.7 22.8 2.3 8.1 22.1 18.9 42.5 14.7 58.8 41.6 52.2 11.3 79.4 26.7 15.8 18.4 64.8 35.7 7.4 33.7 14.3 54.2 7.1 33.2 8.1 6.9 138.1 14.6 34.3 36.9 9.4 31.7 32.2 26.5 22.4 19.1 6.9 97.5 13.1 15.9 87.6 32.7 3.4 9.3 14.6 114.5 23.2 31.7 22.5 27.8 6.4 3.6 14.6 30.8 13.4 10.1 4.7 24.2 13.0 20.5 8.1 12.8 19.8 74.8 27.0 19.3 24.9 27.2 15.5 175.3 167.1 257.0 157.2 244.1 106.9 68.4 104.2 129.9 95.7 62.5 63.5 91.7 621.0 136.9 272.4 52.4 122.1 160.0 8.2 7.6 8.1 9.4 7.3 7.5 17.2 8.1 15.8 8.8 10.5 8.0 369.9 102.5 114.3 1.0 216.5 88.1 129.4 66.3 306.7 14.7 216.5 186.6 17.0 47.1 58.0 22.0 33.3 24.0 396.3 183.6 19.6 112.1 92.5 242.3 170.8 223.1 87.1 36.6 1.1 114.3 42.6 224.4 212.0 288.1 105.2 32.0 58.2 14.6 49.7 1.7 1.2 137.4 57.0 73.9 228.7 9.1 27.4 134.1 72.9 7.5 257.2 16.7 399.6 2.5 1.1 88.6 140.6 7.9 248.6 270.9 155.5 22.4 110.9 46.5 13.1 516.2 225.0 1.3 6.8 118.8 82.7 11.2 301.4 20.5 94.6 95.0 ITGAX CD11C ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382999 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 87.5" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HMC-1: 106.1" "Not detected" "Not detected" "CAB004458, HPA004723, CAB072871" Enhanced NA NA 50000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 12.9 2.3 6.0 42.7 8.1 48.1 4.3 8.8 33.7 2.2 8.4 2.9 2.3 2.8 0.8 2.0 5.9 10.8 3.5 6.2 9.3 2.9 6.3 58.1 23.2 14.6 11.8 1.0 2.9 1.4 2.9 4.6 14.3 3.2 4.3 0.6 4.5 1.5 1.3 2.1 5.5 4.7 13.0 67.5 4.8 0.6 18.4 4.0 2.8 3.2 12.3 9.2 2.1 24.8 0.1 0.6 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 9.0 0.0 0.3 0.1 0.0 0.3 0.1 18.6 0.1 0.1 0.3 0.4 0.0 1.1 106.1 0.1 0.1 1.7 0.2 0.7 1.0 0.0 0.1 0.4 0.0 0.0 0.1 8.8 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.1 0.0 3.3 0.8 0.0 1.6 0.0 0.1 0.1 0.0 0.2 4.9 1.8 0.3 12.8 29.1 27.1 4.8 50.3 0.4 2.1 0.1 0.7 34.7 1.0 0.1 0.7 87.5 41.4 61.0 0.6 0.1 11.5 6.0 8.1 8.8 33.7 6.2 9.3 14.6 11.8 14.3 13.0 18.4 24.8 0.8 12.8 51.1 0.0 9.8 2.8 0.3 0.0 0.0 0.1 0.6 1.3 1.5 0.0 10.5 0.0 0.0 0.4 33.6 0.0 0.0 0.3 0.0 0.4 0.5 4.8 0.0 3.4 0.2 0.0 0.6 4.4 0.0 0.5 74.0 0.0 1.1 0.1 45.1 0.0 0.3 0.0 0.0 51.5 77.3 0.0 0.0 141.7 1.8 56.2 35.3 0.1 68.0 0.5 0.3 0.2 0.0 0.0 5.5 0.2 0.0 0.3 1.5 0.1 0.0 0.6 1.0 0.0 0.2 0.0 1.1 0.4 16.5 0.1 0.0 0.1 ITPRIPL1 KIAA1754L ENSG00000198885 "ITPRIP like 1" Q6GPH6 2 96325317-96330517 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Group enriched" "Detected in many" 10 "Early spermatids: 170.7;Late spermatids: 145.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 12.9" "Lineage enriched" "Detected in many" 5 "T-cells: 12.9" "Cell line enhanced" "Detected in many" "HEK 293: 30.9;HEL: 32.0;MOLT-4: 34.5;RPMI-8226: 33.0;U-698: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.26e-3)" "unprognostic (3.56e-3)" "unprognostic (4.78e-2)" "unprognostic (9.43e-2)" "unprognostic (2.22e-1)" "unprognostic (6.56e-4)" "unprognostic (3.04e-2)" "unprognostic (2.87e-1)" "unprognostic (6.50e-2)" "unprognostic (5.36e-2)" "unprognostic (8.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.41e-5)" "unprognostic (4.97e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (6.39e-2)" 3.4 0.4 0.5 2.9 1.0 1.1 3.8 3.2 0.7 0.9 0.3 0.9 1.2 0.5 0.5 1.5 0.8 1.6 1.3 0.5 0.5 0.5 0.5 1.4 3.9 0.9 0.5 0.4 1.4 0.5 0.4 1.2 0.8 2.0 0.9 0.9 7.5 1.5 1.5 0.8 1.7 1.0 0.6 2.6 1.2 27.8 0.6 5.1 0.7 2.0 4.2 1.5 1.2 0.8 0.0 0.0 7.3 0.1 0.8 1.9 8.3 1.6 8.7 7.2 14.1 3.3 0.3 0.0 0.1 3.1 0.1 0.7 25.4 0.0 8.1 15.7 30.9 32.0 0.2 14.4 3.9 0.1 0.0 5.4 0.0 8.3 0.0 0.0 4.7 20.4 0.0 10.6 0.2 0.0 34.5 5.0 10.5 0.0 0.0 22.7 23.1 33.0 0.3 0.0 21.2 14.2 0.0 0.0 0.1 4.4 0.0 5.3 2.4 0.0 0.8 0.1 0.1 15.4 21.4 35.3 4.1 0.0 6.8 0.4 0.2 0.0 10.2 0.2 12.9 1.6 3.3 9.7 1.2 0.4 0.7 4.1 0.1 2.7 0.0 0.5 6.3 2.3 0.5 1.0 3.2 0.7 0.5 0.5 0.9 0.5 0.8 0.6 0.6 0.8 9.4 3.2 0.0 0.0 2.3 0.3 4.8 1.8 2.2 0.7 3.6 2.9 0.7 2.8 3.5 0.0 4.2 0.9 6.9 1.0 0.0 0.1 170.7 0.2 0.6 2.7 0.0 1.7 0.2 0.2 2.3 0.9 0.5 0.1 0.0 0.8 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.3 2.4 145.2 1.2 1.8 1.8 0.0 0.3 4.3 11.3 0.0 0.0 0.3 0.1 0.7 7.6 3.3 0.0 0.3 0.8 1.7 6.6 0.6 2.9 3.6 2.8 1.7 1.0 0.4 14.8 0.3 0.4 1.3 KCNA3 "HLK3, HPCN3, Kv1.3, MK3" ENSG00000177272 "Potassium voltage-gated channel subfamily A member 3" P22001 1 110672465-110674940 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 25.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 13.1;Inhibitory neurons: 60.2;Plasma cells: 61.6;T-cells: 20.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 4.9;T-cells: 14.3" "Cell line enhanced" "Detected in some" "HDLM-2: 23.1;Karpas-707: 45.6;U-266/70: 32.6;U-266/84: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016625 Approved NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 58: T-cells - T-cell receptor" "HPA016625: AB_2669407" "unprognostic (2.17e-2)" "unprognostic (5.07e-3)" "unprognostic (3.92e-3)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (1.76e-5)" "unprognostic (1.70e-4)" "unprognostic (8.48e-2)" "unprognostic (1.49e-2)" "unprognostic (5.92e-4)" "unprognostic (1.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" 0.5 0.9 3.4 6.4 2.0 4.6 0.9 1.1 4.9 1.1 0.0 2.4 2.5 0.5 0.0 0.5 0.3 1.3 0.4 5.0 7.2 0.2 0.8 5.9 9.4 1.1 3.3 0.7 0.4 0.4 0.4 0.7 5.0 0.5 1.9 0.6 1.4 0.2 0.1 0.2 2.6 0.6 0.2 6.0 4.3 0.5 3.3 25.4 0.7 0.1 7.6 2.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 45.6 0.0 0.0 10.0 0.0 0.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 6.3 0.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.7 0.0 0.0 32.6 31.9 11.6 0.0 2.7 0.0 0.0 1.1 0.0 8.9 0.0 10.0 2.8 13.4 14.3 1.4 4.9 10.4 7.9 0.0 1.3 0.1 0.6 13.4 4.4 3.4 2.0 1.1 4.9 5.0 7.2 1.1 3.3 5.0 0.2 3.3 0.0 0.2 0.0 1.9 1.3 11.5 0.4 0.0 0.0 0.0 2.5 0.1 0.0 0.6 0.0 0.0 1.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.3 13.1 0.0 0.0 0.7 1.5 0.0 0.0 0.0 1.8 0.0 0.4 0.0 60.2 0.0 0.0 1.6 2.4 0.0 0.0 3.1 3.6 2.8 2.4 0.3 3.1 7.5 1.3 0.0 0.0 0.0 61.6 0.0 0.0 0.1 0.0 0.2 6.6 0.0 0.1 4.3 0.9 0.1 0.6 0.0 20.3 0.0 0.0 0.1 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023714 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.1;brain: 21.6;retina: 21.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "basophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Cluster 11: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 1.6 0.8 16.1 9.4 16.4 34.1 1.3 0.0 16.5 0.9 0.0 2.4 2.0 0.7 0.4 0.8 1.2 2.1 0.7 21.6 8.3 0.9 1.5 4.8 12.9 5.9 5.7 0.7 0.8 6.0 0.6 0.9 6.5 0.8 1.8 21.4 1.4 0.7 0.3 0.7 6.7 0.8 1.5 12.3 2.5 13.7 9.5 11.8 1.0 0.4 8.0 2.3 0.8 7.9 1.3 1.5 11.8 0.5 0.0 0.0 3.0 0.1 0.0 0.3 0.1 0.7 0.4 39.1 0.5 0.0 3.4 0.3 1.2 0.3 0.4 1.9 0.4 9.7 0.2 0.2 1.0 29.4 41.0 1.0 4.1 0.4 0.7 0.0 1.5 78.8 4.6 49.6 0.0 0.2 24.5 11.2 5.2 3.9 0.0 8.4 0.1 43.8 0.2 0.0 7.2 1.0 0.6 0.5 0.6 2.1 0.2 8.9 2.8 0.0 3.3 0.0 0.2 90.2 44.7 19.3 3.9 12.8 0.3 6.0 0.0 0.6 0.8 0.2 0.9 0.4 0.6 0.8 0.1 0.3 0.5 0.6 1.0 1.3 0.3 0.1 0.6 0.4 16.1 16.4 0.0 16.5 21.6 8.3 5.9 5.7 6.5 1.5 9.5 7.9 1.5 0.0 3.8 22.5 11.0 1.0 0.5 0.2 0.0 25.7 0.4 0.8 1.5 0.0 0.1 1.8 58.4 0.0 17.4 1.2 0.0 0.5 20.4 0.1 0.2 1.8 0.0 4.8 15.6 1.6 0.1 0.6 1.1 0.4 6.3 0.5 1.4 0.3 1.7 1.7 11.8 1.4 0.0 4.4 3.1 82.1 0.9 5.3 0.0 8.4 2.7 20.0 13.4 14.6 4.0 2.4 0.3 0.0 12.0 0.4 0.2 0.0 0.1 26.1 6.6 0.6 1.1 1.9 3.7 0.1 1.0 0.0 18.0 0.1 1.1 2.0 KIR3DL2 "CD158K, cl-5, nkat4, nkat4a, nkat4b" ENSG00000240403 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2" P43630 19 54850443-54867207 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.9" "Group enriched" "Detected in some" 8 "dendritic cells: 37.7;NK-cells: 14.4;T-cells: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 64: Macrophages - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (6.99e-2)" "unprognostic (1.83e-1)" "unprognostic (3.64e-1)" "unprognostic (4.56e-4)" "unprognostic (1.40e-1)" "unprognostic (2.99e-2)" "unprognostic (8.39e-3)" "unprognostic (5.96e-2)" "unprognostic (2.73e-1)" "unprognostic (2.12e-1)" "unprognostic (4.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.65e-3)" "unprognostic (3.62e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412315-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0" "Group enriched" "Detected in some" 4 "dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 6 "NK-cell: 63.1" "Lineage enriched" "Detected in many" 6 "NK-cells: 63.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.2 0.1 1.3 0.3 1.4 1.9 0.1 0.7 2.1 0.1 0.2 0.5 0.8 0.5 0.1 0.2 0.2 0.6 0.0 1.3 1.7 0.1 0.5 0.6 1.7 1.7 1.1 0.1 0.1 0.0 0.0 0.1 1.2 0.1 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.1 1.3 4.0 0.6 0.2 1.3 0.4 0.1 0.0 0.8 0.1 0.1 2.1 0.0 0.0 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.0 0.0 1.3 7.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.0 0.0 7.0 0.0 0.0 0.1 8.7 0.6 63.1 0.0 0.0 0.0 3.6 1.3 1.4 0.7 2.1 1.3 1.7 1.7 1.1 1.2 1.3 1.3 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 0.1 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 1.0 36.2 2.3 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.1 KLRD1 CD94 ENSG00000134539 "Killer cell lectin like receptor D1" Q13241 12 10226058-10329608 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.0" "Cell type enhanced" "Detected in many" "dendritic cells: 740.2;NK-cells: 1316.2;T-cells: 324.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 512.6;memory CD8 T-cell: 217.7;naive CD8 T-cell: 218.7;NK-cell: 737.5" "Group enriched" "Detected in many" 68 "NK-cells: 737.5;T-cells: 512.6" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA069688 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" "HPA069688: AB_2686170" "unprognostic (3.75e-2)" "unprognostic (2.15e-3)" "unprognostic (4.95e-2)" "unprognostic (2.48e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-3)" "unprognostic (2.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.94e-3)" "unprognostic (4.53e-3)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.47e-3)" "unprognostic (1.78e-1)" "unprognostic (3.07e-1)" "unprognostic (3.06e-1)" "unprognostic (1.37e-2)" 1.6 1.4 1.5 2.8 1.1 8.4 1.8 2.1 2.1 1.2 0.0 1.6 1.8 1.2 1.5 1.3 1.1 1.6 1.1 1.6 0.7 0.8 4.1 4.7 6.8 0.4 0.2 1.1 2.2 0.5 4.6 1.3 0.4 0.6 0.9 1.3 1.3 0.6 1.2 0.9 3.4 0.7 0.1 17.0 2.1 1.2 1.0 0.5 1.2 0.2 4.0 2.1 0.8 3.0 0.2 0.1 0.2 0.4 0.4 0.2 0.2 0.7 0.0 0.0 0.2 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.0 0.2 0.0 0.5 0.5 0.4 0.7 0.1 0.5 0.3 0.2 0.1 0.5 0.1 0.3 0.3 0.1 0.3 0.3 1.2 0.0 0.5 0.3 0.3 0.3 0.2 0.4 0.1 0.4 0.3 0.2 0.3 0.6 0.2 0.2 0.6 0.1 0.9 0.2 0.6 0.3 0.5 0.9 0.4 0.1 0.5 0.5 0.3 0.7 0.2 0.4 1.7 0.8 1.1 512.6 2.0 58.1 0.8 3.5 217.7 1.6 0.8 1.3 218.7 9.2 737.5 1.5 2.1 1.3 163.0 1.5 1.1 2.1 2.1 1.6 0.7 0.4 0.2 0.4 0.1 1.0 3.0 7.4 0.0 10.5 1.3 5.8 0.5 1.2 0.2 0.6 0.7 1.7 1.0 2.7 7.2 1.9 0.0 6.2 1.8 740.2 0.4 0.0 0.6 9.0 1.1 1.2 7.7 0.0 24.0 3.1 0.0 1.0 4.5 10.7 1.8 2.5 0.4 15.0 4.3 0.7 1.7 2.0 0.2 0.0 18.3 1.2 12.6 0.3 7.0 5.4 4.7 5.1 0.3 1316.2 1.5 1.8 0.0 0.0 0.7 91.0 1.3 0.2 1.1 1.5 1.0 0.0 2.2 1.7 1.9 3.5 0.3 0.6 0.8 324.9 0.0 0.3 1.4 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.4" "Group enriched" "Detected in many" 4 "dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 390.9;MAIT T-cell: 461.3" "Lineage enriched" "Detected in all" 22 "T-cells: 461.3" "Cell line enhanced" "Detected in many" "HEL: 25.1;NTERA-2: 22.1;U-937: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051403, HPA076494" Approved Enhanced Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA051403: , HPA076494: AB_2686800" "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 4.1 1.7 2.4 3.8 2.6 3.0 2.5 4.3 2.9 1.3 1.4 1.5 1.0 1.2 2.1 1.0 1.0 3.3 2.0 2.1 3.2 1.4 3.0 2.2 10.4 2.5 3.4 1.0 0.5 0.4 1.1 0.6 2.3 1.1 1.9 1.3 1.6 0.7 1.7 1.0 2.2 1.6 1.7 8.8 1.6 1.1 2.6 2.5 1.0 1.8 5.0 2.4 0.8 3.8 0.2 3.1 1.6 2.3 3.0 0.7 1.4 0.5 0.3 0.4 1.1 1.1 1.1 4.9 0.1 0.4 2.1 0.2 3.3 0.5 0.4 3.6 1.9 25.1 0.4 1.6 0.8 1.1 1.6 1.4 0.4 0.5 0.0 0.4 7.6 2.5 1.4 0.4 0.2 0.7 1.0 2.0 22.1 1.0 1.7 1.2 1.0 0.0 0.5 0.4 0.4 4.4 1.1 0.5 1.6 4.3 0.3 1.7 0.8 0.7 1.0 0.6 1.4 1.4 4.1 2.6 1.8 17.3 0.2 17.5 2.6 1.5 390.9 2.9 461.3 4.2 85.1 237.7 8.2 5.0 23.5 147.7 5.7 20.9 5.4 3.9 8.7 99.7 2.4 2.6 4.3 2.9 2.1 3.2 2.5 3.4 2.3 1.7 2.6 3.8 12.7 0.0 4.3 2.9 4.7 0.4 0.4 0.0 4.0 5.0 1.0 0.9 2.8 1.5 0.1 0.0 8.4 1.0 93.7 0.1 1.9 0.7 1.6 0.8 0.6 2.9 1.2 24.6 3.8 0.2 0.5 1.3 0.5 0.5 118.9 0.9 25.7 2.0 3.4 5.0 3.6 0.1 0.0 9.1 1.4 3.1 0.6 3.7 1.8 2.8 5.4 1.8 164.8 9.5 6.2 0.3 0.1 0.0 16.9 0.2 0.3 3.1 0.1 3.9 0.0 2.1 1.0 7.8 7.3 1.3 0.0 0.3 109.3 0.7 0.6 0.1 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3" "Cell type enhanced" "Detected in many" "Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA Yes "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 7.1 7.6 3.7 11.7 3.6 42.3 7.6 4.9 5.3 9.1 3.5 9.8 9.0 5.3 5.2 12.2 6.8 3.4 4.1 3.6 3.4 6.7 6.4 8.0 16.4 3.8 3.4 8.2 6.6 2.9 5.7 5.8 3.9 7.3 11.9 5.5 7.7 2.9 2.5 15.1 14.5 4.6 3.1 18.2 7.2 28.2 4.0 17.8 5.4 1.4 17.4 6.2 8.9 5.0 33.8 27.6 77.8 17.9 5.9 10.8 35.0 30.6 19.8 29.7 27.9 26.2 27.6 40.2 15.6 14.9 19.5 45.4 34.1 19.1 39.1 28.8 23.7 49.7 57.1 27.1 2.0 49.3 32.8 5.8 4.3 30.7 20.2 15.5 20.5 50.5 50.4 29.4 22.6 25.0 40.9 113.0 39.4 16.3 34.5 55.4 37.8 44.8 17.8 35.6 24.1 31.0 55.7 11.7 16.7 46.2 44.4 28.1 15.1 33.7 32.3 33.3 36.3 39.3 42.3 61.0 20.1 31.3 39.6 2.5 0.5 1.8 0.7 0.7 0.6 1.6 1.1 1.3 0.5 0.9 0.8 1.0 1.6 0.9 1.0 0.8 0.5 0.3 3.7 3.6 4.9 5.3 3.6 3.4 3.8 3.4 3.9 3.1 4.0 5.0 4.3 0.0 2.6 3.3 8.1 4.2 1.9 1.9 2.2 2.2 3.1 3.4 1.8 0.0 1.9 5.5 4.2 7.0 3.8 3.0 0.0 1.5 30.4 3.3 3.9 2.9 0.0 29.5 6.2 0.4 5.9 2.9 10.2 5.2 1.3 14.7 2.2 1.3 4.8 0.0 4.5 2.3 0.0 2.2 4.7 17.7 4.7 4.0 1.8 4.7 1.6 1.1 2.1 2.5 4.4 0.8 1.0 3.0 28.7 1.0 1.5 0.5 5.0 5.0 6.6 3.1 2.9 40.7 39.9 4.9 2.3 2.9 5.3 2.1 5.8 1.6 LAIR2 CD306 ENSG00000167618 "Leukocyte associated immunoglobulin like receptor 2" Q6ISS4 19 54497879-54510687 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.6;pituitary gland: 2.6" "Cell type enriched" "Detected in some" 7 "Extravillous trophoblasts: 696.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "gdT-cell: 14.0;memory CD4 T-cell: 13.8;memory CD8 T-cell: 19.5;naive CD8 T-cell: 13.2;T-reg: 49.5" "Lineage enriched" "Detected in many" 40 "T-cells: 49.5" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Hep G2: 1.0" "Low region specificity" "Detected in some" "Secreted to blood" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (4.19e-2)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (4.86e-4)" "unprognostic (1.06e-2)" "unprognostic (8.37e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (2.21e-1)" "unprognostic (9.52e-2)" "unprognostic (3.68e-9)" "unprognostic (1.21e-2)" "unprognostic (3.15e-3)" "unprognostic (3.40e-5)" "unprognostic (6.71e-2)" 0.2 0.0 0.1 0.4 0.3 0.8 0.1 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.1 0.7 1.6 0.2 0.2 0.0 0.1 0.0 2.6 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.1 0.3 0.3 0.4 0.6 0.1 0.2 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 14.0 0.1 0.4 0.0 13.8 19.5 0.1 0.1 2.4 13.2 0.2 1.2 0.3 0.1 49.5 7.8 0.1 0.3 0.1 0.7 0.3 0.3 0.2 0.2 0.4 0.1 0.4 0.5 0.8 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 10.7 95.4 0.9 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.2 696.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 1.8 0.0 0.5 0.0 46.4 0.0 0.1 0.6 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 32.2 23.2 0.0 0.0 0.0 LCP2 "SLP-76, SLP76" ENSG00000043462 "Lymphocyte cytosolic protein 2" Q13094 5 170246233-170297815 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 163.9;lymphoid tissue: 115.1" "Cell type enhanced" "Detected in many" "granulocytes: 129.6;Kupffer cells: 154.4;Macrophages: 158.2;NK-cells: 91.6;T-cells: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 147.0;HL-60: 152.5;HMC-1: 375.9;Karpas-707: 80.4;MOLT-4: 91.4;THP-1: 80.8;U-937: 99.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004574, HPA036396, HPA036397" Enhanced NA NA 2900000 "Cluster 52: Eosinophils - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436" "unprognostic (1.33e-2)" "unprognostic (3.88e-2)" "unprognostic (7.52e-3)" "prognostic favorable (5.08e-4)" "unprognostic (1.43e-1)" "unprognostic (1.30e-2)" "unprognostic (2.03e-1)" "unprognostic (8.84e-2)" "unprognostic (1.44e-1)" "unprognostic (4.87e-2)" "unprognostic (1.37e-1)" "unprognostic (3.10e-1)" "prognostic unfavorable (6.22e-5)" "unprognostic (1.87e-1)" "unprognostic (3.56e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" 23.0 14.1 5.0 75.7 5.7 163.9 8.4 5.9 22.9 10.3 6.3 14.6 15.8 8.2 4.9 9.6 6.8 28.6 5.7 5.1 6.9 5.6 26.3 31.5 77.5 12.2 8.4 3.7 7.7 3.3 2.2 21.9 11.6 8.0 16.4 0.8 6.6 6.5 3.2 3.9 24.4 16.6 7.9 81.1 17.6 3.9 10.2 115.1 4.7 6.2 47.3 28.2 3.7 12.7 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.0 147.0 0.0 0.0 0.0 152.5 375.9 0.0 0.0 0.0 0.0 0.0 0.1 49.7 1.1 80.4 0.0 0.0 91.4 53.2 0.5 0.0 0.0 14.0 0.0 45.5 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.0 80.8 0.1 0.0 0.1 0.2 0.1 1.4 14.6 0.2 0.3 99.9 1.7 56.8 20.4 76.6 40.5 42.5 40.2 2.7 32.4 38.6 26.6 1.0 29.8 31.0 68.9 41.7 65.8 5.3 39.8 22.9 5.0 5.7 5.9 22.9 5.1 6.9 12.2 8.4 11.6 7.9 10.2 12.7 13.4 16.0 29.2 0.7 12.2 3.2 0.2 0.1 0.0 0.2 0.9 2.8 4.8 1.5 5.6 1.8 0.0 0.5 35.2 0.1 0.0 0.2 1.6 0.4 2.4 14.2 0.0 24.0 2.8 0.0 0.8 9.5 5.1 0.7 129.6 0.0 18.9 2.4 57.9 0.0 7.9 0.7 0.0 154.4 49.4 0.9 2.5 158.2 1.8 31.9 48.2 0.0 91.6 0.5 0.5 0.0 0.0 3.0 12.6 0.4 0.0 0.3 2.9 0.0 26.3 1.3 3.1 0.0 0.2 1.0 1.8 0.8 104.6 0.5 0.0 0.3 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570248-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 27 "classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2" "Group enriched" "Detected in all" 50 "dendritic cells: 1207.2;monocytes: 1464.7" "Group enriched" "Detected in many" 4 "CACO-2: 109.4;Hep G2: 62.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 7.5 1.4 0.6 23.5 1.4 19.2 5.4 0.2 1.1 1.8 0.2 55.0 41.2 3.6 1.0 5.2 4.4 335.5 1.6 0.5 1.0 153.0 5.0 8.6 60.7 1.6 1.2 0.9 211.5 0.2 0.1 1.7 1.4 2.2 81.1 0.1 2.1 0.7 1.9 9.9 198.0 5.2 0.4 59.2 10.7 0.6 1.1 41.3 1.0 0.7 64.0 8.2 0.5 3.4 2.8 1.5 0.9 1.0 0.0 0.0 1.1 1.7 0.0 0.0 0.0 109.4 0.1 0.4 0.3 0.0 0.3 1.7 0.0 0.0 0.0 0.2 1.1 0.0 0.0 62.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 2.8 0.0 1.0 0.4 21.2 0.3 0.0 0.9 1.3 0.0 0.0 0.0 0.3 1.7 1.9 2.4 0.5 1.6 1.7 6.4 2.0 1.0 4.3 0.8 0.0 0.2 0.3 2.7 0.2 1.3 7.7 1464.7 8.7 1.8 553.8 3.3 9.9 1.8 2.1 1207.2 2.3 2.3 1.9 26.8 2.3 39.7 9.6 3.0 981.5 0.6 1.4 0.2 1.1 0.5 1.0 1.6 1.2 1.4 0.4 1.1 3.4 1.6 6.4 3.9 0.0 16.4 17.1 0.1 0.5 0.0 0.0 13.2 7.5 0.3 779.2 1.4 29.5 0.0 0.2 7.0 695.4 127.2 26.3 0.1 0.1 0.3 2.3 73.7 4.8 0.1 206.7 0.3 3.2 5.6 0.2 2.5 0.0 0.7 1.9 26.4 0.0 0.1 413.0 0.0 100.8 982.8 0.3 0.6 150.8 24.9 0.0 164.8 0.0 4.1 0.0 0.1 291.6 331.6 0.0 0.9 0.3 2724.7 1764.8 2.1 0.0 0.0 0.3 2.3 0.0 0.4 0.1 12.4 0.3 8.6 0.0 749.3 0.3 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 118.5" "Cell type enhanced" "Detected in many" "B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" No No "Cluster 13: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favorable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 10.4 8.3 7.5 48.3 8.2 10.2 10.2 7.8 11.8 7.9 4.5 14.5 10.9 7.4 11.9 5.2 7.6 15.1 5.3 7.1 7.8 10.6 14.0 33.5 87.1 9.1 8.8 9.5 8.6 6.5 7.2 5.2 10.2 9.4 19.6 7.0 11.0 7.1 3.8 5.9 26.2 9.7 8.6 44.1 13.0 10.2 10.0 103.3 10.2 5.1 118.5 32.4 6.0 10.9 1.7 2.1 2.0 3.9 7.4 9.3 1.4 50.5 200.7 12.4 22.0 0.4 5.1 149.8 2.0 61.9 9.2 2.0 1.7 137.7 51.4 65.4 0.9 6.8 1.3 1.0 12.8 41.1 329.3 7.2 3.2 170.8 22.0 12.0 80.9 90.0 1.9 285.0 101.5 1.1 144.8 51.6 1.6 2.3 45.8 2.1 2.5 129.2 8.3 71.2 1.0 1.6 2.2 3.2 20.1 2.8 2.7 11.7 79.8 30.8 9.5 199.5 45.9 18.4 18.9 146.5 71.6 36.8 71.6 6.3 74.3 12.2 101.3 41.8 148.9 71.9 102.9 117.6 137.5 46.2 79.6 95.9 14.1 79.2 22.2 124.4 152.1 98.8 7.5 8.2 7.8 11.8 7.1 7.8 9.1 8.8 10.2 8.6 10.0 10.9 4.1 0.0 6.7 22.9 75.9 9.7 6.6 7.2 3.4 4.1 4.0 4.7 2.3 4.3 2.8 0.0 4.2 2.8 80.7 4.2 3.9 2.5 23.0 2.8 1.9 5.9 6.1 13.3 18.2 5.6 1.3 6.6 13.3 2.3 51.5 5.4 2.5 7.6 44.0 1.7 19.8 3.1 6.1 63.7 154.6 8.7 1.8 81.7 19.6 30.0 52.9 2.8 49.4 11.6 27.3 4.1 5.2 3.8 82.2 3.6 6.9 5.7 4.3 4.4 6.6 3.6 3.8 9.2 4.2 2.6 9.7 2.5 90.3 2.9 5.2 27.6 LTA "LT, TNFB, TNFSF1" ENSG00000226979 "Lymphotoxin alpha" P01374 6 31572054-31574324 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 1.9;lymphoid tissue: 5.6;testis: 4.2" "Group enriched" "Detected in some" 4 "B-cells: 13.7;T-cells: 14.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;MOLT-4: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA007729 Uncertain "Secreted to blood" NA NA 8150 "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "HPA007729: AB_1852906" "unprognostic (3.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.36e-3)" "unprognostic (8.99e-5)" "unprognostic (3.22e-1)" "unprognostic (5.13e-3)" "unprognostic (2.07e-1)" "unprognostic (4.71e-2)" "unprognostic (3.10e-2)" "unprognostic (3.39e-4)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (8.72e-12)" "unprognostic (2.59e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-1)" 0.2 0.0 0.1 0.6 0.1 0.8 0.1 0.2 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.4 2.4 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.1 1.9 0.0 0.1 5.6 0.1 4.2 0.1 0.0 0.2 0.0 2.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.0 1.1 2.3 13.7 0.1 0.1 0.0 0.6 0.6 0.5 1.3 2.5 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 1.9 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.4 0.4 0.0 0.3 0.0 1.0 0.4 0.0 1.0 2.5 2.4 0.1 0.0 0.4 0.5 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.3 1.8 0.5 0.5 0.4 0.0 14.5 0.1 0.0 0.0 LY9 "CD229, hly9, mLY9, SLAMF3" ENSG00000122224 "Lymphocyte antigen 9" Q9HBG7 1 160796074-160828261 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1" "Cell type enhanced" "Detected in some" "B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050917 Approved Approved "Plasma membrane,Centriolar satellite" NA NA 43000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "Centriolar satellite" "HPA050917: AB_2681272" "unprognostic (8.04e-4)" "unprognostic (2.31e-5)" "unprognostic (8.08e-3)" "unprognostic (1.20e-3)" "unprognostic (9.83e-3)" "unprognostic (1.87e-5)" "unprognostic (1.16e-2)" "unprognostic (3.84e-3)" "unprognostic (1.23e-2)" "unprognostic (2.89e-3)" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.69e-2)" "unprognostic (9.47e-2)" "unprognostic (3.49e-2)" "unprognostic (6.88e-2)" 2.4 0.9 0.1 13.7 0.2 11.5 2.0 0.1 0.2 0.8 0.2 3.9 4.0 0.6 0.4 0.9 0.9 2.5 0.5 0.1 0.2 1.1 2.3 3.8 30.2 0.3 0.2 0.6 0.2 0.0 0.2 0.3 0.2 1.1 3.8 0.0 7.1 0.4 0.3 0.8 12.0 0.5 0.3 26.7 6.0 0.2 0.2 25.5 1.4 0.2 31.1 3.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 28.0 0.0 0.0 2.3 0.5 0.1 0.8 0.0 1.6 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 70.7 29.3 0.3 0.0 4.0 0.0 1.2 0.8 0.4 112.9 1.1 113.5 56.1 97.6 109.8 5.2 52.8 109.6 112.3 2.4 22.2 0.8 72.8 80.3 53.5 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.0 1.8 0.3 244.0 1.0 0.5 0.1 0.0 0.0 0.4 0.8 0.9 0.0 0.0 0.0 0.0 0.1 36.2 0.1 0.0 0.0 0.1 0.1 0.1 0.7 1.2 28.0 0.1 0.2 0.0 1.4 0.5 0.1 0.0 0.0 1.8 0.4 1.9 0.0 0.1 0.0 0.0 3.2 31.9 0.0 0.0 6.3 71.2 1.9 2.1 0.0 22.6 0.0 0.1 0.1 0.0 0.0 102.5 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.5 1.0 0.1 44.8 0.0 0.3 0.3 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.5;retina: 28.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "T-reg: 1.6" "Lineage enriched" "Detected in single" 15 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947, HPA061485" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Centriolar satellite, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: " "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.1 7.7 9.4 0.3 16.5 0.2 0.1 0.3 33.5 0.3 0.0 0.5 0.0 0.2 0.2 0.2 0.2 0.3 0.2 13.5 6.5 0.4 0.0 0.2 0.5 6.9 6.1 0.2 0.2 3.8 5.4 0.0 7.2 0.6 0.3 28.2 0.1 0.4 0.3 0.2 0.3 0.3 0.0 2.5 0.2 2.6 5.6 0.3 0.1 0.2 0.7 0.4 0.3 19.8 0.0 0.4 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.0 1.2 0.0 0.2 0.1 0.0 6.0 0.9 2.5 0.2 0.0 0.1 0.8 0.5 0.1 0.0 0.0 0.4 0.0 0.4 1.5 0.8 5.0 0.3 0.7 0.8 0.5 0.8 0.0 1.0 3.4 0.0 0.9 0.2 0.1 1.5 0.5 0.6 0.0 1.3 0.3 0.3 0.5 0.3 0.0 0.5 0.0 0.0 2.0 2.3 1.1 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 9.4 16.5 0.3 33.5 13.5 6.5 6.9 6.1 7.2 0.0 5.6 19.8 12.3 0.0 2.2 17.0 0.2 0.4 0.5 0.2 8.6 79.0 0.3 0.6 1.8 0.0 0.1 5.5 221.0 0.2 0.8 2.1 0.0 0.1 92.9 4.6 2.1 2.0 0.0 0.4 177.2 0.2 0.1 2.0 5.1 4.3 1.3 7.7 1.8 0.4 0.5 8.4 149.9 0.3 2.0 0.8 1.2 16.4 0.9 4.3 1.8 43.1 1.6 3.8 1.0 185.5 69.1 0.1 2.2 0.4 0.6 0.3 0.4 0.1 2.8 124.0 0.0 4.1 0.9 1.4 4.2 11.2 0.4 1.4 2.9 2.9 0.2 1.1 MCOLN2 "FLJ36691, TRP-ML2, TRPML2" ENSG00000153898 "Mucolipin 2" Q8IZK6 1 84925583-84997113 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.1;lymphoid tissue: 13.1" "Cell type enhanced" "Detected in many" "B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 29.7" "Group enriched" "Detected in many" 14 "B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9" "Cell line enhanced" "Detected in many" "Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA019114 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "HPA019114: AB_1853645" "unprognostic (3.02e-2)" "unprognostic (5.67e-2)" "unprognostic (3.07e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.38e-1)" "prognostic favorable (2.56e-4)" "unprognostic (8.92e-2)" "unprognostic (1.48e-2)" "unprognostic (6.84e-2)" "unprognostic (2.21e-2)" "unprognostic (3.12e-4)" "unprognostic (3.68e-2)" "unprognostic (4.69e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-2)" 0.7 8.8 0.2 5.3 0.2 2.9 1.0 1.0 0.4 1.1 0.7 10.2 1.7 1.0 4.0 0.7 2.6 1.6 0.4 0.3 0.1 1.1 0.7 5.4 12.9 0.4 0.1 0.5 0.8 1.1 0.6 2.6 0.3 0.7 15.1 0.1 0.8 0.2 0.2 2.1 5.5 0.6 0.1 6.7 2.1 1.5 0.3 2.3 0.5 0.2 13.1 1.6 0.7 0.5 1.5 1.6 0.0 4.0 0.8 0.2 0.3 1.0 5.5 1.6 2.0 0.0 0.1 21.9 0.5 0.0 2.6 0.1 14.7 1.8 1.5 26.9 13.6 1.9 0.4 0.0 1.3 0.0 1.8 0.3 0.0 1.3 1.0 0.1 0.0 5.1 0.0 0.0 0.3 0.5 0.3 0.0 1.6 0.0 2.9 0.0 3.3 0.0 0.1 0.2 0.9 0.0 0.1 0.2 9.2 0.2 2.4 28.5 0.1 1.3 2.1 0.0 4.2 0.0 0.0 18.5 1.2 0.0 4.0 0.1 0.3 0.0 5.9 1.1 2.1 10.3 5.0 8.9 7.1 3.7 0.6 4.5 0.2 0.4 0.2 29.7 0.2 2.6 0.2 0.2 1.0 0.4 0.3 0.1 0.4 0.1 0.3 0.1 0.3 0.5 0.4 0.0 0.6 0.0 26.3 4.5 0.4 0.1 1.2 0.0 1.1 1.8 0.5 0.0 1.3 1.8 0.0 0.1 43.6 31.4 0.0 0.1 53.1 12.3 6.0 0.4 2.4 1.3 0.9 1.4 0.1 1.5 1.5 24.5 0.0 0.1 0.7 0.0 0.7 0.0 0.5 4.5 0.0 1.3 100.8 19.6 0.0 14.4 8.8 2.8 32.3 0.0 1.0 0.0 1.4 0.4 4.7 0.0 13.8 0.6 0.0 2.3 1.5 0.0 0.0 0.7 0.3 1.6 4.3 0.0 3.3 0.3 21.8 1.6 5.4 0.1 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455846-60470752 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 673.3" "Cell type enriched" "Detected in some" 35 "B-cells: 970.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 96 "memory B-cell: 625.4;naive B-cell: 627.0" "Lineage enriched" "Detected in many" 96 "B-cells: 627.0" "Group enriched" "Detected in some" 26 "Daudi: 731.3;U-698: 364.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 3.6 0.4 0.0 149.7 0.0 19.1 0.8 0.0 0.1 0.5 0.1 9.0 3.0 2.2 1.0 4.2 0.5 8.4 1.8 0.0 0.1 3.4 2.1 4.0 500.4 0.2 0.0 0.3 0.2 7.3 0.3 0.9 0.1 5.1 10.6 0.0 8.9 0.3 0.8 0.1 123.5 1.2 0.1 253.8 18.4 1.2 0.1 50.6 6.7 0.1 673.3 16.3 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 731.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.5 0.2 0.0 0.1 0.0 364.1 0.0 0.2 0.0 0.8 0.5 0.3 2.4 0.1 3.7 625.4 2.8 5.5 0.5 627.0 0.5 2.1 2.0 6.5 0.6 0.5 0.8 32.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.0 3.8 0.0 970.5 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 4.5 0.7 0.1 0.3 0.0 7.0 0.0 0.0 0.1 1.8 2.0 0.1 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.2 0.0 0.6 0.3 2.0 0.0 4.6 7.2 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.2 0.1 0.8 0.1 0.0 27.3 0.7 0.2 0.0 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 7.2;cervix: 15.9;fallopian tube: 5.9;salivary gland: 6.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4" "Cancer enriched" "Detected in many" 4 "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 23.3;HeLa: 45.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" NA NA 25000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB055172: AB_2148831, HPA065600: AB_2732736" "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 7.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.9 0.0 0.0 0.0 2.1 0.0 0.3 5.9 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 6.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.6 2.8 0.0 0.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.3 0.1 40.3 0.0 0.0 4.1 0.9 3.4 1.5 81.8 0.0 0.0 2.1 0.2 0.0 0.0 0.2 14.3 74.3 14.8 1.2 0.0 0.0 0.4 0.0 0.4 1.0 0.0 157.8 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 99.7 0.3 0.0 16.4 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 197.4 0.0 0.0 0.0 8.6 0.3 0.2 0.0 0.3 3.3 0.6 0.0 0.0 0.7 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181308-135219173 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0" "Group enriched" "Detected in many" 5 "breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 5.4" "Cell line enhanced" "Detected in many" "HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favorable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favorable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.3 0.5 1.6 5.3 1.7 35.2 20.1 0.0 0.7 1.6 0.4 25.3 10.9 1.0 0.1 3.0 8.4 0.9 0.1 0.3 0.2 0.1 0.4 2.0 6.3 0.9 1.0 0.0 0.3 3.6 0.0 0.4 0.6 1.4 26.5 0.3 0.6 0.9 0.1 3.0 9.4 1.4 0.2 1.2 2.0 0.7 0.3 66.1 0.1 0.0 7.0 1.1 1.3 0.1 1.8 0.3 1.9 3.0 0.0 0.1 0.3 1.0 0.6 1.1 1.1 0.3 1.4 10.9 0.4 0.3 0.4 0.9 5.6 0.0 0.7 18.0 2.5 138.8 1.0 0.5 0.1 219.8 105.1 0.0 0.1 0.6 0.0 0.5 0.3 133.4 114.6 20.1 1.1 11.6 403.1 208.5 1.5 19.2 1.7 244.9 5.9 33.2 0.3 1.5 10.5 6.9 0.5 10.4 0.6 0.5 7.9 343.8 0.4 0.3 1.6 7.9 2.4 27.7 7.7 66.0 0.1 186.1 2.3 4.6 0.7 5.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.4 0.2 1.6 1.7 0.0 0.7 0.3 0.2 0.9 1.0 0.6 0.2 0.3 0.1 0.2 0.0 1.3 0.0 2.3 2.7 1.3 1.3 0.6 0.9 47.8 12.6 0.4 2.8 7.1 0.0 0.0 1.4 9.1 18.1 0.0 0.0 0.1 24.3 0.3 0.3 17.6 83.2 0.6 0.8 0.4 0.5 4.6 2.2 26.0 0.4 0.0 0.0 1.1 0.0 2.7 32.7 26.4 1.2 1.7 0.2 0.0 2.1 8.8 0.0 2.8 0.9 0.0 0.0 0.2 0.1 10.2 0.0 4.6 2.1 2.3 0.0 37.2 0.0 0.0 0.6 0.9 0.0 1.8 10.2 7.0 0.3 3.6 0.1 52.0 2.2 MYBL1 "A-myb, AMYB" ENSG00000185697 "MYB proto-oncogene like 1" P10243 8 66562175-66614247 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1;testis: 11.8" "Group enriched" "Detected in many" 6 "dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.9;MAIT T-cell: 1.3" "Lineage enhanced" "Detected in single" "T-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008791 Uncertain Supported Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA008791: AB_1078540" "unprognostic (1.11e-1)" "unprognostic (2.47e-2)" "unprognostic (2.57e-1)" "unprognostic (7.23e-4)" "unprognostic (2.26e-1)" "unprognostic (1.89e-2)" "unprognostic (6.67e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.78e-2)" "unprognostic (1.13e-2)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.03e-8)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (5.87e-2)" 1.0 0.7 1.1 6.1 2.2 2.5 1.7 2.0 1.7 0.7 0.3 1.0 1.3 1.1 0.5 0.7 0.8 2.3 3.4 1.0 1.3 0.4 2.0 2.3 20.1 2.9 1.7 0.6 0.2 0.4 0.4 0.9 3.2 1.2 1.4 5.9 0.5 1.6 0.9 1.2 1.9 2.3 1.9 7.6 1.3 11.8 1.6 2.5 0.6 0.8 16.1 1.1 0.8 3.7 35.4 11.9 3.7 10.1 1.0 2.1 2.6 47.7 21.8 82.5 69.4 1.6 34.9 87.7 4.2 40.4 31.0 10.0 3.5 4.0 113.0 10.6 5.5 1.8 13.4 1.6 0.2 0.8 3.4 0.7 0.4 22.7 19.0 14.8 2.7 6.4 0.4 28.3 51.0 3.1 5.8 1.3 2.8 3.3 15.8 1.9 14.1 2.2 19.4 1.2 8.2 3.3 8.4 3.0 8.6 5.6 50.6 2.3 14.5 49.4 11.3 11.1 44.2 8.2 12.1 25.7 13.0 5.3 20.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.3 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 1.1 2.2 2.0 1.7 1.0 1.3 2.9 1.7 3.2 1.9 1.6 3.7 3.0 0.0 2.3 3.3 4.0 1.8 0.4 0.3 1.8 10.4 4.7 6.6 9.1 2.8 0.1 0.0 2.1 2.0 127.3 0.5 0.0 0.5 3.9 0.8 2.4 1.7 0.0 6.6 3.9 0.0 0.7 2.7 3.1 1.4 0.0 5.6 4.2 0.9 0.7 5.0 2.7 0.4 0.0 1.6 3.2 4.2 0.9 5.1 1.8 8.4 1.6 10.3 107.1 5.5 12.4 0.2 1.1 0.0 40.2 0.3 0.0 0.5 1.5 9.1 0.0 2.5 4.5 35.8 6.8 3.2 0.4 1.5 89.1 1.4 0.8 0.3 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520778-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1" "Cell type enhanced" "Detected in many" "dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 263.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 46000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 9.6 4.5 5.1 38.9 5.2 96.0 3.5 5.7 7.2 2.7 6.3 5.0 7.4 2.0 0.7 3.3 6.5 10.5 4.6 4.7 5.9 3.8 7.8 24.4 20.7 9.2 7.6 1.2 2.4 1.2 2.2 7.1 8.7 3.7 3.4 0.2 3.7 1.8 1.5 2.7 12.2 6.4 7.5 78.1 6.5 1.4 8.6 5.4 3.0 4.2 8.5 10.2 2.8 10.1 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 6.1 0.4 0.0 0.4 0.0 0.0 0.0 52.4 0.2 38.1 0.0 0.0 0.1 52.3 87.9 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.5 23.8 0.1 0.3 0.1 210.2 0.0 0.1 0.3 1.0 0.0 5.6 0.1 0.0 0.1 0.3 0.0 0.1 0.3 0.1 0.8 154.3 12.3 0.1 0.2 0.2 0.1 0.1 1.9 0.3 0.3 84.3 0.0 64.5 107.6 105.7 56.6 78.7 44.5 5.9 22.3 39.7 62.8 2.8 1.6 17.0 263.2 32.3 98.8 8.1 34.0 101.3 5.1 5.2 5.7 7.2 4.7 5.9 9.2 7.6 8.7 7.5 8.6 10.1 1.9 3.2 12.3 2.0 26.5 3.3 2.4 0.8 1.2 0.7 3.1 4.3 2.6 5.7 2.9 1.8 2.1 5.0 110.2 2.0 1.9 1.7 6.0 0.6 2.9 4.1 1.2 14.3 2.3 0.9 8.2 2.7 3.6 1.2 31.6 2.2 10.8 6.7 75.8 6.7 1.5 2.1 0.0 235.4 49.3 6.8 2.5 122.7 7.2 64.6 195.5 1.5 616.9 1.5 3.4 1.3 3.2 1.2 30.0 1.8 3.0 2.9 0.2 0.8 0.0 3.4 2.2 6.0 3.4 3.6 5.4 5.1 100.1 3.9 2.7 1.9 MYO1G HA-2 ENSG00000136286 "Myosin IG" B0I1T2 7 44962662-44979088 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.6;lymphoid tissue: 27.2" "Cell type enhanced" "Detected in many" "dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA021252 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Plasma membrane" Nucleoplasm "HPA021252: AB_1854254" "unprognostic (2.74e-2)" "prognostic favorable (8.26e-4)" "unprognostic (5.20e-3)" "unprognostic (9.91e-3)" "unprognostic (1.27e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (4.54e-3)" "unprognostic (6.47e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (8.71e-8)" "unprognostic (3.20e-1)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (7.92e-2)" 2.2 0.8 0.4 16.6 0.3 43.6 1.0 0.3 0.6 0.8 0.3 2.0 3.3 0.7 0.3 1.5 1.2 3.5 0.9 0.3 1.0 0.9 1.3 12.0 25.1 1.4 0.7 0.3 0.7 0.1 0.5 1.2 0.6 1.1 1.8 0.0 2.3 0.7 0.3 0.9 7.8 2.8 0.6 19.0 3.3 0.4 1.6 27.2 1.6 0.4 14.8 6.1 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 52.6 0.0 64.1 2.7 0.0 0.0 39.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 97.3 52.1 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 57.3 0.0 41.5 58.3 18.5 61.5 95.5 38.4 27.7 40.5 55.6 42.7 18.9 14.1 29.6 6.0 23.9 129.8 4.5 79.9 79.9 0.4 0.3 0.3 0.6 0.3 1.0 1.4 0.7 0.6 0.6 1.6 0.8 0.9 3.2 7.7 0.0 55.7 2.8 0.4 0.0 0.0 0.2 1.2 1.3 1.1 1.5 1.3 0.0 0.0 0.2 81.3 0.2 0.0 0.3 0.6 0.3 0.5 1.0 0.0 6.3 0.1 1.1 0.3 2.3 2.0 0.6 30.4 0.4 2.2 1.4 10.5 3.3 0.0 0.2 0.0 58.7 65.1 1.6 0.0 74.2 3.6 0.0 392.2 0.3 252.4 0.5 0.0 0.2 0.1 0.4 33.4 0.4 0.0 0.6 0.7 0.2 6.6 2.0 1.4 3.8 1.2 0.2 1.7 0.1 87.1 1.2 0.1 0.2 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906148-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.5" "Group enriched" "Detected in some" 7 "dendritic cells: 30.2;NK-cells: 110.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Region enriched" "Detected in single" 7 "cerebral cortex: 1.0" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049311 Approved "Endoplasmic reticulum" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Endoplasmic reticulum" "HPA049311: AB_2680707" "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 0.2 0.0 0.1 0.2 0.0 0.7 0.1 0.1 1.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 6.6 0.4 0.0 0.0 0.1 1.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 1.8 0.0 1.9 0.1 0.0 110.2 0.5 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favorable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favorable (8.07e-4)" 6.8 5.8 10.9 19.1 10.8 31.5 5.9 12.1 17.6 4.1 10.7 7.2 7.4 3.7 4.7 5.9 3.3 8.3 5.3 11.3 10.6 16.1 10.5 13.6 19.9 11.5 11.4 2.7 8.3 5.3 4.5 5.5 11.2 8.3 5.9 3.7 7.4 3.3 3.5 9.9 12.1 3.6 11.7 35.0 7.0 10.7 11.8 9.9 5.3 3.9 25.1 16.3 5.0 12.3 28.4 7.9 9.5 15.1 3.7 2.8 5.3 4.9 23.8 14.9 15.4 15.0 12.9 15.7 17.0 5.1 39.7 6.2 10.3 15.4 16.6 26.1 6.0 7.9 3.0 17.0 11.4 26.1 23.0 7.1 6.7 13.8 8.8 12.5 10.7 7.2 7.7 39.2 3.9 14.4 5.2 52.7 5.0 44.1 4.0 9.9 8.5 14.0 34.7 30.3 6.1 7.8 3.4 12.5 20.9 8.0 8.6 29.9 18.1 8.4 9.8 5.3 15.4 25.0 11.4 28.7 7.4 28.4 16.1 8.8 7.5 4.0 1.6 9.4 3.2 8.6 2.2 1.5 6.6 6.5 1.0 1.6 3.0 0.8 11.1 8.1 3.1 1.7 10.9 10.8 12.1 17.6 11.3 10.6 11.5 11.4 11.2 11.7 11.8 12.3 7.5 0.0 9.7 1.0 26.0 38.2 28.7 11.6 14.8 3.4 15.3 9.9 5.4 22.8 9.2 3.7 2.1 5.2 12.5 12.2 17.6 49.5 17.3 10.0 6.2 15.9 14.9 1.7 1.1 21.0 8.0 17.3 10.7 12.8 32.5 2.5 6.1 2.0 57.2 3.3 2.0 11.9 6.1 22.6 151.2 34.1 1.8 48.6 48.0 3.7 55.2 3.3 1.0 0.5 0.9 58.9 33.3 2.6 18.7 32.6 14.3 14.4 6.1 4.1 6.6 11.8 11.0 25.9 12.3 11.6 39.2 5.3 13.8 7.0 8.5 34.7 NIBAN3 "BCNP1, FAM129C, FLJ39802" ENSG00000167483 "Niban apoptosis regulator 3" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7" "Cell type enriched" "Detected in some" 8 "B-cells: 11.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 379 "memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7" "Group enriched" "Detected in many" 476 "B-cells: 52.1;dendritic cells: 110.7" "Group enriched" "Detected in some" 19 "Daudi: 50.1;REH: 23.8;U-698: 33.2" "Not detected" "Not detected" HPA043277 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.4 0.0 0.0 10.7 0.1 15.4 0.1 0.0 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.5 0.3 0.4 26.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 16.6 0.0 0.0 34.7 0.7 0.5 0.0 1.8 0.6 0.0 12.2 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 52.1 0.0 0.1 0.0 0.0 0.0 110.7 0.0 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420322 "Metabolic proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.4;lymphoid tissue: 41.7" "Cell type enhanced" "Detected in many" "dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.7;U-266/84: 261.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved NA NA 78000 "Cluster 39: Non-specific - mRNA processing" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "HPA066888: AB_2685741" "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 2.0 5.2 5.3 23.2 5.8 53.4 5.4 7.8 6.5 2.3 4.8 6.4 7.3 2.6 8.4 7.1 4.1 4.6 2.3 5.0 6.2 8.8 19.8 7.6 41.3 6.1 6.7 1.2 13.0 9.7 13.5 6.4 5.5 5.4 5.6 4.8 6.4 2.8 5.2 5.6 22.2 2.4 5.2 32.5 8.5 9.2 5.8 41.7 8.1 1.8 29.0 5.8 2.2 7.3 41.5 72.0 34.8 90.8 0.0 0.0 138.1 0.6 0.0 8.6 0.4 37.2 66.3 167.7 55.6 0.1 3.9 23.8 77.5 0.0 3.2 135.9 57.9 65.2 81.1 39.6 0.0 210.8 22.7 0.0 0.0 0.0 0.0 6.3 0.1 124.1 102.5 174.9 0.0 103.8 112.6 83.4 40.2 12.8 14.8 0.2 0.2 232.7 16.9 38.4 39.8 39.8 51.3 67.7 21.0 15.5 64.8 172.6 0.5 0.1 11.7 0.2 31.8 176.1 261.0 144.9 0.1 116.0 0.3 0.0 2.5 0.9 7.3 3.2 5.8 5.4 5.2 7.2 5.4 3.1 4.3 5.8 0.1 5.5 2.0 5.6 4.8 3.7 5.3 5.8 7.8 6.5 5.0 6.2 6.1 6.7 5.5 5.2 5.8 7.3 0.7 16.0 5.4 16.6 37.3 1.7 1.3 0.5 0.0 25.4 9.6 5.3 11.6 8.6 4.1 5.5 14.6 17.6 57.7 2.9 3.9 5.7 19.2 4.3 1.0 1.0 8.3 41.8 17.9 4.4 5.6 1.1 3.6 8.3 5.1 70.0 3.6 17.0 16.7 35.3 23.4 8.8 4.1 11.3 4.9 23.5 0.6 14.9 1.8 10.3 16.7 3.0 69.0 30.2 17.7 2.6 0.8 0.4 43.7 2.6 2.1 4.5 3.0 19.4 0.0 2.1 1.1 6.4 10.0 3.5 2.4 4.9 37.2 17.8 11.5 1.9 OR2I1P "HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P" ENSG00000237988 "Olfactory receptor family 2 subfamily I member 1 pseudogene" 6 29550407-29557721 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Ductal cells: 1.0;granulocytes: 1.3;monocytes: 1.0" "Cancer enhanced" "Detected in all" "liver cancer: 71.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 3: Monocytes - Immune response regulation" "unprognostic (7.45e-3)" "unprognostic (1.69e-2)" "unprognostic (6.00e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.60e-2)" "unprognostic (1.07e-3)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (5.34e-3)" "prognostic favorable (5.58e-4)" "unprognostic (1.32e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (4.00e-6)" "unprognostic (8.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 OR52N4 ENSG00000181074 "Olfactory receptor family 52 subfamily N member 4" Q8NGI2 11 5754243-5755905 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.7" "Cell type enhanced" "Detected in single" "Excitatory neurons: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (3.44e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-4)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (3.03e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (5.62e-2)" "unprognostic (1.41e-3)" "unprognostic (1.41e-1)" "unprognostic (3.80e-2)" "unprognostic (3.18e-2)" "unprognostic (4.41e-2)" 0.7 0.2 0.2 0.5 0.2 0.5 0.7 0.0 0.3 0.6 0.1 0.4 0.1 0.6 1.3 0.3 0.9 0.3 0.4 0.2 0.4 0.5 0.2 0.8 1.3 0.4 0.2 1.6 0.1 0.0 0.5 0.0 0.3 0.7 0.3 0.7 0.4 0.7 0.2 0.3 1.8 0.1 0.2 2.7 0.2 0.4 0.1 0.5 0.4 0.1 1.2 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.2 0.0 0.3 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.2 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PARVG ENSG00000138964 "Parvin gamma" Q9HBI0 22 44172956-44219533 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 49.7;lymphoid tissue: 30.1" "Cell type enhanced" "Detected in many" "B-cells: 56.9;dendritic cells: 51.7;granulocytes: 60.1;Hofbauer cells: 66.7;Kupffer cells: 87.3;Langerhans cells: 53.4;Macrophages: 91.9;monocytes: 62.0;T-cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HL-60: 116.4;NB-4: 44.9;THP-1: 64.7;U-937: 53.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031833, HPA031834" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "HPA031833: AB_2674063, HPA031834: AB_10601242" "unprognostic (9.83e-3)" "unprognostic (2.30e-2)" "unprognostic (2.06e-1)" "prognostic favorable (4.44e-6)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (3.19e-2)" "unprognostic (7.02e-2)" "unprognostic (2.17e-1)" "unprognostic (3.87e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (3.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.09e-1)" "unprognostic (9.89e-2)" 3.5 2.9 3.7 26.7 3.5 49.7 1.8 4.4 7.1 2.6 4.0 3.1 3.6 2.4 0.6 2.5 2.2 6.2 1.3 3.8 4.7 1.8 3.1 10.4 30.1 8.2 4.9 0.8 1.4 0.5 1.3 3.0 6.9 2.1 3.4 0.2 2.6 1.1 1.2 1.7 12.7 2.9 5.9 28.9 4.4 1.7 7.9 18.4 1.9 0.4 26.8 4.7 1.5 9.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 116.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 16.8 44.9 0.1 0.0 0.0 9.2 0.2 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 64.7 0.0 0.0 11.5 0.2 0.0 0.3 0.0 0.3 0.0 53.9 1.9 12.5 62.0 71.3 13.9 57.6 13.9 21.4 8.0 15.2 49.2 20.4 8.9 10.3 72.2 13.1 65.9 33.3 12.1 44.6 3.7 3.5 4.4 7.1 3.8 4.7 8.2 4.9 6.9 5.9 7.9 9.4 1.3 6.4 14.0 1.0 56.9 2.4 0.1 0.0 0.6 0.2 0.7 1.5 1.1 0.0 3.1 0.0 0.0 0.6 51.7 0.1 0.0 0.0 4.2 3.7 0.4 2.9 0.0 10.1 3.9 0.2 0.7 2.3 3.6 2.5 60.1 0.0 3.9 1.3 66.7 0.0 2.9 0.0 0.0 87.3 53.4 2.7 0.0 91.9 5.4 10.3 62.0 0.0 26.8 0.0 1.4 0.0 0.0 0.0 15.9 0.0 0.0 0.5 1.5 0.2 0.0 0.5 0.4 1.1 0.8 0.4 1.8 1.0 48.3 0.0 0.1 0.1 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1;lymphoid tissue: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 63.3;K-562: 48.9;SK-BR-3: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favorable (5.36e-5)" 6.5 40.1 3.4 17.9 3.2 10.6 6.1 2.7 3.3 6.7 2.3 10.1 2.2 8.7 2.0 3.1 9.3 5.9 3.3 2.4 3.7 6.0 3.9 9.1 36.0 4.8 5.3 23.4 2.7 1.2 2.3 3.6 4.4 5.8 2.7 0.8 3.3 2.3 1.3 2.7 12.2 4.5 3.6 29.5 3.8 13.7 4.8 7.1 3.4 1.2 24.1 9.6 5.4 5.0 3.4 63.3 1.5 0.0 0.5 0.0 3.0 2.0 3.5 0.7 0.3 3.2 12.3 11.5 3.4 6.5 1.2 9.2 0.0 9.4 0.0 13.5 0.0 0.4 0.6 1.3 1.3 2.7 0.5 0.2 4.1 1.1 7.1 8.8 2.7 0.8 48.9 10.6 4.4 1.5 0.7 2.3 10.6 7.9 0.9 0.2 1.6 8.2 9.7 5.2 0.4 0.0 5.7 31.0 0.0 3.2 5.7 4.0 0.8 0.2 0.9 0.1 2.2 11.4 8.6 20.3 3.0 8.7 0.3 1.7 1.1 2.8 42.5 2.3 48.3 50.1 50.7 54.1 6.4 35.6 88.8 83.5 4.5 30.1 2.6 38.1 59.1 35.4 3.4 3.2 2.7 3.3 2.4 3.7 4.8 5.3 4.4 3.6 4.8 5.0 3.4 3.2 5.6 30.3 23.6 1.1 0.9 4.2 9.1 2.5 4.4 6.2 0.5 0.0 1.5 1.8 0.0 0.5 21.1 0.2 0.0 3.2 0.9 5.1 1.4 3.4 10.2 0.4 32.4 12.8 9.1 3.1 1.5 10.3 1.3 47.8 9.7 0.3 37.6 0.0 2.2 1.4 0.0 4.3 1.8 2.5 3.7 10.7 1.8 60.0 5.3 0.9 23.7 17.6 0.6 11.7 0.8 0.7 28.1 1.4 0.1 0.4 0.8 0.1 0.0 1.3 4.4 0.7 0.2 2.8 0.6 2.1 36.2 22.4 0.3 4.2 PDCD1 "CD279, hSLE1, PD-1, PD1, SLEB2" ENSG00000188389 "Programmed cell death 1" Q15116 2 241849884-241858894 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 6.7;lymphoid tissue: 16.1" "Group enriched" "Detected in some" 4 "Plasma cells: 9.5;T-cells: 34.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.4" "Group enriched" "Detected in many" 5 "gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3" "Lineage enriched" "Detected in single" 55 "T-cells: 12.4" "Cell line enhanced" "Detected in some" "JURKAT: 1.5;MOLT-4: 2.4;RPMI-8226: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035981, CAB038418, CAB076386" Enhanced NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664" "unprognostic (2.90e-3)" "unprognostic (4.50e-3)" "unprognostic (7.78e-2)" "prognostic favorable (9.44e-5)" "unprognostic (7.18e-3)" "unprognostic (1.31e-3)" "unprognostic (3.83e-2)" "unprognostic (7.33e-2)" "unprognostic (5.82e-3)" "unprognostic (3.75e-2)" "unprognostic (6.57e-2)" "unprognostic (3.94e-1)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (5.06e-3)" 1.2 0.3 0.0 3.2 0.2 0.9 0.4 0.0 0.1 0.6 0.2 0.8 0.3 0.4 0.0 0.8 0.6 0.3 6.7 0.1 0.1 0.7 0.4 1.8 16.1 0.1 1.4 0.2 0.3 0.0 1.5 0.0 0.2 0.7 0.1 0.0 1.0 0.2 0.1 0.3 3.8 0.2 0.1 7.0 1.8 0.3 0.4 3.1 1.5 0.0 4.0 1.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.8 0.2 8.7 12.4 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 4.3 2.1 0.0 0.2 0.0 0.1 0.1 0.1 0.1 1.4 0.2 0.1 0.4 0.2 0.4 0.0 0.6 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.6 0.0 34.7 0.0 0.0 0.1 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 99 "retina: 2050.3" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 4448.6" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basophil: 127.0;NK-cell: 220.2" "Group enriched" "Detected in all" 6 "granulocytes: 127.0;NK-cells: 220.2" "Cell line enhanced" "Detected in some" "Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2" "Region enhanced" "Detected in some" "hippocampal formation: 4.7" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 79: Retina - Phototransduction" "Cluster 5: NTERA-2 - Transcription" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 1.5 0.3 0.0 4.7 0.1 7.8 0.9 0.2 0.5 1.0 0.2 1.6 0.6 0.2 0.1 0.8 0.7 2.5 0.4 0.1 0.7 2.1 4.2 3.0 20.6 0.1 0.2 0.0 0.0 0.1 0.1 12.0 0.2 0.2 1.0 2050.3 0.5 0.4 1.2 0.3 1.6 0.9 0.1 19.9 1.7 0.8 0.3 8.3 0.4 0.3 7.1 3.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 5.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.8 0.2 0.1 0.2 0.4 0.3 0.0 5.8 8.9 0.0 0.0 11.9 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.1 0.1 6.2 0.1 0.8 1.2 0.2 0.0 0.0 0.1 0.1 0.6 0.9 0.4 3.1 0.1 127.0 18.1 30.5 4.1 26.2 1.3 2.7 0.8 2.3 28.9 5.1 2.1 7.4 2.4 220.2 15.5 2.9 0.1 13.5 0.0 0.1 0.2 0.5 0.1 0.7 0.1 0.2 0.2 0.1 0.3 0.2 0.3 0.0 0.6 0.3 1.1 0.9 0.0 0.0 0.6 422.5 0.3 0.4 0.2 0.0 0.0 5.5 517.1 0.2 4.3 0.1 1.9 0.4 0.8 1.5 0.3 27.2 0.0 1.7 0.2 0.2 0.4 0.2 0.0 0.5 23.6 0.1 2.9 0.2 22.6 262.5 0.1 0.2 0.0 4.8 8.0 2.3 0.0 4.4 3.6 0.0 13.3 709.0 11.3 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.1 1.0 0.0 4448.6 0.0 0.1 0.1 1.1 0.2 0.3 1.4 0.3 1.7 2.1 0.0 0.1 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651731-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 60.9;lymphoid tissue: 50.4" "Cell type enhanced" "Detected in many" "dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: AB_2679153" "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 7.2 3.1 6.8 33.4 6.3 60.9 3.9 6.1 7.5 6.2 6.4 5.4 5.2 4.9 1.7 4.9 6.1 7.0 3.3 7.0 5.3 6.4 3.5 12.0 46.9 7.3 6.6 7.0 3.0 2.9 2.8 4.2 7.8 4.6 3.4 0.6 5.1 2.7 1.2 3.0 17.2 4.7 6.6 50.4 5.7 4.0 9.3 24.3 5.5 3.5 32.0 7.4 5.1 8.5 8.1 5.2 0.4 1.4 1.3 1.1 0.7 12.1 24.5 26.0 21.1 0.3 3.3 21.5 4.9 9.8 12.4 2.4 2.0 11.0 16.2 153.3 0.4 2.4 1.3 9.0 5.1 56.0 18.7 4.3 4.5 29.2 9.8 11.4 3.8 14.9 8.0 0.1 15.0 0.6 5.4 65.9 2.2 0.3 1.4 68.9 13.0 0.7 10.9 0.0 1.7 1.5 2.7 4.9 11.9 6.8 0.8 65.4 9.8 7.7 7.9 0.2 11.5 4.9 4.9 30.1 16.7 78.6 4.4 18.0 23.5 40.2 21.6 23.0 22.6 12.8 16.3 19.9 22.5 13.6 20.9 23.1 63.2 25.9 29.2 25.7 13.3 38.3 6.8 6.3 6.1 7.5 7.0 5.3 7.3 6.6 7.8 6.6 9.3 8.5 1.7 9.6 13.4 2.0 22.2 1.5 2.2 1.8 4.0 0.7 2.0 1.7 3.1 0.0 1.1 0.0 2.1 0.3 44.0 0.1 1.9 3.9 3.0 2.0 1.7 2.7 0.0 10.3 6.7 2.0 0.5 2.9 0.0 1.0 25.3 4.2 3.6 0.0 14.7 0.0 13.4 0.1 0.0 35.2 6.0 2.8 1.2 23.1 3.6 29.0 19.3 2.5 29.9 1.0 1.1 11.3 0.0 1.5 8.2 4.1 0.2 3.8 3.3 1.3 6.6 2.0 4.7 1.5 3.4 2.9 1.1 0.3 37.1 1.5 0.2 2.1 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802722-8867677 "Metabolic proteins, Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.9" "Cell type enhanced" "Detected in some" "Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 21.9;eosinophil: 75.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 75.8" "Cell line enriched" "Detected in some" 8 "HMC-1: 148.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 0.4 0.0 1.1 1.8 1.6 2.2 0.4 0.9 1.1 0.6 0.8 0.8 1.5 0.9 0.1 0.5 0.2 1.2 1.3 1.0 1.1 0.0 0.3 1.2 2.1 1.4 1.5 0.0 0.4 0.1 0.0 0.6 1.6 0.3 0.6 0.0 0.2 0.3 0.5 0.8 2.2 0.7 1.1 2.9 1.0 0.4 1.9 2.1 0.0 0.3 1.5 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 14.1 0.0 19.4 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 2.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 21.9 7.2 75.8 0.5 9.6 0.4 2.7 0.1 0.3 10.8 0.3 0.1 0.2 1.1 1.5 7.8 0.0 0.0 3.3 1.1 1.6 0.9 1.1 1.0 1.1 1.4 1.5 1.6 1.1 1.9 1.6 0.2 0.0 1.3 0.3 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 11.5 0.0 0.1 2.6 0.0 0.4 0.6 0.0 0.1 0.2 0.5 0.0 47.4 0.0 0.4 0.0 7.6 0.0 0.5 0.0 0.0 4.4 1.6 20.6 0.0 3.9 1.8 7.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 1.6 0.1 0.0 0.0 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924713-104937761 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3" "Cell type enriched" "Detected in many" 7 "dendritic cells: 284.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 3621.6" "Lineage enriched" "Detected in all" 5 "dendritic cells: 3621.6" "Group enriched" "Detected in some" 4 "HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2900000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.4 1.0 5.1 5.7 4.7 13.4 1.5 7.0 7.1 1.0 0.4 0.8 3.8 1.0 0.2 0.6 1.8 2.4 0.5 4.5 7.3 0.8 0.5 1.8 11.3 15.7 6.8 0.5 1.1 1.2 2.1 0.8 10.3 1.7 0.5 0.5 3.5 1.8 0.3 0.6 5.1 0.5 13.9 10.4 2.8 0.6 9.4 2.8 0.6 0.0 9.4 1.9 0.4 16.7 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 127.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.1 10.7 0.1 0.0 0.1 30.0 0.1 85.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 191.5 0.0 0.1 0.3 0.1 0.2 0.4 0.0 0.1 0.2 1.6 0.3 4.6 43.0 699.5 1.0 188.4 1.9 222.7 0.8 1.2 545.8 198.4 1.7 0.4 9.8 25.4 297.9 3621.6 1.0 72.9 5.1 4.7 7.0 7.1 4.5 7.3 15.7 6.8 10.3 13.9 9.4 16.7 0.8 0.0 0.0 0.3 34.7 0.4 0.1 0.0 0.0 2.7 0.6 2.8 1.4 0.0 0.0 0.0 0.0 0.2 284.8 0.0 0.0 0.0 0.7 0.1 0.3 2.7 0.0 5.5 0.1 0.0 0.4 1.1 1.1 0.4 3.8 0.0 0.0 0.0 30.6 1.7 0.1 0.0 0.0 1.3 32.0 4.7 0.0 38.0 5.4 22.5 11.3 0.1 2.1 0.5 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.1 0.0 1.1 6.6 1.6 0.3 1.6 1.6 0.0 0.4 0.3 2.2 0.0 0.1 0.0 PSMB8 "beta5i, D6S216E, LMP7, PSMB5i, RING10" ENSG00000204264 "Proteasome 20S subunit beta 8" P28062 6 32840717-32844679 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046995, HPA050327" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No 2700000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Cytokinetic bridge" "HPA046995: AB_2679896, HPA050327: AB_2681088" "prognostic favorable (5.08e-4)" "unprognostic (4.22e-2)" "unprognostic (2.39e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (7.78e-2)" "unprognostic (1.09e-1)" "unprognostic (5.71e-2)" "unprognostic (1.17e-2)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-3)" "unprognostic (7.11e-3)" 62.7 76.9 3.3 11.2 3.4 9.8 56.5 3.3 7.3 42.7 3.4 79.9 12.9 41.3 3.2 59.5 41.6 5.8 34.2 3.4 3.5 63.7 99.2 78.2 18.2 4.3 3.4 32.1 29.5 8.2 26.6 4.4 3.7 45.2 20.4 0.7 44.2 6.4 14.4 58.0 93.9 8.9 4.0 150.4 57.0 5.9 3.6 13.5 40.8 0.1 17.2 41.3 48.1 4.1 15.1 3.9 0.3 0.0 5.1 13.1 11.2 4.9 22.9 29.1 39.3 0.0 20.9 45.7 9.4 10.5 25.5 8.1 6.8 16.6 8.0 19.2 0.0 27.6 5.9 0.3 30.3 5.2 7.5 14.9 10.3 12.9 6.8 1.9 18.1 11.8 1.1 8.1 6.1 0.1 12.9 11.7 0.1 0.0 7.3 29.3 1.3 24.1 21.3 4.9 0.8 0.2 8.6 10.4 8.5 0.1 7.0 41.0 4.3 8.8 7.6 7.8 0.6 21.0 15.9 11.2 2.2 27.7 9.0 56.8 70.3 94.6 58.1 88.0 51.2 73.4 49.1 61.1 67.5 71.1 34.8 49.6 90.2 63.0 78.2 58.5 81.2 156.0 3.3 3.4 3.3 7.3 3.4 3.5 4.3 3.4 3.7 4.0 3.6 4.1 237.0 38.5 55.8 2.9 162.0 84.4 64.1 183.7 54.7 1.8 85.3 92.5 8.7 71.4 103.2 62.5 0.0 2.7 211.2 219.9 86.1 219.4 0.6 63.2 74.9 158.5 65.7 45.0 0.1 247.6 18.3 60.7 93.8 81.5 50.7 51.4 114.5 75.0 165.9 6.7 0.5 243.8 120.1 143.5 94.9 1.9 39.1 128.2 56.9 10.3 214.3 39.9 279.1 3.0 0.7 179.6 287.9 30.5 153.2 100.1 319.8 78.9 103.2 3.0 39.5 33.2 56.8 0.4 1.2 60.5 79.6 2.7 181.6 110.9 222.6 121.6 PSMB9 "beta1i, LMP2, PSMB6i, RING12" ENSG00000240065 "Proteasome 20S subunit beta 9" P28065 6 32844136-32859851 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 160.9" "Cell type enhanced" "Detected in many" "monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015180, HPA042818, HPA053280" Enhanced Supported Cytosol NA NA 340000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098" "unprognostic (1.09e-2)" "unprognostic (1.68e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-3)" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (5.68e-2)" "unprognostic (6.67e-2)" "unprognostic (1.56e-2)" "unprognostic (6.50e-3)" "unprognostic (1.87e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.96e-3)" "unprognostic (5.99e-2)" 47.0 31.1 4.8 18.4 4.9 6.9 41.4 4.3 5.5 28.8 2.6 38.4 10.2 26.8 2.3 25.7 25.9 4.7 31.6 4.8 5.6 36.3 37.4 60.2 26.2 7.6 4.9 18.1 12.1 1.5 14.0 3.4 5.9 26.5 8.7 1.3 20.3 5.0 11.9 27.7 78.1 5.7 5.7 160.9 26.5 4.9 5.1 15.0 28.7 3.8 22.2 23.6 30.8 5.8 5.5 0.3 0.0 0.2 3.4 8.5 3.0 0.7 11.5 17.3 27.7 0.0 3.1 40.8 1.3 2.9 14.3 10.0 0.2 5.8 2.6 9.3 0.1 17.6 0.7 0.8 17.3 1.8 2.2 2.1 0.3 7.0 1.0 3.3 2.7 10.1 1.4 12.8 1.9 1.0 16.1 8.0 0.0 0.0 0.8 19.0 1.2 7.4 2.1 2.5 0.0 0.0 1.0 2.1 10.7 0.0 4.4 10.3 0.0 2.5 1.6 14.7 1.2 11.3 23.9 9.3 7.5 6.8 4.0 92.7 30.3 75.6 56.1 55.8 45.9 59.7 45.1 55.9 26.6 45.3 41.0 49.6 96.3 61.5 60.9 20.5 61.0 46.2 4.8 4.9 4.3 5.5 4.8 5.6 7.6 4.9 5.9 5.7 5.1 5.8 258.6 41.7 51.1 1.3 197.2 72.5 37.4 155.6 30.1 2.4 25.3 47.0 7.3 50.1 64.8 25.8 0.0 1.5 216.2 88.0 19.6 116.6 1.3 28.9 47.5 146.5 33.5 29.9 0.0 115.6 6.6 45.1 34.1 42.6 77.3 20.0 119.6 26.6 117.2 0.0 0.1 148.0 99.7 126.8 155.7 2.1 29.2 145.2 35.6 8.4 323.0 22.7 495.4 0.5 8.3 67.8 150.3 15.8 136.1 40.4 318.5 40.5 133.7 1.7 32.9 23.1 50.8 1.5 7.4 21.0 58.7 1.4 241.8 45.3 110.6 39.1 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267698-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 7.9;lymphoid tissue: 6.3" "Cell type enhanced" "Detected in some" "dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.0" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "gdT-cell: 68.0;NK-cell: 90.3" "Group enriched" "Detected in many" 33 "NK-cells: 90.3;T-cells: 68.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA049668 Enhanced NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 2.0 0.5 0.2 2.1 1.7 1.4 1.2 0.8 0.7 2.1 2.6 5.6 0.7 1.5 1.0 0.4 1.3 1.6 1.9 0.1 0.3 0.5 1.1 1.7 3.2 2.4 0.6 0.8 0.3 0.4 2.1 0.2 0.4 0.8 7.9 0.0 1.1 0.4 0.6 0.6 1.4 0.8 1.5 6.3 1.3 0.2 0.4 0.9 1.1 0.4 1.1 0.9 1.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 68.0 0.0 33.5 0.1 9.0 40.9 0.1 0.0 1.4 22.5 2.3 90.3 0.4 0.2 0.2 12.9 0.2 1.7 0.8 0.7 0.1 0.3 2.4 0.6 0.4 1.5 0.4 0.1 2.9 3.2 0.0 0.0 0.9 0.5 0.0 0.0 0.6 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 50.6 3.2 0.0 0.0 0.0 0.2 0.1 2.0 1.2 2.7 0.2 0.0 0.0 1.5 1.1 0.1 1.3 0.2 2.2 0.5 0.1 0.0 0.2 7.5 0.0 1.9 0.4 0.0 0.0 4.6 1.8 1.0 0.4 0.0 187.4 0.0 0.1 0.0 2.8 0.0 4.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 5.5 0.0 0.0 0.1 0.1 0.0 31.4 2.2 14.6 0.0 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.3;brain: 102.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 127.4;REH: 141.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 14: REH - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favorable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favorable (5.11e-4)" "unprognostic (3.33e-3)" 19.7 10.8 46.9 52.6 54.4 106.3 11.5 22.8 102.9 11.5 38.3 29.8 34.1 9.9 8.9 19.2 15.6 12.7 10.6 96.3 8.5 15.9 15.2 28.6 78.3 0.0 26.0 4.7 12.6 7.1 13.7 8.0 0.0 25.5 23.5 4.4 26.6 12.3 5.0 45.2 48.8 10.7 0.2 78.3 22.2 9.5 27.0 86.0 12.5 5.4 73.6 21.0 15.1 37.0 38.2 10.4 2.8 3.0 76.6 5.5 21.5 2.9 1.9 1.9 2.7 9.9 21.5 127.4 4.0 5.8 3.1 34.3 1.1 31.3 1.1 8.7 0.8 26.4 10.6 2.0 15.7 28.5 45.5 41.6 46.0 2.6 17.3 13.0 1.0 36.0 31.7 85.6 2.1 4.0 49.1 57.0 2.2 33.0 2.6 141.2 0.7 88.3 8.5 29.5 19.2 3.5 13.4 9.3 5.0 6.5 11.5 72.1 17.5 1.3 2.8 2.5 1.0 68.0 32.0 68.9 5.2 60.6 2.4 47.3 48.4 36.9 33.9 43.0 22.2 46.0 17.0 24.3 36.1 46.6 20.8 25.9 45.8 29.0 53.5 11.7 18.2 50.1 46.9 54.4 22.8 102.9 96.3 8.5 0.0 26.0 0.0 0.2 27.0 37.0 6.9 3.2 29.8 16.6 64.3 37.7 38.7 19.7 6.8 5.4 5.9 7.7 3.7 8.6 13.0 14.7 0.0 2.9 33.4 65.5 0.0 8.0 1.2 7.1 1.8 9.6 7.8 20.2 109.2 8.3 26.5 3.5 22.4 5.3 28.5 1.1 5.0 24.1 23.1 8.4 9.2 21.9 10.2 68.4 32.1 1.0 1.5 55.3 8.8 22.5 62.5 2.8 70.0 7.5 15.1 13.3 42.0 0.7 68.1 18.6 44.6 16.1 13.9 3.9 0.0 3.3 3.3 4.2 6.4 4.8 30.1 1.9 46.6 1.0 18.1 17.9 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 44.1" "Cell type enhanced" "Detected in many" "Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.2;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 6500000 "Cluster 48: NK-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 0.3 2.6 7.9 1.1 10.2 1.0 11.9 0.0 11.9 3.0 0.0 4.9 5.1 0.8 0.4 14.0 1.1 3.8 0.1 13.3 5.2 0.3 1.3 7.2 0.5 0.0 0.1 0.2 4.1 2.3 1.0 1.1 0.6 20.5 5.3 1.0 14.0 1.0 0.2 15.6 4.9 0.9 0.1 1.7 44.1 4.5 2.6 1.4 0.3 0.5 5.2 6.2 5.2 3.3 7.8 22.4 0.8 0.0 1.5 19.3 0.0 1.7 13.5 1.8 1.3 0.0 8.6 1.3 0.1 3.9 16.7 14.5 0.2 9.0 0.5 0.0 0.5 63.3 5.0 0.0 2.6 3.4 7.0 15.3 46.6 25.5 56.0 21.1 1.2 0.3 0.0 3.9 16.1 7.9 0.2 7.4 0.2 14.0 14.7 0.0 0.0 0.3 4.1 28.9 0.2 10.3 2.2 13.4 0.0 0.1 8.3 0.3 0.3 18.8 0.6 9.8 2.0 0.4 0.0 0.0 165.2 35.6 0.9 0.6 0.0 0.1 2.2 0.0 0.5 0.0 0.7 1.1 0.0 0.0 0.2 1.0 0.2 2.6 0.0 0.0 0.0 1.6 7.9 10.2 0.0 11.9 13.3 5.2 0.0 0.1 0.6 0.1 2.6 3.3 0.3 48.1 37.6 3.3 0.9 25.6 8.6 18.2 8.0 2.4 59.8 25.3 0.5 8.6 36.9 5.5 2.1 6.5 15.0 5.7 1.9 7.2 259.3 30.9 4.4 1.9 4.2 3.4 101.0 41.0 4.5 2.0 178.4 64.0 246.6 0.4 2.5 0.9 0.6 6.7 75.8 31.3 20.3 0.6 2.7 209.9 2.1 38.1 7.2 2.8 2.1 1.4 29.9 98.5 2.6 34.0 18.6 0.4 3.2 78.9 3.0 0.0 15.8 0.4 6.6 0.3 2.2 7.9 1.4 79.2 49.2 2.9 13.9 0.5 7.9 42.2 RAC2 EN-7 ENSG00000128340 "Rac family small GTPase 2" P15153 22 37225270-37244448 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 411.9;lymphoid tissue: 387.9" "Cell type enhanced" "Detected in many" "B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022946, HPA047820" Enhanced NA Yes 3300000 "Cluster 5: Granulocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB022946: , HPA047820: AB_2680167" "prognostic favorable (1.03e-5)" "unprognostic (2.91e-1)" "unprognostic (3.21e-2)" "unprognostic (1.82e-3)" "unprognostic (6.74e-2)" "unprognostic (7.78e-2)" "unprognostic (3.47e-1)" "unprognostic (5.00e-2)" "unprognostic (8.52e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (3.81e-1)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.45e-1)" "unprognostic (1.75e-1)" "unprognostic (6.21e-2)" "unprognostic (1.50e-2)" 24.7 8.4 3.6 207.2 3.8 411.9 11.4 3.9 8.0 12.2 4.4 34.8 35.3 10.1 4.7 15.9 11.7 37.1 6.5 3.8 4.7 10.9 19.3 63.4 387.9 6.5 5.3 5.5 5.3 2.1 3.4 12.4 7.1 10.9 33.9 0.4 21.5 8.3 4.9 7.6 96.9 19.6 5.2 299.9 42.7 3.5 6.1 323.9 9.5 7.2 309.1 54.0 9.9 7.2 136.6 0.2 0.0 0.0 14.3 130.5 0.6 17.9 41.1 14.2 28.8 0.3 44.8 167.4 19.8 52.9 0.8 33.3 1.0 231.6 15.6 522.5 0.6 209.6 3.6 0.6 35.8 734.5 1427.9 96.4 32.3 25.1 84.3 0.9 239.7 159.1 50.5 684.5 1.9 0.2 218.9 291.2 2.8 13.1 87.2 72.3 0.7 193.8 22.6 0.1 2.0 0.6 0.9 23.0 2.7 0.8 9.7 391.8 258.7 0.6 23.5 1.0 2.0 307.0 171.4 176.6 618.6 316.5 35.1 1319.9 519.8 1602.2 972.1 695.5 731.5 761.7 768.6 858.9 494.0 672.8 584.3 759.8 1336.4 972.2 879.5 728.7 1163.4 1566.2 3.6 3.8 3.9 8.0 3.8 4.7 6.5 5.3 7.1 5.2 6.1 7.2 4.4 16.0 47.7 0.0 329.0 5.4 2.2 26.0 16.5 0.0 8.6 9.5 1.1 2.8 12.6 1.8 0.0 0.8 381.4 3.4 0.0 13.6 0.2 1.1 0.8 5.6 4.2 109.7 0.4 2.2 1.5 9.2 33.6 1.0 520.5 0.3 13.6 3.4 150.8 0.0 0.1 6.3 0.0 129.9 63.9 0.9 0.3 147.9 30.2 3.7 125.9 0.0 717.9 0.5 0.0 18.2 18.1 0.0 287.8 0.5 0.6 1.5 4.4 0.0 13.1 2.4 4.5 0.0 1.0 5.1 4.0 2.9 419.6 3.7 11.2 3.6 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959906-79090780 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 26.5;lung: 7.5;retina: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 0.1 0.1 4.2 1.0 4.1 0.0 0.1 24.4 24.4 0.6 0.0 0.2 0.2 0.4 0.1 0.1 0.4 0.1 0.0 12.2 6.4 0.7 0.0 7.5 1.3 13.9 10.2 0.8 2.3 0.6 1.1 0.2 16.4 0.5 0.2 7.4 0.1 0.2 0.0 0.0 1.4 0.1 8.7 0.6 0.2 0.3 14.9 0.5 0.0 0.0 1.4 0.3 0.1 26.5 8.5 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.5 1.2 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 10.4 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.9 13.0 0.1 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.7 0.0 0.0 15.1 0.0 0.3 0.0 3.8 2.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.1 24.4 24.4 12.2 6.4 13.9 10.2 16.4 8.7 14.9 26.5 0.2 3.2 80.6 8.5 4.5 0.6 0.6 0.2 0.0 13.7 0.2 0.1 1.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.6 0.4 0.5 0.0 0.0 80.9 0.0 2.7 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.0 25.2 91.2 0.0 0.0 0.3 16.1 0.0 0.0 1.8 3.6 5.6 0.6 1.1 0.0 1.5 121.5 0.3 0.0 0.4 2.1 0.2 0.0 6.8 2.0 2.5 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.8 0.1 1.6 0.0 0.4 RBM38 "dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D" ENSG00000132819 "RNA binding motif protein 38" Q9H0Z9 20 57391396-57409333 "Predicted intracellular proteins" "Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 136.4;skeletal muscle: 221.7" "Cell type enhanced" "Detected in many" "B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 95.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 140.6;U-698: 150.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB017036 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "CAB017036: " "unprognostic (1.03e-1)" "prognostic favorable (3.64e-7)" "unprognostic (3.71e-2)" "unprognostic (7.73e-3)" "unprognostic (4.16e-2)" "unprognostic (4.85e-2)" "unprognostic (1.53e-2)" "unprognostic (4.37e-3)" "unprognostic (3.04e-1)" "unprognostic (9.04e-3)" "unprognostic (3.90e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.13e-2)" "unprognostic (2.29e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.83e-1)" 11.7 10.7 6.7 26.6 9.4 136.4 12.8 13.3 10.3 18.8 15.1 96.6 8.7 38.4 0.9 16.8 28.9 5.1 72.6 5.9 6.4 16.3 16.4 21.0 43.4 8.6 11.5 27.8 10.8 1.9 12.2 5.5 8.0 27.0 4.1 0.6 19.7 11.9 221.7 9.1 39.8 8.7 6.6 65.8 23.0 38.1 9.4 26.6 9.4 32.7 12.2 42.9 13.6 7.9 20.1 20.4 9.7 25.1 0.0 1.6 56.3 6.5 1.6 13.5 3.5 84.2 20.6 140.6 54.1 1.9 13.2 18.3 8.0 8.0 2.1 29.0 34.5 118.0 7.6 52.6 6.0 57.8 54.2 1.9 3.8 5.7 1.1 1.9 9.2 52.5 100.9 24.6 1.6 87.8 42.7 58.5 36.9 10.7 25.5 82.0 23.6 114.2 10.1 9.2 40.9 26.3 15.2 50.5 24.7 8.7 28.3 79.4 17.0 4.4 42.6 6.0 27.6 60.1 86.8 150.7 1.1 40.3 4.2 0.0 0.5 2.2 3.1 1.8 1.9 3.2 2.5 2.1 1.0 3.3 3.0 2.8 0.7 3.5 1.7 1.3 4.7 2.1 6.7 9.4 13.3 10.3 5.9 6.4 8.6 11.5 8.0 6.6 9.4 7.9 13.9 3.2 5.2 10.1 110.9 9.1 28.3 7.9 13.6 1.0 15.8 21.0 42.5 8.6 6.6 1.8 0.0 1.9 156.9 41.6 9.8 6.2 4.2 54.2 5.2 11.9 62.8 280.4 2.5 5.0 5.8 8.8 12.2 21.5 8.8 31.5 10.4 6.0 9.6 0.0 1.3 56.4 12.2 8.1 18.9 4.0 4.4 27.6 1.8 2.8 5.8 12.8 54.6 4.5 4.6 5.9 35.4 6.0 52.8 18.8 2.8 16.4 22.5 1.4 6.6 20.6 7.6 2.4 13.2 9.1 8.4 2.3 81.0 13.3 34.0 18.5 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7115736-7128889 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 443.5;liver: 324.2" "Cell type enriched" "Detected in many" 8 "Proximal tubular cells: 3197.2" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.0;Hep G2: 13.4;K-562: 26.3" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Vesicles "HPA038723: AB_2676175" "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favorable (3.68e-4)" 6.4 11.7 0.0 15.0 0.1 1.6 5.1 0.3 0.3 11.2 0.2 8.5 4.6 8.6 3.2 3.8 8.1 5.9 1.4 0.0 0.0 443.5 324.2 3.8 31.2 0.5 0.3 4.9 5.2 1.3 6.2 0.3 0.3 10.0 4.9 0.8 3.7 5.0 0.7 2.4 20.6 5.4 0.0 97.1 5.2 2.2 0.2 14.2 7.9 0.0 21.4 7.4 4.6 0.0 0.9 1.3 0.0 0.3 0.0 0.0 0.2 1.1 0.0 0.0 0.2 1.1 1.2 1.0 0.3 0.0 0.1 1.2 0.1 0.0 0.0 1.6 0.0 6.0 3.9 13.4 0.0 0.2 0.9 0.2 0.0 0.0 0.0 2.4 0.0 0.6 26.3 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.1 1.2 0.0 0.2 1.4 0.9 0.0 0.6 0.5 0.7 0.7 0.6 0.5 2.8 0.4 0.3 0.1 0.0 0.3 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.5 0.3 0.3 0.0 0.2 0.0 4.9 0.0 0.6 0.7 15.2 1.5 0.5 0.1 0.0 1.2 1.3 1.3 0.1 5.7 0.1 80.9 0.0 0.1 0.3 0.1 352.1 0.2 4.1 0.3 1.7 28.8 0.0 0.0 2.1 0.4 0.0 8.2 0.0 0.5 0.0 0.2 8.9 361.1 0.1 5.0 1.1 0.0 0.0 8.1 2.6 6.7 2.5 16.6 0.0 1.9 0.0 1.4 0.0 0.5 0.1 0.2 0.0 0.4 0.1 0.5 0.0 3197.2 0.9 1.7 0.0 0.1 4.3 0.7 0.4 0.2 2.3 0.0 7.3 2.4 0.1 0.3 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 68.9" "Cell type enhanced" "Detected in many" "Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 9.8 6.1 3.3 2.1 3.2 6.6 2.5 5.2 3.9 6.3 5.3 8.5 1.3 7.1 0.1 2.7 14.9 8.8 2.8 3.4 4.5 12.4 3.3 9.5 3.1 8.9 4.8 3.9 2.7 0.2 68.9 0.6 8.9 7.3 0.4 1.9 4.7 6.2 0.9 1.7 7.3 2.4 3.6 13.6 25.7 29.9 5.3 10.1 3.5 0.3 3.1 4.0 3.7 4.4 0.1 0.2 10.8 0.1 0.4 0.5 0.6 0.4 0.5 1.0 0.8 0.1 1.2 0.2 0.1 0.0 0.6 0.5 0.3 0.0 0.7 1.0 0.2 0.4 0.7 0.0 8.7 0.2 1.5 4.8 0.5 0.4 0.1 4.1 1.9 0.4 0.1 1.4 0.0 0.2 11.7 1.8 3.4 0.0 0.1 0.2 0.0 0.1 0.4 0.4 0.2 47.4 0.0 0.1 0.4 26.0 0.2 0.5 0.4 0.0 0.2 0.3 0.1 1.7 0.5 0.1 0.0 0.2 0.2 2.2 0.1 9.7 4.7 1.1 5.4 1.6 1.7 2.7 3.2 1.7 0.7 2.4 0.1 2.8 5.8 5.2 2.9 1.2 3.3 3.2 5.2 3.9 3.4 4.5 8.9 4.8 8.9 3.6 5.3 4.4 9.5 12.8 10.8 3.6 6.8 1.9 4.4 15.8 8.6 14.9 2.8 2.0 2.0 25.8 14.8 27.6 0.0 1.4 10.2 5.1 5.9 2.9 150.6 43.5 10.6 4.8 4.8 25.9 3.8 2.7 3.2 10.0 73.9 21.9 3.8 7.9 3.6 2.1 2.3 6.7 5.1 2.5 10.2 5.7 3.9 74.5 4.7 6.6 1.8 2.8 4.0 21.1 2.1 5.5 4.6 5.0 0.7 3.0 11.0 1.5 4.1 24.7 51.4 2.0 0.0 3.7 3.9 8.3 43.4 1.3 2.0 0.4 11.3 33.8 2.4 4.0 RGS1 "1R20, BL34, IER1, IR20" ENSG00000090104 "Regulator of G protein signaling 1" Q08116 1 192575763-192580024 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 25.7;T-reg: 21.9" "Group enriched" "Detected in many" 5 "granulocytes: 25.7;T-cells: 21.9" "Cell line enriched" "Detected in some" 4 "U-266/70: 962.6" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 85.5" HPA074572 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "HPA074572: " "unprognostic (3.68e-3)" "unprognostic (1.14e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-1)" "unprognostic (4.37e-1)" "unprognostic (3.87e-3)" "unprognostic (6.61e-2)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.91e-5)" "prognostic unfavorable (9.57e-4)" "unprognostic (4.01e-2)" "unprognostic (9.90e-2)" "unprognostic (4.56e-2)" 34.7 88.2 18.2 170.3 17.4 151.6 57.9 22.1 77.4 50.7 42.2 75.4 24.7 19.2 5.2 68.3 22.8 112.8 31.4 14.6 43.7 19.9 59.9 78.9 142.9 39.1 21.7 14.3 19.1 25.6 40.0 22.2 27.9 50.7 112.7 26.6 56.0 13.8 2.9 17.9 72.7 44.9 29.3 74.6 36.6 8.5 25.3 154.2 23.9 5.1 90.7 127.7 39.3 46.7 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 4.3 0.0 0.0 2.8 4.6 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 220.6 0.0 0.0 0.4 5.6 0.2 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 962.6 4.1 3.5 0.0 0.1 0.2 0.0 0.0 25.7 0.8 0.1 1.9 0.0 5.1 4.5 0.7 0.0 0.4 3.7 0.1 0.7 0.1 4.9 21.9 0.7 18.2 17.4 22.1 77.4 14.6 43.7 39.1 21.7 27.9 29.3 25.3 46.7 10.8 12.8 103.2 0.0 170.6 49.2 6.9 0.3 5.7 0.7 11.7 18.7 1.2 4.3 13.2 0.0 0.0 2.1 148.8 1.4 0.0 1.4 1.8 1.7 2.0 32.7 4.8 16.4 0.0 2.8 2.8 15.4 47.4 2.5 1398.7 0.0 5.3 3.8 390.4 0.0 0.0 1.6 0.0 211.2 1133.6 7.4 3.1 860.4 250.8 7.5 333.9 0.9 2.1 0.0 0.0 0.2 3.5 0.7 902.4 3.7 1.3 1.2 11.3 1.9 19.7 2.0 8.5 0.4 1.2 3.5 40.2 6.0 748.2 0.2 4.0 8.3 RUBCNL "C13orf18, FLJ21562, KIAA0226L, PACER" ENSG00000102445 "Rubicon like autophagy enhancer" Q9H714 13 46334681-46438190 "Predicted intracellular proteins" "Autophagy, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 6.1;B-cells: 20.7;Endometrial stromal cells: 6.7;Hofbauer cells: 16.7;Macrophages: 5.2" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2" "Group enriched" "Detected in many" 15 "B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0" "Group enriched" "Detected in some" 4 "Daudi: 179.1;U-698: 341.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026614 Approved Approved Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Cytosol "HPA026614: AB_10602693" "unprognostic (3.35e-2)" "unprognostic (2.61e-1)" "unprognostic (1.94e-3)" "prognostic favorable (3.76e-5)" "unprognostic (1.09e-2)" "unprognostic (8.30e-4)" "unprognostic (7.83e-2)" "unprognostic (2.62e-3)" "unprognostic (1.07e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (5.95e-5)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (7.47e-2)" "unprognostic (7.00e-3)" 4.2 1.3 3.7 18.0 3.8 14.8 4.0 3.5 4.1 6.6 2.5 11.9 3.0 3.7 1.2 1.0 3.7 4.0 1.0 3.4 6.8 1.1 2.2 5.2 41.2 6.2 4.8 0.6 0.7 0.3 2.0 4.2 6.1 1.5 16.2 3.9 3.0 2.6 10.1 2.0 13.2 3.6 4.9 20.3 2.2 15.7 6.3 22.9 1.9 1.4 40.6 7.5 1.3 5.9 0.5 0.1 3.6 0.2 0.1 0.2 0.3 0.0 0.2 0.2 0.1 7.5 0.2 179.1 1.8 0.0 0.9 0.2 0.1 0.0 0.1 0.7 0.3 0.2 0.2 0.1 0.0 0.2 0.2 4.7 0.0 0.6 0.9 0.0 0.0 8.2 0.3 0.4 0.0 0.1 1.9 1.4 1.5 0.0 1.4 62.6 0.1 6.1 0.0 0.1 3.4 0.1 0.2 0.3 4.4 10.8 0.2 53.0 0.1 0.2 1.6 0.3 0.4 0.9 37.3 341.2 1.1 0.3 0.2 0.5 4.5 0.1 0.1 8.9 0.1 161.2 0.3 0.1 5.1 155.8 0.1 0.1 124.0 3.5 7.1 106.2 0.2 7.5 3.7 3.8 3.5 4.1 3.4 6.8 6.2 4.8 6.1 4.9 6.3 5.9 0.2 3.2 6.1 0.0 20.7 0.0 0.0 0.0 0.0 0.0 2.9 3.9 0.0 0.0 2.5 0.0 0.0 0.3 0.3 0.0 0.0 1.4 0.0 1.3 6.7 0.4 0.0 0.0 0.0 1.2 0.4 1.1 0.0 2.5 2.5 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 RUFY4 "FLJ46536, ZFYVE31" ENSG00000188282 "RUN and FYVE domain containing 4" Q6ZNE9 2 218034960-218090581 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;lymphoid tissue: 2.2" "Group enriched" "Detected in some" 4 "Granulosa cells: 9.5;Langerhans cells: 4.0;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "Karpas-707: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA037980 Uncertain NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA037980: AB_10672501" "unprognostic (1.27e-3)" "unprognostic (4.60e-3)" "unprognostic (9.39e-3)" "unprognostic (6.79e-2)" "unprognostic (5.92e-2)" "unprognostic (6.57e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-2)" "unprognostic (1.31e-3)" "unprognostic (1.50e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-1)" "unprognostic (2.41e-14)" "unprognostic (1.36e-2)" "unprognostic (1.13e-3)" "unprognostic (3.45e-1)" "unprognostic (1.43e-5)" 0.1 0.2 0.5 0.9 0.6 0.8 0.1 0.4 1.8 0.1 0.4 0.2 0.7 0.0 0.0 0.4 0.2 0.5 0.0 0.9 0.4 0.1 0.2 0.4 1.1 0.4 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.1 0.5 0.1 0.5 0.1 0.0 0.3 0.7 0.0 0.5 2.2 0.6 0.1 0.4 1.7 0.1 0.0 0.8 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.4 1.8 0.9 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.0 0.0 0.0 2.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 9.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.3 4.0 0.3 0.0 0.9 0.0 1.0 2.0 0.0 0.0 13.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 RUNX2 "AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1" ENSG00000124813 "RUNX family transcription factor 2" Q13950 6 45328157-45664349 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.7" "Cell type enhanced" "Detected in many" "dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 22.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008374, HPA022040, CAB062561, CAB068226, HPA070715" Enhanced Enhanced Nucleoplasm No No "Cluster 48: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: " "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (3.99e-2)" "unprognostic (2.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-1)" "unprognostic (1.23e-1)" "unprognostic (3.70e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (3.97e-9)" "prognostic unfavorable (2.24e-4)" "unprognostic (5.52e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (6.66e-5)" 1.7 0.7 1.1 4.3 1.0 9.7 2.8 1.2 1.4 6.7 0.9 3.7 2.0 1.5 0.8 1.4 0.9 3.4 0.7 1.3 1.5 1.5 0.7 2.7 4.5 1.9 1.8 2.2 0.6 0.6 1.6 1.5 1.9 4.8 3.9 0.1 10.7 2.6 0.8 2.4 6.0 1.6 1.6 3.6 3.2 0.5 2.0 4.5 1.8 0.9 5.6 3.6 4.9 1.9 3.6 1.1 0.8 0.0 3.2 8.3 0.0 3.3 7.9 10.9 15.2 0.0 1.9 0.0 3.8 4.7 4.9 4.3 0.0 3.1 19.7 13.7 1.5 0.0 2.4 0.0 16.7 14.2 0.1 22.5 2.5 9.7 10.9 39.3 0.2 5.6 0.0 62.3 19.7 1.0 0.4 24.7 0.7 3.2 0.5 0.1 51.8 0.0 10.7 7.0 0.0 0.0 2.4 0.1 4.1 9.2 3.6 1.2 0.5 11.1 8.8 17.2 12.1 19.6 0.0 55.2 12.5 5.3 5.0 8.6 0.9 4.5 1.5 0.2 12.9 0.2 3.5 4.0 2.4 0.2 0.6 1.8 6.5 22.1 0.1 15.4 3.2 1.0 1.1 1.0 1.2 1.4 1.3 1.5 1.9 1.8 1.9 1.6 2.0 1.9 0.9 0.0 2.7 4.6 5.7 2.8 16.6 5.3 1.2 0.0 2.0 1.4 2.7 0.0 4.9 3.7 0.0 0.0 55.8 0.3 0.0 0.6 128.3 0.7 3.5 0.8 0.0 3.8 17.4 0.2 0.0 7.0 4.1 0.5 2.5 0.1 1.1 0.8 3.7 0.0 95.2 1.0 20.3 6.7 20.8 20.0 1.2 16.3 7.2 128.4 18.6 0.0 7.2 6.6 5.2 0.4 0.1 2.2 44.4 16.5 0.0 3.3 5.1 0.0 6.6 1.5 6.2 0.8 0.5 1.2 1.6 0.1 21.4 0.2 0.2 28.0 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "RUNX family transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 68.8;lymphoid tissue: 35.1" "Cell type enhanced" "Detected in many" "dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4" "Cancer enhanced" "Detected in all" "melanoma: 25.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" Cytosol "CAB025416: , HPA004195: , HPA059006: AB_2683877" "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavorable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.5 1.4 3.7 21.1 3.6 68.8 3.5 3.8 4.6 19.7 3.7 3.7 5.0 1.6 0.7 2.6 1.6 5.3 1.1 3.6 3.8 1.6 3.7 9.5 34.7 4.7 4.4 0.6 0.9 0.4 0.7 0.9 4.3 1.9 4.2 0.1 4.7 0.8 3.8 11.5 15.0 1.6 4.1 35.1 5.5 2.3 4.3 11.2 1.8 0.7 29.0 6.5 1.5 4.5 0.3 10.4 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.5 0.0 0.5 0.0 19.3 18.4 16.4 0.1 0.4 11.1 0.0 0.7 124.9 1.9 0.4 1.8 0.1 0.0 4.5 42.8 0.1 0.0 0.0 1.1 0.0 0.0 3.1 0.1 155.6 0.0 0.0 1.5 37.9 0.7 0.0 3.2 0.0 0.1 22.7 0.0 0.5 3.5 0.0 7.3 0.1 92.4 2.9 0.0 25.7 0.0 0.0 1.9 0.0 0.5 54.6 40.4 18.2 0.1 42.0 4.4 0.7 1.1 7.0 21.7 4.5 11.3 6.7 7.9 18.7 1.4 5.7 3.9 14.6 1.3 28.7 7.7 1.5 9.2 5.5 3.7 3.6 3.8 4.6 3.6 3.8 4.7 4.4 4.3 4.1 4.3 4.5 4.4 0.0 3.6 0.0 57.7 7.6 0.8 4.6 2.2 0.0 9.8 11.3 2.4 0.0 1.5 1.8 0.0 0.1 336.4 0.5 0.0 0.2 2.3 1.1 1.2 2.4 0.0 13.7 0.0 0.2 0.1 3.3 13.3 2.3 45.2 0.0 2.2 1.5 4.6 0.0 0.0 0.5 0.0 22.9 133.9 1.0 0.0 55.6 46.2 1.0 51.1 0.0 251.3 0.0 0.1 0.1 0.1 0.7 87.1 1.2 0.0 0.3 0.5 0.0 0.0 3.5 3.6 0.3 4.1 2.3 5.8 0.3 215.4 0.1 0.4 0.4 SCML4 dJ47M23.1 ENSG00000146285 "Scm polycomb group protein like 4" Q8N228 6 107702154-107824317 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 10.1;lymphoid tissue: 12.1" "Cell type enhanced" "Detected in many" "dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2" "Group enriched" "Detected in many" 6 "NK-cells: 53.2;T-cells: 74.8" "Cell line enriched" "Detected in some" 5 "HDLM-2: 65.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA063326, HPA065958" Approved Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm "HPA063326: AB_2684986, HPA065958: AB_2685587" "unprognostic (4.00e-5)" "unprognostic (2.10e-3)" "unprognostic (4.71e-2)" "unprognostic (4.24e-3)" "unprognostic (1.38e-3)" "unprognostic (4.75e-4)" "unprognostic (3.84e-3)" "unprognostic (6.65e-3)" "unprognostic (4.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.13e-4)" "unprognostic (3.68e-1)" "unprognostic (3.77e-4)" "unprognostic (8.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.52e-3)" "unprognostic (5.09e-3)" 0.6 0.8 0.8 7.2 0.6 3.3 1.0 1.2 0.7 0.5 0.2 2.3 10.1 0.5 4.6 0.9 0.7 1.4 0.6 0.6 0.9 0.6 1.6 1.7 12.1 0.5 0.5 0.6 0.7 0.2 1.9 0.3 0.3 0.6 2.0 0.9 1.0 0.4 0.4 0.9 8.2 0.5 0.1 7.4 2.8 2.2 1.3 9.3 0.8 0.2 9.8 1.1 0.7 0.6 0.1 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.0 0.0 0.0 1.4 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.1 65.1 0.0 0.1 0.4 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.7 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.1 0.3 0.1 0.1 13.8 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.3 0.2 0.7 0.1 0.1 0.1 4.2 0.3 3.5 48.2 0.1 47.7 10.1 74.8 65.7 0.2 5.8 69.1 59.5 6.6 53.2 0.4 1.2 5.8 26.6 0.8 0.6 1.2 0.7 0.6 0.9 0.5 0.5 0.3 0.1 1.3 0.6 0.5 0.0 0.0 0.7 18.0 1.5 0.0 0.0 0.6 0.6 0.4 0.4 1.1 0.0 0.0 0.0 0.0 1.3 31.7 0.4 0.0 1.2 72.1 0.0 0.1 0.7 0.0 1.3 2.7 0.0 0.2 1.0 4.6 0.1 1.3 0.0 1.1 1.8 0.2 1.7 2.5 1.4 0.0 0.8 1.4 168.4 0.9 1.2 3.6 1.9 2.0 0.0 35.0 0.5 0.1 0.1 2.6 0.7 11.6 0.0 5.5 0.4 0.7 0.0 0.0 0.3 0.6 1.1 0.5 0.3 0.1 0.1 73.3 0.0 4.7 0.1 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633168-52669683 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6" "Cell type enhanced" "Detected in some" "B-cells: 4.3;dendritic cells: 9.8;Endometrial stromal cells: 2.6;Hofbauer cells: 1.8;Macrophages: 2.2;T-cells: 6.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 8.7" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0" "Cell line enhanced" "Detected in some" "Daudi: 4.1;Karpas-707: 9.4;NB-4: 2.9;RPMI-8226: 13.0" "Region enhanced" "Detected in some" "hypothalamus: 4.0" "Low region specificity" "Detected in some" HPA030744 Uncertain NA NA "Cluster 37: B-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.4 0.2 0.8 2.3 0.7 1.7 0.2 0.8 1.0 1.0 0.4 0.4 0.3 0.4 0.7 0.2 0.6 0.3 0.1 0.5 8.7 0.3 0.2 0.7 5.6 1.0 1.6 0.0 0.2 0.0 2.0 0.1 1.1 0.4 0.3 0.1 0.3 0.3 0.3 0.0 3.7 0.0 0.9 5.4 0.5 0.8 2.5 1.0 0.7 0.2 5.2 0.3 0.2 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 2.9 1.6 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.0 0.0 3.9 10.1 6.2 5.6 0.0 9.8 4.3 2.6 0.0 5.9 0.0 0.0 2.1 1.6 0.8 0.7 0.8 1.0 0.5 8.7 1.0 1.6 1.1 0.9 2.5 1.2 0.6 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.6 2.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.4 0.5 0.0 0.0 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532555-113629575 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.8" "Cell type enhanced" "Detected in many" "B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 33.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035862 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.2 2.8 5.2 5.2 5.6 3.4 5.4 4.7 6.4 3.1 0.0 6.2 2.0 0.7 0.2 1.4 1.9 3.7 0.4 6.4 3.6 0.8 0.6 1.8 8.8 2.8 3.5 0.2 0.7 0.5 5.4 1.0 2.1 5.1 10.2 0.4 10.8 1.5 0.3 0.5 5.4 0.7 5.7 7.1 3.5 0.9 4.9 5.2 0.4 0.4 8.8 4.5 0.9 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 1.5 0.0 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 4.2 0.0 15.4 4.2 0.2 0.0 16.2 21.0 6.2 0.0 0.5 0.0 14.9 0.2 0.1 0.0 4.2 0.2 0.0 13.8 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 7.0 0.1 7.1 7.5 4.7 5.8 1.5 6.6 5.9 5.1 0.3 9.1 0.0 33.7 3.9 3.4 5.2 5.6 4.7 6.4 6.4 3.6 2.8 3.5 2.1 5.7 4.9 3.3 1.6 6.4 3.3 7.2 47.4 0.4 1.4 1.9 0.0 1.4 9.7 4.7 1.1 4.3 4.2 1.8 0.0 0.0 34.5 17.2 0.0 0.4 5.0 3.1 0.7 1.0 10.2 0.8 117.8 1.1 0.2 0.4 8.2 6.3 3.8 0.0 0.4 0.5 11.2 0.0 86.8 23.3 2.0 3.5 1.8 1.5 0.0 10.1 5.4 23.4 2.6 0.1 21.6 4.5 4.0 0.8 3.9 0.0 14.5 3.9 2.2 0.1 9.3 0.2 0.0 0.7 0.7 0.2 0.1 0.9 0.3 0.1 16.4 0.3 7.0 1.9 SLC25A53 MCART6 ENSG00000269743 "Solute carrier family 25 member 53" Q5H9E4 X 104099214-104157009 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Daudi: 6.1;Karpas-707: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034959 Uncertain NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA034959: AB_10602025" "unprognostic (4.70e-2)" "unprognostic (1.16e-2)" "unprognostic (7.16e-3)" "unprognostic (5.94e-2)" "unprognostic (2.68e-2)" "unprognostic (5.23e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" "unprognostic (4.45e-3)" "unprognostic (7.94e-2)" "unprognostic (9.76e-5)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (3.48e-2)" "unprognostic (1.74e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-2)" 0.1 0.3 1.0 1.0 1.0 0.4 0.2 1.3 1.1 0.2 0.3 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.3 1.1 0.9 0.1 0.1 0.2 1.9 0.9 1.1 0.4 0.5 0.1 0.2 0.1 0.9 0.2 0.4 0.4 0.1 0.1 0.1 0.2 1.0 0.2 1.0 1.3 0.4 0.6 1.0 0.5 0.1 0.0 1.6 0.2 0.1 1.3 0.0 0.1 1.7 1.1 0.1 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 6.1 0.1 0.0 0.3 0.1 2.0 0.0 0.1 0.5 0.8 0.7 0.2 0.1 0.1 1.1 0.7 0.3 0.0 0.2 0.0 0.3 0.4 0.6 0.1 13.9 0.1 0.1 0.2 0.1 2.2 0.1 0.4 2.5 0.9 0.2 0.3 0.2 1.5 2.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.8 0.1 0.4 0.1 0.0 2.2 0.1 1.6 0.4 0.2 0.1 0.2 0.3 0.1 0.6 0.5 0.3 0.5 0.1 0.4 0.0 0.3 0.7 0.2 0.0 0.0 0.5 0.1 1.0 1.0 1.3 1.1 1.1 0.9 0.9 1.1 0.9 1.0 1.0 1.3 6.6 6.4 4.6 26.4 11.4 5.2 8.8 6.2 4.0 3.5 7.2 5.7 15.1 5.7 4.6 9.2 0.0 3.7 9.6 17.3 25.4 4.3 6.8 6.9 4.7 5.3 7.2 19.4 15.5 6.0 4.2 7.6 7.7 7.2 7.0 2.7 6.4 25.1 10.6 3.3 14.1 7.8 4.1 8.8 5.7 1.3 3.1 7.5 1.8 16.9 11.4 4.0 17.5 17.1 23.5 7.8 21.8 3.0 10.2 8.8 19.7 25.9 10.8 8.1 0.0 5.2 5.0 4.8 2.3 4.7 5.7 6.2 11.0 3.0 4.5 11.3 SMIM35 TMPRSS4-AS1 ENSG00000255274 "Small integral membrane protein 35" A0A1B0GVV1 11 118003634-118088299 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.2;kidney: 1.1" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Karpas-707: 10.9;RPMI-8226: 7.2" "Group enriched" "Detected in some" 5 "basal ganglia: 1.2;olfactory bulb: 3.5" "Region enriched" "Detected in some" 6 "basal ganglia: 7.9" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" "unprognostic (8.83e-2)" "unprognostic (3.42e-2)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-4)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" 0.1 0.1 0.2 0.5 0.3 1.2 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 1.1 0.1 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 7.2 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.3 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 1.6 0.1 0.2 0.3 0.1 0.5 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677688-88686507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 31.3" "Cell type enhanced" "Detected in some" "dendritic cells: 19.7;granulocytes: 9.5;Kupffer cells: 14.6;Langerhans cells: 9.3;Macrophages: 9.4;NK-cells: 17.5;Plasma cells: 14.0;T-cells: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NB-4: 18.2;RPMI-8226: 28.6" "Region enhanced" "Detected in single" "basal ganglia: 1.5" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.7 0.5 1.5 2.4 2.4 1.8 0.4 0.0 3.3 0.6 0.0 1.2 1.5 0.6 0.3 0.6 0.8 1.0 2.4 1.9 0.0 0.7 0.8 2.2 3.9 2.1 0.0 0.5 1.7 1.5 0.7 0.1 3.7 0.8 0.3 0.3 1.2 0.2 31.3 0.6 3.7 0.2 0.0 6.9 3.3 0.9 0.0 0.8 0.9 7.3 2.6 1.4 0.5 0.0 0.3 0.9 0.3 1.3 0.0 0.0 0.6 0.3 0.0 0.0 0.1 3.5 0.3 2.3 0.5 0.0 0.8 0.8 0.3 0.2 0.0 0.4 1.2 1.1 0.1 1.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.5 2.1 4.3 0.0 3.2 0.2 18.2 0.4 0.3 0.4 3.9 0.3 28.6 0.0 0.4 1.7 0.2 0.7 0.0 0.2 0.4 1.2 2.2 0.3 0.1 1.0 0.2 0.0 0.7 4.2 4.0 0.3 4.9 0.5 5.2 14.1 48.5 10.2 5.3 18.8 7.8 16.7 9.8 16.7 6.1 10.0 6.4 30.9 1.1 1.5 11.9 21.4 10.9 1.5 2.4 0.0 3.3 1.9 0.0 2.1 0.0 3.7 0.0 0.0 0.0 0.3 3.2 0.0 2.0 8.5 0.5 0.1 0.4 0.0 0.2 0.4 0.5 2.0 0.0 0.7 0.0 0.0 0.0 19.7 0.0 1.9 0.1 0.0 0.6 0.0 0.4 0.0 0.4 6.4 0.4 0.5 0.2 0.5 0.1 9.5 0.0 0.4 0.1 6.9 0.0 3.7 0.1 2.0 14.6 9.3 0.3 0.0 9.4 5.4 0.0 5.3 0.1 17.5 1.0 1.9 0.1 1.1 0.4 14.0 0.1 0.0 0.2 1.0 0.9 0.0 0.7 0.4 0.0 1.5 0.2 0.3 0.1 14.0 0.0 0.3 0.1 SP110 "IFI41, IFI75" ENSG00000135899 "SP110 nuclear body protein" Q9HB58 2 230165186-230225729 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.7" "Cell type enhanced" "Detected in many" "B-cells: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 99.3" "Low region specificity" "Detected in all" HPA058554 Supported Nucleoplasm No No "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA058554: AB_2683754" "unprognostic (9.72e-2)" "unprognostic (1.15e-2)" "unprognostic (5.02e-2)" "unprognostic (8.33e-4)" "unprognostic (2.93e-1)" "unprognostic (1.80e-1)" "unprognostic (6.65e-2)" "unprognostic (9.44e-2)" "unprognostic (9.68e-2)" "unprognostic (1.46e-2)" "unprognostic (4.11e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.38e-1)" "unprognostic (2.66e-2)" "unprognostic (2.99e-3)" "unprognostic (9.50e-3)" 14.0 7.3 8.4 38.5 10.3 29.8 11.8 9.4 10.8 11.6 11.5 12.6 11.9 10.5 7.9 9.2 9.6 18.0 8.1 8.1 10.3 11.9 14.8 21.0 53.7 15.3 10.9 16.5 7.9 9.7 5.3 17.5 11.6 9.6 14.0 2.0 17.0 7.6 5.7 7.8 17.6 13.4 12.1 49.8 12.9 3.1 10.9 35.7 7.4 8.4 50.1 18.9 9.3 12.3 8.3 4.4 2.7 4.7 14.2 23.6 8.3 14.8 30.8 70.3 99.3 0.2 12.7 34.5 13.8 15.8 67.0 5.1 9.0 23.0 25.7 30.5 6.0 14.9 6.2 8.9 14.5 22.1 17.1 32.7 11.8 20.8 27.4 13.2 25.3 23.6 5.3 12.1 20.6 4.9 33.0 43.5 8.6 4.2 5.1 20.1 25.4 12.8 56.2 11.1 0.5 5.7 5.7 12.7 32.7 0.9 9.6 18.5 18.8 12.9 7.9 3.2 7.5 12.9 4.6 16.2 14.4 20.6 10.7 92.2 49.7 124.4 55.2 85.8 47.8 142.8 53.5 50.5 44.1 135.8 54.1 58.7 268.6 56.9 143.4 84.4 70.7 48.5 8.4 10.3 9.4 10.8 8.1 10.3 15.3 10.9 11.6 12.1 10.9 12.3 77.8 44.8 23.8 17.3 141.7 9.9 5.2 25.7 16.5 0.4 21.6 19.3 3.7 7.2 19.6 11.0 0.0 3.8 84.0 17.0 13.7 19.9 5.2 17.2 21.3 28.6 6.7 9.7 1.1 28.5 12.7 22.8 9.2 20.1 38.0 21.2 26.4 6.2 26.9 0.0 2.1 11.4 73.2 47.4 25.8 4.2 11.8 62.3 19.6 42.2 56.7 9.7 59.8 19.6 18.2 26.0 11.6 10.1 35.7 3.5 10.7 14.4 21.0 4.9 6.6 8.6 16.2 4.8 2.3 9.8 10.1 4.7 68.8 23.5 6.1 3.0 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 71.8;lung: 28.3;lymphoid tissue: 51.1" "Cell type enhanced" "Detected in many" "dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 218.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA 270000 "Cluster 51: Monocytes - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 4.0 0.6 0.8 14.4 1.0 71.8 1.8 1.1 0.9 1.4 0.2 3.9 5.5 1.6 1.1 3.0 2.0 4.3 2.8 0.9 1.4 0.8 2.6 28.3 26.3 3.5 1.3 0.6 1.0 0.6 0.2 0.9 2.5 1.3 5.3 0.3 2.3 1.1 0.8 2.8 6.3 2.3 1.8 19.0 5.0 0.4 2.5 51.1 0.8 0.3 23.0 4.2 0.5 4.1 0.2 0.2 0.1 0.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.9 0.1 0.6 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 278.8 0.2 2.0 0.0 281.5 158.3 0.0 0.0 0.1 0.0 0.1 0.0 68.0 96.1 76.9 0.5 0.2 122.2 70.1 0.1 0.0 0.0 98.4 1.1 2.2 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.3 0.1 164.1 0.4 0.0 0.2 0.2 0.2 0.3 5.8 40.7 0.3 205.4 0.3 13.6 23.2 14.6 96.3 96.3 51.4 3.7 38.5 65.5 34.0 1.1 26.3 47.6 3.6 69.4 218.0 27.2 34.7 52.1 0.8 1.0 1.1 0.9 0.9 1.4 3.5 1.3 2.5 1.8 2.5 4.1 1.2 9.6 16.9 0.0 10.8 2.2 0.9 0.0 0.0 0.6 1.0 0.8 5.3 1.5 2.5 1.8 0.0 0.2 131.6 0.1 0.0 0.1 0.1 0.5 0.6 3.0 0.0 125.9 0.0 0.0 0.4 3.0 5.1 0.7 43.7 0.8 4.6 1.5 27.0 1.7 0.0 0.3 0.0 28.8 30.3 0.0 0.0 65.8 1.8 1.9 66.4 0.5 352.2 1.5 0.0 0.0 0.1 0.0 60.3 0.5 0.1 0.6 1.5 1.9 0.0 0.8 1.0 0.2 0.6 0.1 2.0 0.3 94.8 0.1 0.2 0.6 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966479-45080021 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Cell type enhanced" "Detected in all" "B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 45000 "Cluster 18: Basophils - Vesicular transport" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 10.0 8.5 6.9 33.8 8.0 57.7 9.1 6.2 10.8 7.9 9.9 11.1 10.2 8.5 7.6 9.1 6.2 11.7 4.6 7.2 8.7 6.0 9.2 15.9 43.1 8.7 7.6 7.0 6.0 5.9 4.1 10.4 9.2 6.7 13.0 7.3 7.4 8.0 3.3 11.2 13.5 9.3 8.3 30.4 12.7 9.7 7.5 33.1 7.6 4.9 41.7 15.0 6.9 10.3 27.8 18.7 23.3 16.1 13.5 16.9 16.0 23.6 35.7 39.4 35.6 52.7 14.6 66.6 20.4 16.9 33.4 28.5 24.3 31.8 49.7 30.8 13.8 48.6 27.8 36.8 23.8 63.5 66.4 13.8 25.6 36.7 39.6 19.4 14.6 44.6 23.5 37.0 19.9 21.7 47.6 42.3 13.9 17.7 12.5 30.2 25.2 31.2 14.4 18.7 10.9 13.2 35.6 20.0 27.0 17.2 18.3 39.1 18.7 29.2 28.6 34.4 27.8 48.4 41.7 73.2 28.6 29.5 22.0 80.6 19.7 54.8 34.4 19.9 34.3 26.2 32.2 32.0 18.4 26.9 33.1 28.0 101.8 28.5 38.0 10.0 34.3 22.3 6.9 8.0 6.2 10.8 7.2 8.7 8.7 7.6 9.2 8.3 7.5 10.3 26.2 16.0 24.6 18.9 372.8 55.7 49.3 33.8 28.5 27.3 22.9 17.4 7.6 14.3 25.2 42.3 52.1 24.1 341.8 23.7 9.8 16.3 5.9 19.1 25.1 32.1 25.7 46.3 76.7 17.6 30.3 29.7 34.1 25.1 133.6 114.0 26.0 22.0 61.1 43.7 38.2 20.7 28.5 109.3 606.9 5.0 22.7 154.4 133.4 85.3 367.5 20.2 278.1 34.2 48.1 21.6 27.9 17.0 336.2 32.6 23.2 13.4 26.1 69.9 13.1 25.5 29.2 44.2 42.4 20.9 53.0 19.4 414.5 48.1 19.5 45.5 SYTL1 "exophilin-7, FLJ14996, JFC1, SLP1" ENSG00000142765 "Synaptotagmin like 1" Q8IYJ3 1 27342020-27353937 "Plasma proteins, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;pancreas: 106.3;skin 1: 87.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 4.3;cerebellum: 8.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA037825 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 24: NB-4 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA037825: AB_10671635" "unprognostic (4.23e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-1)" "prognostic favorable (6.83e-7)" "unprognostic (7.81e-3)" "unprognostic (5.81e-2)" "unprognostic (1.05e-1)" "unprognostic (7.18e-3)" "unprognostic (4.41e-1)" "unprognostic (1.14e-2)" "unprognostic (2.07e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (1.45e-1)" "unprognostic (3.02e-1)" "unprognostic (1.72e-2)" "unprognostic (5.88e-3)" 2.0 0.6 4.3 19.1 0.7 46.7 7.7 8.8 1.4 22.6 6.1 6.7 7.8 1.3 1.2 103.9 15.5 8.6 0.9 1.0 1.0 2.8 2.1 13.1 32.9 0.7 0.8 0.6 106.3 4.2 15.6 2.9 0.8 63.6 3.3 0.0 47.6 12.7 0.5 87.2 17.6 0.4 0.5 42.0 41.8 0.9 1.2 21.4 9.8 0.5 20.0 21.6 50.9 0.6 11.3 0.2 0.0 0.4 0.0 0.0 47.8 0.0 0.0 0.0 0.0 1.2 55.8 8.5 10.9 0.0 0.3 34.7 0.0 21.0 0.0 0.0 2.1 1.0 0.9 15.3 0.8 21.9 0.0 0.0 37.8 0.0 7.8 0.2 0.0 28.2 0.7 9.5 0.0 15.5 12.9 81.8 0.5 19.1 5.7 14.9 0.1 40.2 8.6 9.6 15.9 0.9 0.0 15.9 0.6 0.5 40.4 23.3 0.2 0.1 5.1 0.0 0.0 44.3 11.7 8.0 1.6 27.7 0.0 47.0 18.9 176.5 65.0 49.1 58.4 42.8 51.5 53.2 51.0 32.3 30.6 37.3 34.1 49.0 100.8 3.0 63.4 40.0 4.3 0.7 8.8 1.4 1.0 1.0 0.7 0.8 0.8 0.5 1.2 0.6 1.9 22.4 13.6 0.0 68.6 41.2 78.2 84.4 158.8 0.6 33.6 49.8 3.9 8.6 69.2 0.0 0.0 37.4 92.3 4.8 7.9 3.7 0.8 67.8 2.4 2.3 11.4 15.8 0.3 25.5 10.1 3.1 100.9 18.3 1.3 0.2 2.2 1.1 3.2 0.0 0.3 47.6 32.6 6.7 12.7 0.7 0.3 15.7 10.6 0.0 18.8 2.0 208.1 0.0 0.1 12.1 3.7 0.7 52.3 46.8 3.1 6.4 62.8 0.8 0.0 1.3 5.6 30.3 23.1 179.1 55.3 14.1 74.9 0.2 9.4 95.3 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853816 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 126.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Approved "Endoplasmic reticulum,Centriolar satellite" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: AB_2686513" "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 28.4 24.9 16.1 50.1 16.2 13.7 20.7 15.8 20.3 21.6 16.2 30.3 36.0 20.5 2.5 31.6 17.8 12.7 25.4 14.7 16.2 21.8 19.3 52.7 50.0 24.0 16.1 12.1 14.5 7.0 11.6 12.1 21.2 21.9 12.5 1.7 25.9 7.0 16.3 51.2 42.6 11.5 18.6 73.0 33.4 11.5 19.4 25.5 17.0 7.4 21.3 23.9 24.4 17.4 22.9 13.7 0.1 16.1 8.8 11.4 126.2 8.1 34.3 59.3 86.5 2.0 27.3 41.8 25.0 12.6 48.9 45.8 4.5 20.6 5.3 81.0 6.1 26.5 4.1 10.8 42.3 0.1 17.5 15.0 17.9 17.1 10.4 8.6 15.4 8.4 1.9 55.0 10.6 10.5 17.7 27.4 0.8 3.1 11.1 47.6 5.2 32.8 25.0 10.5 0.2 1.2 6.7 38.0 33.4 1.7 30.9 37.4 9.7 21.5 8.1 53.1 11.4 59.9 82.6 12.6 16.6 16.6 16.4 176.8 99.5 270.1 155.8 101.6 133.8 137.3 125.2 153.7 95.0 107.5 120.9 124.6 295.6 132.9 94.6 94.8 213.8 221.2 16.1 16.2 15.8 20.3 14.7 16.2 24.0 16.1 21.2 18.6 19.4 17.4 72.1 25.6 24.0 9.1 62.1 74.7 47.1 54.5 27.3 4.8 21.5 15.9 7.3 24.3 33.1 5.5 0.0 5.6 108.0 78.8 5.9 81.6 0.5 31.3 39.3 63.6 16.8 12.6 1.1 75.3 95.0 26.9 42.8 77.9 26.6 13.8 27.1 11.1 45.9 15.2 1.9 55.9 57.0 31.9 90.6 0.3 13.1 43.9 23.2 16.9 115.9 25.1 149.3 12.1 3.6 91.3 38.8 10.5 84.8 70.2 84.6 6.9 29.4 2.8 6.6 18.1 27.8 1.0 1.3 20.4 76.4 4.8 92.3 18.2 54.5 52.1 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838770 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "monocytes: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.4;U-251 MG: 52.0" HPA001312 Approved Supported "Nuclear speckles,Endoplasmic reticulum" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavorable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 17.1 11.7 1.0 4.3 1.0 8.8 14.7 0.8 1.2 16.3 0.5 14.6 10.2 13.7 1.1 26.0 11.9 1.1 14.4 1.2 2.0 12.4 11.5 25.7 7.9 1.6 1.1 9.2 9.0 3.7 8.2 3.1 1.5 9.9 5.5 2.5 11.2 2.1 8.6 14.5 25.2 4.1 0.8 29.8 11.4 2.5 1.8 9.7 12.3 5.8 8.1 10.6 17.2 1.7 4.4 2.0 0.5 5.0 6.1 6.5 0.0 2.3 3.3 13.1 17.7 3.9 41.0 36.5 7.5 9.1 37.1 38.8 15.8 61.4 6.9 43.8 1.9 20.3 11.6 1.3 8.5 0.0 29.5 0.6 2.6 10.3 24.8 0.0 12.1 0.0 20.0 12.2 0.4 1.6 5.8 2.4 0.5 0.0 11.7 25.8 0.0 12.8 10.9 1.1 0.0 0.0 16.0 37.3 4.1 1.0 7.4 1.9 5.7 25.7 6.9 3.9 52.0 17.9 31.4 33.3 19.5 25.7 10.9 1.8 1.3 1.6 3.0 3.2 1.7 0.4 0.8 1.7 0.8 0.3 0.6 0.7 3.8 1.9 2.8 1.3 1.2 0.8 1.0 1.0 0.8 1.2 1.2 2.0 1.6 1.1 1.5 0.8 1.8 1.7 48.2 0.0 7.5 7.5 20.7 0.0 15.6 0.0 3.4 5.0 9.2 8.0 3.5 4.3 3.7 14.7 2.1 1.9 37.9 21.0 1.9 34.1 0.1 18.0 19.4 32.0 3.6 4.0 6.6 33.4 45.8 8.0 10.7 41.9 5.1 8.7 16.4 8.3 23.9 18.5 14.6 14.9 0.0 18.9 0.0 0.0 5.6 20.3 0.0 14.0 69.3 17.7 47.4 10.6 6.5 35.1 12.6 6.0 18.0 29.7 55.9 4.8 1.5 5.8 0.0 8.6 10.3 0.7 2.5 11.1 0.0 1.6 24.0 20.3 14.3 16.7 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6" "Group enriched" "Detected in many" 4 "B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA069743 Enhanced Approved "Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA069743: AB_2686186" "prognostic favorable (3.83e-4)" "prognostic favorable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favorable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 2.3 0.7 0.7 25.8 1.2 40.4 1.1 0.4 1.2 1.4 0.8 4.1 5.5 0.9 0.1 2.3 1.9 3.2 0.9 0.6 0.6 2.5 2.6 8.9 56.7 0.9 0.5 0.5 0.8 0.2 0.5 0.8 0.6 1.9 1.5 0.0 3.8 0.7 0.9 1.4 25.6 0.5 0.5 58.6 7.6 0.5 0.7 46.0 7.6 0.6 21.8 3.2 1.7 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.1 1.2 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.1 0.0 0.0 0.3 47.1 64.7 0.0 0.0 0.0 6.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 4.5 0.0 0.0 0.1 0.2 0.0 0.4 0.5 12.2 0.0 24.6 0.0 191.0 46.0 270.4 237.7 120.4 169.7 177.3 201.5 208.3 65.6 184.2 206.7 192.0 237.6 148.0 167.0 55.8 286.6 261.6 0.7 1.2 0.4 1.2 0.6 0.6 0.9 0.5 0.6 0.5 0.7 1.1 2.5 6.4 19.5 0.0 109.6 1.1 0.1 0.1 0.6 1.0 1.4 1.9 1.5 2.8 2.5 0.0 0.0 0.2 144.4 0.2 0.0 0.2 0.2 2.4 0.4 1.9 1.2 12.6 0.2 0.0 0.3 2.0 2.0 1.1 23.4 0.1 5.0 1.4 23.7 0.0 0.1 0.0 0.0 16.0 6.9 0.6 0.0 23.1 3.6 1.0 24.5 0.3 284.2 0.0 0.5 0.0 0.0 0.0 40.2 0.1 0.1 1.1 1.3 0.5 0.0 1.3 1.1 0.1 0.2 0.0 1.0 0.4 147.7 0.1 0.1 0.1 TFAP2E AP2E ENSG00000116819 "Transcription factor AP-2 epsilon" Q6VUC0 1 35573314-35595328 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.8;Excitatory neurons: 9.0;Inhibitory neurons: 9.8;Oligodendrocytes: 11.3;Rod photoreceptor cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 4.6;SK-MEL-30: 1.7;U-937: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (7.06e-4)" "unprognostic (1.96e-2)" "unprognostic (9.05e-2)" "unprognostic (2.29e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-2)" "unprognostic (3.27e-2)" "unprognostic (9.39e-2)" "unprognostic (4.02e-1)" "unprognostic (7.45e-2)" "unprognostic (1.67e-15)" "unprognostic (2.03e-1)" "unprognostic (4.83e-1)" "unprognostic (3.48e-2)" "unprognostic (7.40e-2)" 1.0 0.6 3.0 0.9 2.8 1.5 1.0 9.2 4.0 3.5 0.2 1.1 0.1 1.3 0.3 1.2 2.5 0.2 0.9 2.6 2.2 1.1 0.3 1.3 0.9 2.8 2.3 2.5 0.6 0.0 3.2 0.2 3.0 1.7 0.1 4.4 1.0 0.1 0.4 5.2 1.2 0.0 2.4 1.9 1.0 2.2 2.4 0.3 0.5 0.0 0.3 0.8 3.1 5.1 0.2 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.2 0.5 0.4 0.3 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 4.6 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 1.7 0.1 0.4 1.4 0.1 0.1 0.7 0.4 0.1 0.8 0.4 0.0 0.1 3.6 0.5 0.5 0.8 0.5 0.9 0.3 0.3 0.4 0.5 0.8 0.4 0.4 0.2 0.8 0.0 0.9 0.4 0.3 0.8 0.5 3.0 2.8 9.2 4.0 2.6 2.2 2.8 2.3 3.0 2.4 2.4 5.1 0.2 0.0 1.3 4.9 0.2 3.7 0.1 0.3 0.0 9.8 0.5 0.5 0.4 0.0 0.8 0.0 2.1 0.4 0.9 0.1 0.0 0.2 0.5 0.3 0.4 0.3 0.0 0.0 9.0 0.0 0.0 0.4 2.6 0.5 0.0 0.1 0.4 0.2 1.0 0.0 9.8 0.0 0.0 1.0 0.0 1.0 2.1 0.6 1.8 1.9 0.5 0.3 3.1 3.5 11.3 0.2 0.3 0.7 0.3 0.1 0.1 0.0 0.2 5.6 0.0 0.2 0.4 2.4 0.4 0.0 4.4 0.1 0.9 0.1 0.4 0.2 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 215.5;lymphoid tissue: 126.0" "Cell type enhanced" "Detected in many" "dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2" "Group enriched" "Detected in all" 6 "dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6" "Cell line enhanced" "Detected in many" "Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 30.7 10.6 10.8 72.8 13.1 215.5 12.7 13.6 14.4 7.2 12.3 14.7 10.1 5.7 3.9 8.0 10.2 23.6 6.6 11.2 16.6 9.2 19.1 45.8 47.9 22.2 14.3 3.3 5.4 2.7 4.9 18.8 19.1 5.4 10.1 0.9 11.1 3.9 3.4 4.5 28.2 15.5 15.4 126.0 12.2 22.4 17.8 16.0 11.0 4.5 29.9 26.9 6.4 24.6 9.1 0.3 3.4 0.5 11.4 15.6 1.5 1.9 20.0 28.7 40.2 1.3 2.4 12.8 1.2 6.6 15.9 1.3 5.2 1.2 4.6 1.7 1.2 18.0 0.4 2.3 22.3 23.0 27.8 7.9 0.3 14.8 0.1 1.5 11.1 1.0 24.7 135.9 2.1 6.1 0.9 20.1 11.8 0.3 1.8 4.1 12.8 23.2 8.6 0.3 0.2 5.0 0.1 0.8 26.2 2.1 0.3 20.2 6.9 1.7 0.2 5.6 0.3 98.4 6.1 0.8 32.3 62.1 0.5 41.7 403.3 341.0 71.9 441.4 66.1 41.5 53.1 60.2 309.6 21.8 45.6 48.2 498.1 61.9 454.6 125.2 56.4 380.7 10.8 13.1 13.6 14.4 11.2 16.6 22.2 14.3 19.1 15.4 17.8 24.6 2.2 3.2 20.0 0.3 42.6 3.2 1.1 2.7 0.6 0.4 1.0 0.6 0.7 2.8 8.7 0.0 0.0 0.8 87.5 0.3 0.0 0.9 2.3 4.5 1.8 6.8 10.7 6.1 6.2 8.3 1.3 1.8 1.1 6.4 13.3 7.1 3.6 1.3 62.6 0.0 0.7 0.2 36.7 135.9 59.9 5.2 0.6 125.4 17.8 6.5 144.8 0.1 54.6 0.5 14.7 8.7 0.0 0.4 57.3 3.0 0.0 0.4 3.2 0.2 0.0 21.9 2.1 1.8 2.9 0.1 1.1 2.5 21.2 3.0 0.8 5.0 TIFAB ENSG00000255833 "TIFA inhibitor" Q6ZNK6 5 135444226-135452351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.6" "Cell type enhanced" "Detected in some" "dendritic cells: 8.0;Early spermatids: 4.2;Hofbauer cells: 4.0;Langerhans cells: 17.6;Late spermatids: 9.2;monocytes: 4.6" "Cancer enriched" "Detected in single" 4 "testis cancer: 0.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "myeloid DC: 4.5;plasmacytoid DC: 13.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 13.9" "Cell line enriched" "Detected in some" 5 "THP-1: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049372 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "HPA049372: AB_2680733" "unprognostic (1.33e-2)" "unprognostic (1.09e-2)" "unprognostic (1.63e-2)" "unprognostic (1.71e-2)" "unprognostic (1.35e-1)" "unprognostic (1.98e-5)" "unprognostic (3.87e-1)" "unprognostic (3.25e-3)" "unprognostic (5.29e-2)" "unprognostic (1.09e-2)" "unprognostic (6.08e-2)" "unprognostic (1.96e-1)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (9.01e-2)" 0.1 0.0 0.0 3.7 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.9 1.0 0.1 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.5 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.9 1.0 0.2 0.0 2.6 0.7 0.3 0.0 1.9 0.0 0.0 4.9 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 17.6 9.2 0.0 2.2 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMC6 "EVER1, EVIN1, LAK-4P, TNRC6C-AS1" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78107397-78132407 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 110.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 108.7;SK-BR-3: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA051430: AB_2681483" "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.20e-4)" 29.5 6.8 19.2 45.4 50.5 72.7 25.2 43.4 33.5 11.3 5.2 23.5 21.7 7.6 1.0 25.4 14.1 9.7 35.9 19.3 26.4 20.6 9.1 40.3 69.7 59.3 49.7 3.8 14.6 3.1 5.6 8.8 55.9 20.2 6.6 0.6 29.3 7.9 3.5 17.9 50.6 3.5 35.8 110.5 14.6 2.6 48.4 26.3 12.9 1.8 32.4 14.6 18.4 81.9 17.9 14.0 7.5 6.0 0.0 0.0 15.2 0.0 0.0 0.2 0.2 25.2 19.2 19.7 23.7 0.0 6.3 31.0 1.0 5.9 0.0 2.0 11.3 41.3 4.2 31.0 1.9 38.3 67.0 1.1 16.2 0.0 1.3 0.2 14.7 9.2 108.7 73.3 0.0 36.1 18.9 65.4 5.9 32.9 4.9 8.4 0.6 58.9 11.4 65.1 1.9 4.9 5.7 121.0 33.2 9.7 68.7 57.6 5.2 0.0 8.7 0.1 0.3 57.6 27.3 13.2 0.0 60.4 1.0 17.7 11.6 23.2 56.2 38.3 49.0 28.5 41.7 46.2 18.6 21.7 36.5 39.6 15.3 35.8 63.5 5.7 38.0 33.5 19.2 50.5 43.4 33.5 19.3 26.4 59.3 49.7 55.9 35.8 48.4 81.9 43.8 41.7 29.6 8.1 69.5 11.1 21.0 22.3 7.4 3.2 17.4 6.5 14.7 10.0 41.5 16.5 0.0 1.2 79.8 25.0 0.0 41.2 0.3 5.1 1.6 19.7 9.1 28.4 0.2 23.1 26.4 4.6 10.2 8.0 40.5 0.7 23.6 2.2 67.0 1.7 0.2 14.0 40.7 66.2 29.9 1.2 9.6 44.7 14.2 20.6 62.0 7.5 85.5 1.5 50.8 40.5 53.7 1.2 62.6 31.5 20.3 2.0 20.3 1.8 13.1 4.6 13.5 0.5 2.2 8.4 10.2 3.7 83.7 2.5 30.3 37.4 TNFAIP3 "A20, OTUD7C" ENSG00000118503 "TNF alpha induced protein 3" P21580 6 137867214-137883312 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Inflammatory response, Ubl conjugation pathway" "DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 519.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002116 Approved Approved Centrosome,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" "Centrosome, Cytosol" "HPA002116: AB_1858162" "unprognostic (5.50e-3)" "unprognostic (9.98e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-2)" "unprognostic (4.01e-2)" "unprognostic (9.47e-2)" "unprognostic (5.01e-3)" "unprognostic (4.40e-2)" "unprognostic (2.92e-2)" "unprognostic (2.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (6.06e-2)" "unprognostic (3.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" 57.0 15.6 4.4 114.6 3.8 519.5 23.3 2.9 23.9 27.5 12.0 22.6 21.4 31.3 5.2 26.6 23.4 47.8 23.0 3.2 2.8 13.8 27.4 56.2 76.8 6.1 3.9 73.2 25.8 25.8 7.5 28.9 6.7 17.3 24.7 19.1 16.1 10.3 8.6 50.5 30.7 33.5 6.6 46.1 22.8 8.3 9.5 71.1 11.7 3.8 55.7 171.1 14.6 6.2 32.6 4.8 1.8 2.8 10.1 16.9 7.8 18.8 67.6 4.8 5.7 34.9 8.8 7.3 43.1 20.0 106.5 22.6 1.1 50.4 8.9 46.8 2.2 7.5 19.8 21.1 11.2 10.3 12.8 15.6 7.3 56.4 53.6 5.6 2.9 21.2 17.4 161.3 8.4 1.8 56.2 41.4 1.5 2.1 1.4 151.5 39.4 6.1 14.8 15.1 0.7 0.3 3.6 5.3 16.9 7.0 3.4 11.7 14.8 46.9 6.8 46.0 9.6 48.7 131.4 14.0 16.9 13.1 6.1 7.3 12.6 9.6 19.6 9.3 27.9 7.4 19.4 18.0 14.3 7.8 13.1 10.1 13.6 11.1 5.1 26.2 19.2 14.8 4.4 3.8 2.9 23.9 3.2 2.8 6.1 3.9 6.7 6.6 9.5 6.2 71.8 38.5 76.3 2.0 94.5 774.9 150.2 102.1 384.7 1.1 29.0 42.3 4.6 25.8 53.7 0.0 29.2 8.1 395.5 53.9 1.9 60.0 2.6 605.2 365.9 114.8 11.9 5.2 0.1 26.9 104.8 110.1 111.1 1498.3 255.9 2.3 48.5 13.5 45.7 0.0 0.3 38.6 67.1 125.2 461.8 3.2 6.8 596.6 129.9 8.4 59.1 1.7 14.4 2.0 0.3 30.5 29.5 6.0 331.4 170.2 37.3 3.1 84.3 13.3 6.6 29.0 94.9 2.7 2.2 367.9 745.7 23.1 624.2 14.9 20.9 78.1 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805412-59119147 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 52.4" "Group enriched" "Detected in many" 5 "Astrocytes: 316.3;Excitatory neurons: 198.3;Inhibitory neurons: 155.0;Oligodendrocyte precursor cells: 455.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 36.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.5;NK-cells: 18.4;T-cells: 36.6" "Cell line enhanced" "Detected in many" "JURKAT: 75.9;MOLT-4: 149.1;SH-SY5Y: 43.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: AB_2686584" "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 0.7 1.0 7.1 5.8 9.3 2.9 1.0 0.1 10.7 1.8 0.0 11.4 9.5 1.3 0.4 3.3 0.8 4.6 0.7 6.4 8.0 3.0 1.1 4.6 18.2 2.0 4.4 5.7 1.4 2.4 1.8 1.3 2.2 2.0 8.6 6.0 1.6 1.0 0.1 0.5 10.3 2.5 0.0 5.5 7.9 6.3 5.8 52.4 1.1 0.6 18.9 2.0 1.4 4.9 0.9 0.2 15.7 0.0 1.6 3.5 0.0 3.3 7.5 1.8 0.3 0.0 0.0 0.0 0.0 14.4 0.8 1.2 3.9 0.0 0.4 0.5 1.5 0.0 2.8 0.0 12.7 2.8 0.7 1.9 0.5 2.3 2.9 1.0 25.9 75.9 0.0 0.0 1.2 0.0 149.1 0.0 2.7 0.2 0.4 3.1 10.7 0.1 0.4 0.4 14.3 43.8 0.0 0.1 0.0 3.6 0.0 0.0 0.2 3.9 1.8 12.9 4.4 0.0 0.0 9.9 0.5 0.1 2.8 21.5 0.2 3.2 12.1 0.0 5.5 5.4 8.6 18.2 1.4 1.3 3.3 9.7 0.3 18.4 0.0 0.0 36.6 5.6 7.1 9.3 0.1 10.7 6.4 8.0 2.0 4.4 2.2 0.0 5.8 4.9 0.6 9.6 31.6 316.3 12.3 1.3 0.1 0.1 1.2 18.4 0.2 0.9 1.8 1.5 2.5 1.8 0.0 3.9 23.2 3.7 0.0 0.9 2.0 1.9 2.7 1.8 46.0 4.2 198.3 0.7 0.2 2.7 6.1 0.8 16.5 0.0 0.4 0.7 3.7 0.0 155.0 34.8 2.0 0.6 9.6 2.2 0.9 2.8 0.0 47.8 0.6 14.3 34.0 455.4 5.0 2.6 9.6 0.4 22.4 0.1 4.0 1.3 10.4 2.2 0.0 0.2 0.6 1.0 0.7 0.5 1.3 0.8 35.0 0.0 10.3 0.1 TRAF5 RNF84 ENSG00000082512 "TNF receptor associated factor 5" O00463 1 211326615-211374946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 75.9;Early spermatids: 55.0;Late spermatids: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008052, CAB010277" Enhanced Supported Centrosome,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 57: B-cells - Immune response" Cytosol Centrosome "CAB010277: AB_2287961, HPA008052: AB_1858230" "unprognostic (6.44e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.39e-2)" "unprognostic (6.44e-3)" "unprognostic (7.94e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.94e-10)" "unprognostic (3.72e-1)" "unprognostic (1.34e-1)" "unprognostic (1.71e-2)" "prognostic favorable (7.29e-5)" 8.6 3.3 3.6 17.0 4.6 4.1 6.0 1.5 3.2 10.8 26.3 14.0 5.0 17.3 7.4 5.6 17.8 8.1 3.5 3.6 2.2 5.0 1.8 5.7 29.7 2.7 2.7 6.2 21.3 1.6 2.9 5.4 2.8 9.0 9.5 0.7 7.5 10.8 1.5 2.8 17.4 20.0 2.2 16.7 9.3 6.9 3.1 13.5 3.0 2.6 27.2 13.5 6.5 2.4 6.2 4.5 7.9 7.1 6.8 4.9 2.8 8.6 10.3 12.2 10.8 2.2 11.9 18.8 4.8 13.6 6.2 1.2 15.1 1.4 6.1 36.3 5.4 0.9 7.1 0.0 9.9 3.0 13.3 5.8 2.7 6.6 2.0 18.4 8.6 16.3 7.6 8.7 3.4 4.8 8.3 3.4 9.5 9.7 3.8 12.6 11.0 17.6 9.3 4.3 14.0 14.6 6.4 0.3 18.3 29.2 4.4 0.3 5.4 7.9 6.1 2.7 9.8 2.4 3.8 20.0 2.1 0.0 3.0 13.8 0.3 0.4 9.2 0.3 17.3 22.2 11.6 12.5 1.5 19.6 10.2 10.2 0.7 21.3 0.5 1.1 17.7 7.4 3.6 4.6 1.5 3.2 3.6 2.2 2.7 2.7 2.8 2.2 3.1 2.4 15.2 12.8 7.2 3.3 75.9 3.7 4.0 2.7 9.6 2.5 13.9 13.7 2.5 0.0 6.8 11.0 0.0 9.5 31.0 3.6 0.0 0.9 55.0 5.3 23.6 9.0 14.8 4.6 13.4 9.8 2.2 16.9 16.8 8.1 15.2 5.3 6.1 0.3 10.0 0.0 14.1 11.4 4.1 4.8 12.6 47.9 14.3 17.3 8.8 20.6 16.3 1.0 32.0 7.5 2.8 7.1 11.4 27.4 11.3 3.4 1.8 0.8 8.6 0.7 13.1 7.3 29.1 3.8 2.7 4.4 4.0 1.4 41.6 5.0 14.3 2.6 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822770-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "lymphoid tissue: 79.8" "Cell type enriched" "Detected in some" 10 "T-cells: 129.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 395.1" "Group enriched" "Detected in many" 155 "granulocytes: 395.1;T-cells: 313.1" "Group enriched" "Detected in some" 25 "JURKAT: 29.9;MOLT-4: 76.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130, HPA072760" Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes NA "Cluster 32: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Mitotic spindle, Centriolar satellite" "CAB026130: , HPA002356: AB_1080375, HPA072760: " "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 1.1 0.6 0.0 11.0 0.0 2.7 0.8 0.0 0.0 0.4 0.0 1.3 1.4 0.4 0.4 1.0 0.3 2.5 0.4 0.1 0.0 0.3 1.3 2.1 23.9 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 1.5 0.0 0.6 0.1 0.1 0.6 3.0 0.5 0.0 8.5 2.4 0.4 0.0 79.8 0.4 0.4 12.4 2.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 2.1 0.0 0.0 76.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 395.1 0.6 0.2 57.0 0.2 116.4 1.0 229.5 119.6 0.3 0.4 313.1 77.7 3.5 2.2 0.7 0.8 111.1 139.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.2 0.0 3.3 8.4 0.1 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 1.8 0.0 0.0 8.9 0.1 0.0 0.0 2.3 0.1 0.1 1.1 0.0 2.7 0.1 0.0 0.0 1.7 7.7 0.1 2.5 0.0 1.8 0.6 0.2 0.0 0.2 0.0 0.0 1.0 12.2 2.2 0.0 1.8 3.6 0.0 3.2 0.0 3.1 0.0 0.2 0.0 0.0 0.0 5.1 0.2 0.0 0.5 0.0 0.0 0.0 0.3 0.8 0.0 0.1 0.0 8.0 0.1 129.3 0.6 0.0 0.2 TRAV12-1 ENSG00000211785 "T cell receptor alpha variable 12-1" A0A0B4J245 14 21841240-21841774 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 4.1;Plasma cells: 1.4;T-cells: 6.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 72 "MAIT T-cell: 128.5;memory CD4 T-cell: 205.2;memory CD8 T-cell: 199.7;naive CD4 T-cell: 138.6;naive CD8 T-cell: 251.7;T-reg: 193.9" "Lineage enriched" "Detected in many" 97 "T-cells: 251.7" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (4.83e-3)" "unprognostic (9.56e-5)" "unprognostic (2.18e-2)" "unprognostic (3.33e-3)" "unprognostic (8.05e-2)" "unprognostic (2.99e-4)" "unprognostic (3.16e-4)" "unprognostic (3.23e-2)" "unprognostic (1.77e-3)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" "unprognostic (3.97e-4)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.92e-2)" 0.5 0.0 0.0 6.5 0.0 1.2 1.3 0.0 0.2 0.6 0.0 1.3 2.8 0.4 0.8 0.7 0.4 2.5 0.1 0.0 0.0 0.1 0.5 1.3 13.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.2 0.0 0.4 0.0 2.3 1.2 0.0 4.9 1.9 0.1 0.0 21.1 0.2 0.2 14.3 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.9 1.9 0.4 128.5 0.2 205.2 199.7 0.3 0.6 138.6 251.7 2.6 0.3 1.0 0.2 193.9 100.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 TRAV12-2 ENSG00000211789 "T cell receptor alpha variable 12-2" A0A075B6T6 14 21887857-21888502 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.4" "Cell type enriched" "Detected in some" 6 "T-cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 17 "memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3" "Lineage enriched" "Detected in many" 77 "T-cells: 143.3" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.74e-2)" "unprognostic (4.98e-3)" "unprognostic (4.75e-2)" "unprognostic (2.41e-4)" "unprognostic (2.22e-2)" "unprognostic (7.44e-2)" "unprognostic (5.23e-4)" "unprognostic (1.73e-3)" "unprognostic (1.74e-1)" "unprognostic (1.43e-1)" "unprognostic (1.03e-3)" "unprognostic (3.69e-1)" "unprognostic (3.34e-3)" "unprognostic (9.87e-2)" "unprognostic (3.01e-2)" 0.8 0.8 0.0 7.5 0.0 0.9 1.0 0.0 0.1 1.0 0.0 1.6 4.1 0.8 0.5 0.8 1.2 2.5 0.3 0.0 0.0 0.3 0.6 2.5 15.7 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.8 2.1 0.0 1.7 0.1 0.2 0.5 2.9 0.5 0.0 5.9 2.3 0.0 0.0 22.4 0.6 0.0 13.5 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.5 1.2 0.0 5.7 0.1 101.9 87.7 0.2 0.1 90.3 65.2 1.8 0.1 0.2 0.1 143.3 27.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 TRAV12-3 "TCRAV12S3, TCRAV2S2, TRAV123" ENSG00000211794 "T cell receptor alpha variable 12-3" A0A0B4J271 14 21965451-21966061 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 60.3" "Group enriched" "Detected in some" 4 "Erythroid cells: 1.7;T-cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 186.5;T-reg: 256.6" "Lineage enriched" "Detected in many" 23 "T-cells: 256.6" "Cell line enriched" "Detected in single" 43 "JURKAT: 4.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.62e-4)" "unprognostic (7.68e-4)" "unprognostic (5.17e-2)" "unprognostic (1.33e-3)" "unprognostic (2.32e-1)" "unprognostic (1.80e-3)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (7.55e-4)" "unprognostic (9.00e-3)" "unprognostic (1.03e-1)" "unprognostic (1.20e-1)" "unprognostic (4.52e-5)" "unprognostic (3.75e-1)" "unprognostic (4.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.68e-2)" 0.5 0.1 0.0 9.3 0.0 1.5 1.1 0.0 0.1 1.7 0.0 2.1 2.2 0.6 0.9 0.4 0.6 6.1 0.5 0.0 0.0 0.3 0.4 2.8 18.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 3.2 0.0 0.3 0.2 0.1 0.4 2.7 0.5 0.0 4.6 1.9 0.1 0.0 60.3 0.2 0.0 17.4 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.5 0.2 0.4 0.2 12.7 0.4 186.5 57.4 0.4 1.8 119.7 153.3 4.6 0.9 0.7 0.5 256.6 48.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TRAV13-1 ENSG00000211788 "T cell receptor alpha variable 13-1" A0A0B4J241 14 21868839-21869365 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 62.5" "Cell type enriched" "Detected in single" 26 "T-cells: 15.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 329.3" "Lineage enriched" "Detected in many" 28 "T-cells: 329.3" "Cell line enriched" "Detected in single" 20 "JURKAT: 1.9" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.10e-3)" "unprognostic (9.80e-3)" "unprognostic (1.60e-2)" "unprognostic (3.04e-3)" "unprognostic (5.71e-2)" "unprognostic (3.30e-5)" "unprognostic (7.68e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.16e-5)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.20e-2)" "unprognostic (5.59e-2)" 1.1 0.3 0.0 13.7 0.1 2.2 1.1 0.0 0.2 0.2 0.0 3.7 3.6 0.7 0.3 0.8 0.9 3.7 0.5 0.0 0.0 0.4 1.0 4.4 29.2 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 1.1 3.0 0.0 1.2 0.4 0.2 0.2 7.5 0.4 0.0 8.4 3.8 0.2 0.0 62.5 0.6 0.7 29.9 5.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.7 0.4 1.4 0.4 62.6 0.4 203.8 179.6 0.5 0.6 232.3 292.5 6.2 0.5 0.5 0.9 329.3 80.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.6 0.0 0.0 0.0 TRAV13-2 ENSG00000211791 "T cell receptor alpha variable 13-2" A0A0B4J235 14 21918188-21918756 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "lymphoid tissue: 51.7" "Group enriched" "Detected in some" 4 "NK-cells: 4.1;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 38 "MAIT T-cell: 32.9;memory CD4 T-cell: 94.0;memory CD8 T-cell: 57.3;naive CD4 T-cell: 101.8;naive CD8 T-cell: 114.1;T-reg: 114.8" "Lineage enriched" "Detected in many" 53 "T-cells: 114.8" "Cell line enriched" "Detected in some" 4 "JURKAT: 6.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.15e-3)" "unprognostic (1.47e-2)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" "unprognostic (5.58e-1)" "unprognostic (4.38e-4)" "unprognostic (1.08e-1)" "unprognostic (6.47e-2)" "unprognostic (2.85e-2)" "unprognostic (4.16e-2)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (3.66e-4)" "unprognostic (1.52e-1)" "unprognostic (9.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.77e-2)" 0.3 0.0 0.0 6.6 0.0 1.4 0.9 0.0 0.2 0.4 0.0 1.3 2.1 0.2 1.2 0.7 0.3 1.4 0.2 0.0 0.0 0.2 0.4 1.6 14.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.5 0.1 0.1 0.5 1.6 0.5 0.1 4.6 1.9 0.2 0.0 51.7 0.2 0.0 10.0 1.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.1 2.2 0.2 32.9 0.4 94.0 57.3 0.1 0.2 101.8 114.1 2.1 0.6 0.2 0.3 114.8 40.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.0 0.0 TRAV14DV4 "hADV14S1, TCRAV6S1-hDV104S1, TRAV14/DV4" ENSG00000211792 "T cell receptor alpha variable 14/delta variable 4" A0A0A6YYC5 14 21924063-21924651 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 25.7" "Cell type enriched" "Detected in single" 12 "T-cells: 6.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 38.2;memory CD8 T-cell: 78.1;naive CD4 T-cell: 30.7;naive CD8 T-cell: 122.3;T-reg: 42.6" "Lineage enriched" "Detected in single" 176 "T-cells: 122.3" "Cell line enhanced" "Detected in single" "JURKAT: 1.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.82e-3)" "unprognostic (1.00e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-3)" "unprognostic (3.00e-5)" "unprognostic (2.52e-1)" "unprognostic (7.61e-4)" "unprognostic (3.77e-1)" "unprognostic (2.82e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (2.62e-5)" "unprognostic (3.01e-1)" "unprognostic (4.17e-2)" "unprognostic (2.90e-1)" "unprognostic (1.60e-2)" 0.6 0.1 0.0 4.2 0.0 1.5 0.6 0.0 0.1 0.5 0.0 0.8 2.0 0.3 0.0 0.6 0.6 1.6 0.2 0.0 0.0 0.2 1.1 2.5 12.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.2 0.1 0.0 0.2 1.7 0.1 0.0 3.4 1.3 0.0 0.0 25.7 0.2 0.0 8.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.2 9.9 0.1 38.2 78.1 0.0 0.2 30.7 122.3 0.3 0.4 0.3 0.0 42.6 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 TRAV2 ENSG00000211776 "T cell receptor alpha variable 2" A0A0B4J234 14 21712321-21712843 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "lymphoid tissue: 56.3" "Cell type enriched" "Detected in single" 5 "T-cells: 2.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 40.9" "Lineage enriched" "Detected in single" 124 "T-cells: 40.9" "Cell line enriched" "Detected in single" 21 "Daudi: 2.1" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.38e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (1.93e-2)" "unprognostic (1.86e-3)" "unprognostic (3.64e-2)" "unprognostic (4.45e-2)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (5.84e-2)" "unprognostic (9.93e-5)" "unprognostic (1.92e-1)" "unprognostic (4.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" 0.4 0.2 0.0 8.2 0.0 2.5 0.3 0.0 0.5 0.3 0.0 2.0 0.8 0.0 0.0 0.9 0.3 0.9 0.3 0.0 0.0 0.2 0.3 1.6 19.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.8 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 3.3 2.7 0.2 0.0 56.3 0.2 0.0 13.2 2.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 31.3 0.0 31.5 9.9 0.0 0.0 24.5 9.6 0.1 0.0 0.0 0.3 40.9 5.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 TRAV21 ENSG00000211801 "T cell receptor alpha variable 21" A0A0B4J279 14 22052514-22053056 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 63.2" "Group enriched" "Detected in some" 12 "Gastric mucus-secreting cells: 6.1;T-cells: 23.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 220.5;memory CD8 T-cell: 233.5;naive CD4 T-cell: 198.6;naive CD8 T-cell: 204.8;T-reg: 391.9" "Lineage enriched" "Detected in many" 76 "T-cells: 391.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.53e-4)" "unprognostic (1.03e-2)" "unprognostic (3.94e-3)" "unprognostic (3.69e-4)" "unprognostic (1.74e-1)" "unprognostic (1.22e-3)" "unprognostic (4.86e-3)" "unprognostic (2.47e-2)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" "unprognostic (4.20e-2)" "unprognostic (9.80e-2)" "unprognostic (4.53e-3)" "unprognostic (3.13e-1)" "unprognostic (2.96e-2)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" 0.4 0.1 0.0 5.9 0.0 0.8 1.4 0.0 0.1 1.1 0.0 1.8 2.0 0.1 1.7 0.9 0.7 1.7 0.1 0.0 0.1 0.7 0.5 2.7 14.2 0.2 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.7 2.7 0.0 1.0 0.1 0.4 0.3 2.6 0.7 0.1 5.4 2.4 0.1 0.0 63.2 3.8 0.0 17.0 2.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.9 1.7 0.2 17.4 0.5 220.5 233.5 0.9 0.8 198.6 204.8 5.1 0.4 0.7 0.6 391.9 73.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.0 0.0 0.0 0.0 TRAV27 ENSG00000211809 "T cell receptor alpha variable 27" A0A087WT01 14 22147995-22148633 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 19.8" "Cell type enriched" "Detected in some" 4 "T-cells: 4.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 51.6;memory CD8 T-cell: 58.9;naive CD4 T-cell: 60.4;naive CD8 T-cell: 59.1;T-reg: 81.9" "Lineage enriched" "Detected in many" 63 "T-cells: 81.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.86e-3)" "unprognostic (1.66e-2)" "unprognostic (4.15e-2)" "unprognostic (2.78e-4)" "unprognostic (1.61e-1)" "unprognostic (2.21e-3)" "unprognostic (3.13e-1)" "unprognostic (8.30e-2)" "unprognostic (1.12e-2)" "unprognostic (2.07e-2)" "unprognostic (6.61e-2)" "unprognostic (2.14e-1)" "unprognostic (1.75e-4)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.68e-1)" "unprognostic (3.12e-3)" 0.1 0.0 0.0 2.3 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.6 0.3 0.2 0.0 0.4 0.3 0.2 0.1 0.0 0.0 0.1 0.1 0.7 5.0 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.2 0.2 0.7 0.0 0.0 1.7 0.9 0.0 0.1 19.8 0.1 0.0 5.6 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.5 0.0 3.2 0.2 51.6 58.9 0.0 0.0 60.4 59.1 1.0 1.3 0.1 0.3 81.9 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 TRAV8-6 ENSG00000211795 "T cell receptor alpha variable 8-6" A0A0B4J262 14 21978459-21979120 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 24.7" "Group enriched" "Detected in some" 19 "Spermatocytes: 1.2;Spermatogonia: 1.5;T-cells: 3.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 89.3;memory CD8 T-cell: 64.2;naive CD4 T-cell: 92.6;naive CD8 T-cell: 38.7;T-reg: 125.0" "Lineage enriched" "Detected in many" 45 "T-cells: 125.0" "Cell line enriched" "Detected in single" 97 "JURKAT: 9.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.42e-2)" "unprognostic (9.23e-4)" "unprognostic (5.47e-3)" "unprognostic (1.27e-3)" "unprognostic (7.80e-2)" "unprognostic (7.74e-5)" "unprognostic (2.88e-3)" "unprognostic (5.41e-3)" "unprognostic (2.59e-3)" "unprognostic (2.24e-2)" "unprognostic (9.25e-2)" "unprognostic (2.92e-1)" "unprognostic (9.78e-5)" "unprognostic (4.65e-1)" "unprognostic (2.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.61e-3)" 0.2 0.0 0.0 3.0 0.0 0.8 0.8 0.0 0.0 0.4 0.0 0.9 0.7 0.3 0.7 0.3 0.3 2.0 0.2 0.0 0.0 0.3 0.3 1.4 10.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.1 0.1 0.2 1.3 0.4 0.1 2.9 1.5 0.4 0.0 24.7 0.1 0.1 8.2 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.1 17.9 0.2 89.3 64.2 0.1 0.1 92.6 38.7 2.8 0.1 0.1 0.2 125.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 TRAV9-2 ENSG00000211793 "T cell receptor alpha variable 9-2" A0A087WT02 14 21941128-21941657 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 27.8" "Cell type enriched" "Detected in single" 6 "T-cells: 5.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8" "Lineage enriched" "Detected in many" 78 "T-cells: 350.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.02e-3)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (1.14e-5)" "unprognostic (1.37e-2)" "unprognostic (2.23e-2)" "unprognostic (5.98e-4)" "unprognostic (9.53e-3)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (9.00e-4)" "unprognostic (2.49e-1)" "unprognostic (4.28e-2)" "unprognostic (3.38e-1)" "unprognostic (2.56e-2)" 0.2 0.0 0.0 5.6 0.0 0.1 0.3 0.0 0.2 0.7 0.0 1.8 0.8 0.2 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.2 1.1 1.8 18.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.4 0.0 0.1 0.4 0.2 0.2 2.0 0.5 0.0 5.0 3.1 0.1 0.0 27.8 0.2 0.2 16.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.8 0.0 14.3 0.6 178.3 43.4 0.2 0.3 172.2 42.5 4.4 0.3 0.2 1.1 350.8 40.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 TRBJ1-1 "TCRBJ1S1, TRBJ11" ENSG00000282320 "T cell receptor beta joining 1-1" A0A0J9YXA8 7 142786880-142786927 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 83.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 1111.5" "Lineage enriched" "Detected in all" 18 "T-cells: 1111.5" "Cell line enhanced" "Detected in some" "Daudi: 1.2;K-562: 1.2;U-266/84: 4.4;U-698: 1.0" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 58: T-cells - T-cell receptor" 2.1 0.0 0.6 33.1 0.4 7.8 0.8 0.0 0.8 1.0 0.0 4.6 5.9 1.6 0.0 2.8 0.9 4.2 0.4 0.2 0.1 0.3 6.1 5.6 44.8 0.3 0.2 1.6 3.0 0.0 0.0 0.5 0.3 1.6 7.9 0.3 1.4 0.5 3.4 0.0 6.1 0.6 0.2 18.6 9.8 0.3 0.6 83.9 0.1 5.5 48.6 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.0 0.0 0.0 0.0 46.7 1.3 2.9 163.0 0.9 240.7 5.8 622.5 480.8 1.9 1.9 690.1 869.6 16.2 62.1 1.5 4.7 1111.5 312.7 0.6 0.4 0.0 0.8 0.2 0.1 0.3 0.2 0.3 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRBJ1-2 "TCRBJ1S2, TRBJ12" ENSG00000282420 "T cell receptor beta joining 1-2" A0A0J9YX06 7 142787017-142787064 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 107.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 495.1;memory CD8 T-cell: 334.7;naive CD4 T-cell: 467.6;naive CD8 T-cell: 296.5;T-reg: 801.8" "Lineage enriched" "Detected in all" 90 "T-cells: 801.8" "Cell line enriched" "Detected in some" 151 "JURKAT: 255.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" 0.6 1.0 0.2 32.4 1.2 7.6 0.4 0.0 0.9 0.0 0.1 3.5 2.9 0.7 1.6 0.3 0.3 4.3 0.4 0.5 0.2 0.2 2.1 8.3 39.4 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.4 1.7 5.6 0.4 4.7 1.0 0.0 1.1 6.2 1.5 0.1 20.3 10.0 0.2 0.4 107.2 0.3 0.0 46.3 0.8 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.2 0.6 0.6 59.0 0.8 56.9 2.5 495.1 334.7 1.2 2.0 467.6 296.5 7.3 8.9 1.8 1.7 801.8 183.4 0.2 1.2 0.0 0.9 0.5 0.2 0.5 0.1 0.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRBJ1-5 "TCRBJ1S5, TRBJ15" ENSG00000282173 "T cell receptor beta joining 1-5" A0A0J9YXM7 7 142788498-142788547 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 322.1" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebral cortex: 5.5" "Group enriched" "Detected in all" 31 "gdT-cell: 857.2;MAIT T-cell: 363.2;memory CD4 T-cell: 549.3;memory CD8 T-cell: 445.4;naive CD4 T-cell: 513.7;naive CD8 T-cell: 498.0;NK-cell: 363.5;T-reg: 845.4" "Group enriched" "Detected in all" 34 "NK-cells: 363.5;T-cells: 857.2" "Group enriched" "Detected in some" 164 "JURKAT: 425.6;U-266/84: 208.7" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" 4.1 2.9 0.3 100.7 0.5 16.5 16.4 0.0 5.5 4.4 0.7 16.9 9.7 2.9 0.0 3.3 1.4 10.5 2.3 0.2 0.0 0.9 8.3 15.7 119.8 1.0 0.2 3.7 0.0 1.2 0.0 1.6 0.3 8.5 28.8 0.3 4.5 0.5 4.7 1.5 17.6 4.1 0.4 80.7 24.5 1.9 0.2 322.1 1.6 1.3 166.1 8.1 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 425.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.0 208.7 0.5 0.0 0.0 0.0 7.3 3.5 2.2 857.2 1.7 363.2 1.2 549.3 445.4 2.8 2.1 513.7 498.0 17.9 363.5 4.1 3.8 845.4 514.1 0.3 0.5 0.0 5.5 0.2 0.0 1.0 0.2 0.3 0.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ2-1 "TCRBJ2S1, TRBJ21" ENSG00000211764 "T cell receptor beta joining 2-1" A0A0A0MTA7 7 142796365-142796414 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "bone marrow: 26.8;lymphoid tissue: 71.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 8.7" "Immune cell enhanced" "Detected in all" "T-reg: 1684.5" "Lineage enriched" "Detected in all" 8 "T-cells: 1684.5" "Cell line enriched" "Detected in some" 16 "MOLT-4: 2783.5" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.57e-2)" "prognostic favorable (8.15e-4)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (2.30e-5)" "unprognostic (8.63e-2)" "unprognostic (6.12e-2)" "unprognostic (3.74e-1)" "unprognostic (9.28e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.31e-1)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (7.65e-3)" 0.7 4.2 0.8 26.9 1.0 26.8 0.4 0.0 1.4 1.0 0.0 2.1 7.8 0.4 0.0 0.0 1.4 2.2 0.7 0.3 0.0 1.0 0.6 4.5 41.7 0.0 2.2 1.6 0.0 0.0 0.0 0.7 0.2 2.8 2.9 0.8 1.2 0.0 3.1 0.0 8.4 0.7 0.1 29.8 7.5 1.2 8.7 71.3 0.8 0.0 35.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 1.9 0.0 0.9 175.1 160.3 0.0 0.0 0.0 0.0 2783.5 2.6 1.7 0.0 0.0 0.0 0.0 1.4 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.7 0.0 0.0 3.2 0.0 57.2 0.0 0.0 0.0 10.9 3.2 2.6 255.6 2.4 535.8 97.1 906.2 1179.2 2.8 69.8 916.2 888.4 11.3 209.4 4.6 8.4 1684.5 527.9 0.8 1.0 0.0 1.4 0.3 0.0 0.0 2.2 0.2 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TRBJ2-2 "TCRBJ2S2, TRBJ22" ENSG00000211765 "T cell receptor beta joining 2-2" 7 142796560-142796610 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 19.5;lymphoid tissue: 33.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.6" "Group enriched" "Detected in many" 7 "MAIT T-cell: 518.4;memory CD4 T-cell: 335.7;memory CD8 T-cell: 331.8;naive CD4 T-cell: 388.7;naive CD8 T-cell: 324.2;T-reg: 721.0" "Lineage enriched" "Detected in all" 12 "T-cells: 721.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 21.0;JURKAT: 42.2;MOLT-4: 90.4;RT4: 13.6;U-698: 16.3" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.16e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (2.98e-4)" "unprognostic (3.51e-1)" "unprognostic (8.42e-2)" "unprognostic (6.98e-4)" 0.3 1.3 0.4 17.1 0.2 19.5 0.4 0.0 1.6 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.8 2.4 0.0 0.0 0.0 0.1 0.4 2.8 26.4 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.1 1.3 0.0 0.0 0.0 6.8 0.0 0.1 12.4 3.9 0.5 0.8 33.1 0.0 0.0 15.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 42.2 0.0 0.0 0.0 0.0 90.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 2.1 0.8 1.1 57.6 0.6 518.4 31.6 335.7 331.8 0.7 31.2 388.7 324.2 9.8 58.7 1.6 1.2 721.0 191.0 0.4 0.2 0.0 1.6 0.0 0.0 0.4 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TRBJ2-3 "TCRBJ2S3, TRBJ23" ENSG00000211767 "T cell receptor beta joining 2-3" A0A0B4J200 7 142796847-142796895 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 86.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "thalamus: 19.7" "Group enriched" "Detected in all" 12 "gdT-cell: 1486.3;MAIT T-cell: 905.3;memory B-cell: 1210.1;memory CD4 T-cell: 1124.0;memory CD8 T-cell: 1154.0;naive B-cell: 1430.2;naive CD4 T-cell: 1106.3;naive CD8 T-cell: 1031.1;NK-cell: 933.5;T-reg: 2317.4" "Group enriched" "Detected in all" 15 "B-cells: 1430.2;NK-cells: 933.5;T-cells: 2317.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 31.8;JURKAT: 65.6;MOLT-4: 72.9;RT4: 39.1;U-698: 218.9" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (4.65e-3)" "unprognostic (7.01e-3)" "unprognostic (7.69e-2)" "prognostic favorable (1.47e-5)" "unprognostic (1.76e-5)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.84e-3)" "unprognostic (1.25e-1)" "unprognostic (3.05e-2)" "unprognostic (1.65e-1)" "unprognostic (1.81e-3)" "unprognostic (1.20e-1)" "unprognostic (1.74e-2)" "unprognostic (3.35e-1)" "unprognostic (1.64e-3)" 2.9 2.1 4.4 86.4 2.0 17.6 4.7 1.2 5.7 1.9 1.0 5.4 19.2 3.4 0.0 0.8 0.5 2.9 0.4 2.4 1.8 1.1 5.3 12.2 82.8 2.1 9.3 5.0 0.0 0.0 0.0 0.9 1.2 2.6 7.2 1.6 5.0 0.0 4.4 1.0 22.2 1.6 2.2 78.6 20.5 2.3 19.7 60.8 0.4 2.7 51.8 2.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 21.5 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 31.8 65.6 0.0 0.0 0.0 0.0 72.9 0.0 5.0 0.0 7.5 0.0 0.0 0.0 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.3 218.9 0.0 0.0 0.0 106.3 7.7 5.8 1486.3 3.1 905.3 1210.1 1124.0 1154.0 9.3 1430.2 1106.3 1031.1 43.1 933.5 10.8 18.1 2317.4 1057.6 4.4 2.0 1.2 5.7 2.4 1.8 2.1 9.3 1.2 2.2 19.7 4.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TRBJ2-7 "TCRBJ2S7, TRBJ27" ENSG00000211771 "T cell receptor beta joining 2-7" A0A0A0MT78 7 142797456-142797502 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 45.4;lymphoid tissue: 155.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 10.8" "Group enriched" "Detected in all" 7 "MAIT T-cell: 1275.2;memory CD4 T-cell: 2387.1;memory CD8 T-cell: 2649.6;naive CD4 T-cell: 2393.9;naive CD8 T-cell: 2831.0;T-reg: 4224.6" "Lineage enriched" "Detected in all" 18 "T-cells: 4224.6" "Cell line enhanced" "Detected in some" "JURKAT: 43.8;MOLT-4: 212.6;U-698: 55.5" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (9.07e-3)" "unprognostic (9.26e-3)" "unprognostic (4.37e-2)" "prognostic favorable (4.79e-4)" "unprognostic (1.14e-3)" "unprognostic (2.57e-3)" "unprognostic (6.68e-3)" "unprognostic (9.60e-2)" "unprognostic (2.17e-2)" "unprognostic (6.18e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (7.27e-2)" "unprognostic (3.43e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" 3.5 4.6 1.9 96.9 3.1 45.4 2.5 1.5 4.2 0.0 0.0 7.5 18.1 5.2 0.0 0.7 0.5 9.5 0.8 0.7 2.8 0.4 0.0 4.4 108.7 1.0 2.3 2.8 5.1 0.0 0.0 1.1 0.9 2.3 6.2 0.3 3.6 0.9 0.0 0.0 36.0 0.0 0.9 54.0 25.2 2.0 10.8 155.0 0.0 0.0 47.7 4.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 8.3 43.8 0.0 0.0 0.0 3.7 212.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 42.7 6.9 10.3 360.2 6.3 1275.2 233.4 2387.1 2649.6 6.9 233.7 2393.9 2831.0 64.7 122.4 13.1 9.8 4224.6 1638.0 1.9 3.1 1.5 4.2 0.7 2.8 1.0 2.3 0.9 0.9 10.8 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TRBV10-3 "TCRBV10S3, TCRBV12S1A1N2, TRBV103" ENSG00000275791 "T cell receptor beta variable 10-3" A0A0K0K1G6 7 142544212-142544685 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 31 "lymphoid tissue: 88.6" "Group enriched" "Detected in some" 5 "Late spermatids: 1.7;T-cells: 5.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD8 T-cell: 160.1;T-reg: 203.1" "Lineage enriched" "Detected in single" 375 "T-cells: 203.1" "Cell line enriched" "Detected in single" 53 "MOLT-4: 49.7" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.61e-3)" "unprognostic (4.86e-3)" "unprognostic (2.44e-2)" "unprognostic (8.96e-3)" "unprognostic (3.16e-1)" "unprognostic (4.23e-6)" "unprognostic (9.84e-4)" "unprognostic (7.96e-2)" "unprognostic (4.05e-2)" "unprognostic (7.99e-4)" "unprognostic (1.52e-1)" "unprognostic (1.66e-1)" "unprognostic (9.59e-6)" "unprognostic (5.93e-2)" "unprognostic (1.69e-1)" "unprognostic (1.05e-1)" "unprognostic (1.80e-3)" 0.3 0.2 0.0 8.0 0.0 2.8 0.2 0.0 0.0 0.4 0.0 1.1 0.0 0.1 0.0 0.3 0.2 1.0 0.1 0.0 0.0 0.1 0.4 0.5 16.8 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.9 0.1 0.0 0.0 1.4 0.3 0.0 2.1 2.3 0.1 0.1 88.6 0.2 0.0 12.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.9 0.0 49.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 9.3 0.4 77.0 160.1 0.0 0.3 101.7 41.2 0.3 0.1 0.5 0.5 203.1 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 TRBV12-3 "TCRBV12S3, TCRBV8S1, TRBV123" ENSG00000274752 "T cell receptor beta variable 12-3" P01733 7 142560423-142560931 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "lymphoid tissue: 61.0" "Group enriched" "Detected in some" 19 "Gastric mucus-secreting cells: 4.6;T-cells: 10.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "memory CD4 T-cell: 29.2;memory CD8 T-cell: 14.9;naive CD4 T-cell: 32.5;naive CD8 T-cell: 23.9;T-reg: 46.0" "Lineage enriched" "Detected in many" 11 "T-cells: 46.0" "Cell line enriched" "Detected in some" 339 "JURKAT: 1248.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (5.41e-3)" "unprognostic (9.35e-4)" "unprognostic (5.34e-3)" "unprognostic (1.39e-4)" "unprognostic (5.43e-6)" "unprognostic (1.97e-2)" "unprognostic (5.06e-2)" "unprognostic (7.76e-3)" "unprognostic (2.50e-2)" "unprognostic (7.32e-2)" "unprognostic (1.58e-1)" "unprognostic (9.57e-5)" "unprognostic (2.45e-1)" "unprognostic (1.76e-3)" "unprognostic (3.22e-1)" "unprognostic (2.70e-2)" 0.3 0.0 0.0 4.4 0.0 2.3 0.4 0.0 0.0 1.4 0.0 1.0 1.0 0.2 0.3 0.5 0.1 1.3 0.3 0.0 0.0 0.2 0.6 1.4 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.3 0.0 0.8 0.0 0.4 0.1 2.2 0.1 0.0 3.8 2.1 0.2 0.0 61.0 0.3 0.0 12.6 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.2 1.0 0.9 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.7 0.0 1248.3 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 4.0 0.0 0.0 0.5 0.1 1.2 0.0 29.2 14.9 0.0 0.0 32.5 23.9 1.0 0.0 0.0 0.0 46.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 TRBV15 "TCRBV15S1, TCRBV24S1A3T" ENSG00000276819 "T cell receptor beta variable 15" 7 142592928-142593473 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 67 "lymphoid tissue: 46.9" "Cell type enriched" "Detected in single" 27 "T-cells: 2.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 48 "MAIT T-cell: 21.9;memory CD4 T-cell: 14.6;memory CD8 T-cell: 21.1;naive CD4 T-cell: 18.8;naive CD8 T-cell: 12.3;T-reg: 27.8" "Lineage enriched" "Detected in single" 158 "T-cells: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.07e-2)" "unprognostic (1.03e-3)" "unprognostic (1.89e-3)" "unprognostic (1.39e-3)" "unprognostic (2.09e-4)" "unprognostic (1.08e-2)" "unprognostic (6.75e-2)" "unprognostic (5.47e-3)" "unprognostic (7.77e-2)" "unprognostic (4.14e-2)" "unprognostic (3.86e-1)" "unprognostic (2.52e-3)" "unprognostic (2.38e-1)" "unprognostic (8.34e-2)" "unprognostic (3.23e-1)" "unprognostic (2.55e-2)" 0.1 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 3.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.4 0.1 0.0 46.9 0.1 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.9 0.0 14.6 21.1 0.0 0.0 18.8 12.3 0.1 0.0 0.0 0.0 27.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 TRBV2 "TCRBV22S1A2N1T, TCRBV2S1" ENSG00000226660 "T cell receptor beta variable 2" A0A1B0GX68 7 142300924-142301432 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 89.2" "Cell type enriched" "Detected in single" 80 "T-cells: 8.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 120.3;memory CD8 T-cell: 64.5;naive CD4 T-cell: 71.5;naive CD8 T-cell: 44.5;T-reg: 122.7" "Lineage enriched" "Detected in many" 21 "T-cells: 122.7" "Cell line enriched" "Detected in single" 10 "RPMI-8226: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.62e-4)" "unprognostic (4.94e-4)" "unprognostic (5.79e-2)" "unprognostic (1.29e-3)" "unprognostic (1.09e-1)" "unprognostic (4.71e-5)" "unprognostic (3.60e-2)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (1.16e-2)" "unprognostic (1.94e-2)" "unprognostic (1.77e-1)" "unprognostic (3.70e-5)" "unprognostic (3.83e-1)" "unprognostic (6.31e-2)" "unprognostic (1.89e-1)" "unprognostic (3.41e-2)" 1.1 0.3 0.0 8.3 0.0 3.9 1.2 0.0 0.1 1.1 0.0 2.6 2.5 0.3 1.1 1.7 0.2 2.4 0.1 0.0 0.0 0.4 0.9 1.6 25.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 2.1 0.0 0.3 0.5 0.0 0.3 1.7 0.8 0.0 6.8 3.5 0.3 0.0 89.2 0.5 0.3 22.1 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.9 0.0 5.5 0.1 120.3 64.5 0.3 0.1 71.5 44.5 1.2 0.1 0.1 5.8 122.7 29.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 TRBV24-1 "TCRBV15S1, TCRBV24S1, TRBV241" ENSG00000211750 "T cell receptor beta variable 24-1" A0A075B6N3 7 142656701-142657213 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.7;lymphoid tissue: 6.7" "Cell type enriched" "Detected in single" 23 "T-cells: 2.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 2.7" "Immune cell enhanced" "Detected in many" "naive CD8 T-cell: 26.6" "Lineage enriched" "Detected in single" 129 "T-cells: 26.6" "Not detected" "Not detected" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.42e-2)" "unprognostic (1.64e-5)" "unprognostic (1.59e-1)" "unprognostic (9.71e-3)" "unprognostic (3.82e-1)" "unprognostic (9.30e-2)" "unprognostic (3.08e-2)" "unprognostic (1.81e-1)" "unprognostic (6.73e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.43e-7)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.76e-3)" "unprognostic (4.39e-2)" 0.2 0.0 0.1 0.0 2.7 0.2 0.0 0.0 0.5 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.4 2.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 1.0 0.0 0.9 0.2 0.0 1.3 1.6 0.4 0.5 6.7 0.1 0.0 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 9.0 0.0 5.7 0.0 15.4 15.5 0.0 0.0 11.4 26.6 0.2 0.0 0.0 0.0 23.2 4.6 0.1 2.7 0.0 0.5 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TRBV27 "TCRBV14S1, TCRBV27S1" ENSG00000211752 "T cell receptor beta variable 27" A0A0K0K1C4 7 142715346-142715861 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 81.6" "Cell type enriched" "Detected in some" 4 "T-cells: 6.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 61.1;memory CD8 T-cell: 112.2;naive CD4 T-cell: 48.2;naive CD8 T-cell: 75.8;T-reg: 94.7" "Lineage enriched" "Detected in single" 137 "T-cells: 112.2" "Group enriched" "Detected in some" 4 "HAP1: 2.9;JURKAT: 3.3;U-937: 3.6" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.08e-2)" "unprognostic (2.10e-2)" "unprognostic (5.66e-2)" "unprognostic (5.85e-4)" "unprognostic (8.84e-2)" "unprognostic (7.89e-2)" "unprognostic (1.91e-2)" "unprognostic (1.28e-4)" "unprognostic (1.49e-1)" "unprognostic (4.36e-2)" "unprognostic (1.91e-7)" "unprognostic (4.03e-1)" "unprognostic (3.91e-2)" "unprognostic (8.10e-2)" "unprognostic (6.43e-2)" 0.6 0.5 0.0 3.5 0.6 1.9 0.8 0.0 0.3 0.7 0.0 1.2 1.0 0.9 0.1 0.8 0.2 1.8 0.2 0.0 0.0 0.4 0.5 1.7 19.7 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.0 0.5 1.7 0.0 1.7 0.0 0.3 0.2 2.8 0.2 0.0 4.8 1.9 5.7 0.2 81.6 0.6 0.8 10.6 1.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.4 0.1 0.6 3.3 0.0 10.4 0.1 61.1 112.2 0.1 0.1 48.2 75.8 0.8 0.1 0.2 0.1 94.7 27.3 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 TRBV28 "TCRBV28S1, TCRBV3S1" ENSG00000211753 "T cell receptor beta variable 28" A0A5B6 7 142720660-142721160 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "lymphoid tissue: 199.4" "Cell type enriched" "Detected in some" 12 "T-cells: 33.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 154.5" "Lineage enriched" "Detected in many" 79 "T-cells: 154.5" "Cell line enriched" "Detected in single" 30 "JURKAT: 23.7" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.34e-3)" "prognostic favorable (1.52e-4)" "unprognostic (1.94e-3)" "prognostic favorable (2.48e-5)" "unprognostic (5.54e-2)" "prognostic favorable (3.62e-4)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.35e-5)" "unprognostic (2.47e-3)" "unprognostic (3.33e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.48e-8)" "unprognostic (1.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-3)" 0.5 0.9 0.0 9.3 0.2 3.0 2.1 0.2 0.2 1.2 0.0 2.6 3.4 0.6 0.3 1.3 0.3 2.9 0.5 0.0 0.0 0.5 1.9 3.5 24.8 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.7 1.7 0.0 1.3 0.3 0.2 0.1 4.0 0.3 0.0 9.5 2.0 0.4 0.0 199.4 0.5 0.6 33.8 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 3.8 0.0 26.1 0.5 94.5 80.1 0.1 0.2 98.1 53.3 1.9 1.6 0.1 0.4 154.5 34.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.6 0.0 TRBV29-1 "TCRBV29S1, TCRBV4S1A1T, TRBV291" ENSG00000232869 "T cell receptor beta variable 29-1" A0A5B7 7 142740206-142740894 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 98.5" "Cell type enriched" "Detected in single" 11 "T-cells: 4.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 44 "MAIT T-cell: 45.1;memory CD4 T-cell: 128.6;memory CD8 T-cell: 83.2;naive CD4 T-cell: 137.8;naive CD8 T-cell: 110.8;T-reg: 178.2" "Lineage enriched" "Detected in many" 69 "T-cells: 178.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "prognostic favorable (1.23e-4)" "unprognostic (9.31e-4)" "unprognostic (1.29e-1)" "unprognostic (8.13e-3)" "unprognostic (3.28e-2)" "unprognostic (3.47e-4)" "unprognostic (6.84e-3)" "unprognostic (1.71e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-2)" "unprognostic (1.94e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.45e-1)" "unprognostic (2.46e-2)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" 0.8 0.3 0.0 6.5 0.0 4.4 1.2 0.3 0.1 1.4 0.1 1.9 2.7 0.6 0.0 1.0 0.3 2.6 0.2 0.0 0.0 0.4 1.2 1.5 21.7 0.0 0.0 0.6 21.2 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.7 0.6 0.1 0.4 3.9 1.2 0.0 5.4 2.3 0.1 0.0 98.5 0.6 0.5 23.4 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.7 0.1 45.1 2.0 128.6 83.2 0.1 1.8 137.8 110.8 2.5 0.2 0.3 0.7 178.2 51.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 TRBV3-1 "TCRBV3S1, TCRBV9S1A1T, TRBV31" ENSG00000237702 "T cell receptor beta variable 3-1" A0A576 7 142308542-142309048 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 51.1" "Group enriched" "Detected in some" 22 "Plasma cells: 10.1;T-cells: 12.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 52.4;memory CD8 T-cell: 45.9;naive CD4 T-cell: 71.6;naive CD8 T-cell: 117.4;T-reg: 99.6" "Lineage enriched" "Detected in many" 32 "T-cells: 117.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (7.98e-5)" "unprognostic (2.38e-3)" "unprognostic (5.19e-3)" "unprognostic (2.46e-2)" "unprognostic (1.19e-2)" "unprognostic (6.19e-4)" "unprognostic (1.46e-2)" "unprognostic (5.42e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.56e-1)" "unprognostic (2.20e-1)" "unprognostic (2.01e-4)" "unprognostic (1.75e-1)" "unprognostic (1.13e-3)" "unprognostic (1.53e-2)" "unprognostic (1.26e-2)" 0.4 0.0 0.0 5.3 0.0 1.9 0.4 0.0 0.1 0.3 0.0 0.9 0.5 0.3 0.1 0.3 0.3 1.2 0.2 0.0 0.0 0.1 0.2 0.8 10.7 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 1.0 0.0 0.8 0.2 0.0 0.2 2.2 0.2 0.0 2.7 1.0 0.0 0.0 51.1 0.3 0.1 10.4 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.1 0.3 1.8 0.1 16.6 0.2 52.4 45.9 0.1 0.1 71.6 117.4 2.0 0.4 0.1 0.4 99.6 29.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 TRBV4-1 "BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41" ENSG00000211710 "T cell receptor beta variable 4-1" A0A577 7 142313184-142313666 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "lymphoid tissue: 115.0" "Cell type enriched" "Detected in some" 7 "T-cells: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 176.7" "Lineage enriched" "Detected in many" 89 "T-cells: 176.7" "Cell line enriched" "Detected in single" 8 "U-266/84: 1.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.58e-4)" "unprognostic (3.14e-3)" "unprognostic (1.49e-2)" "unprognostic (5.74e-4)" "unprognostic (1.88e-1)" "unprognostic (6.43e-3)" "unprognostic (5.89e-2)" "unprognostic (2.96e-2)" "unprognostic (6.43e-3)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (6.71e-5)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.67e-2)" "unprognostic (8.99e-2)" 0.5 0.0 0.0 7.1 0.1 2.6 0.7 0.0 0.2 0.8 0.0 0.8 0.1 0.2 0.7 1.1 0.9 0.8 0.1 0.0 0.0 0.4 0.4 0.7 15.3 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.8 0.0 0.2 0.0 0.1 0.2 4.3 0.4 0.1 4.1 2.3 0.1 0.0 115.0 0.3 0.0 10.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 2.5 0.1 40.2 0.1 69.8 167.3 0.0 0.2 152.1 152.7 1.9 0.8 0.4 0.8 176.7 43.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 TRBV4-2 "TCRBV4S2, TCRBV7S3A2T, TRBV42" ENSG00000211745 "T cell receptor beta variable 4-2" A0A539 7 142345421-142345985 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 21.0" "Cell type enriched" "Detected in some" 8 "T-cells: 23.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 100.2" "Lineage enriched" "Detected in single" 293 "T-cells: 100.2" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.89e-3)" "unprognostic (4.65e-4)" "unprognostic (1.28e-3)" "unprognostic (1.06e-2)" "unprognostic (4.60e-2)" "unprognostic (7.05e-4)" "unprognostic (2.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.19e-3)" "unprognostic (1.32e-2)" "unprognostic (6.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.82e-4)" "unprognostic (5.50e-2)" "unprognostic (5.99e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-2)" 0.2 0.0 0.0 1.4 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.4 5.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 2.3 0.3 0.5 0.0 21.0 0.3 0.0 4.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 100.2 0.0 25.6 27.8 0.1 0.0 23.9 14.4 0.1 0.0 0.2 0.3 44.8 8.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 23.9 0.0 0.0 0.0 TRBV5-4 "TCRBV5S4, TCRBV5S6A3N2T, TRBV54" ENSG00000230099 "T cell receptor beta variable 5-4" A0A0C4DH59 7 142462916-142463581 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 22.1;pancreas: 11.6" "Group enriched" "Detected in some" 9 "Plasma cells: 6.1;T-cells: 6.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 115.7" "Lineage enriched" "Detected in many" 115 "T-cells: 115.7" "Cell line enriched" "Detected in some" 5 "MOLT-4: 11.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.48e-3)" "unprognostic (6.75e-4)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-1)" "unprognostic (1.76e-3)" "unprognostic (5.82e-2)" "unprognostic (2.79e-2)" "unprognostic (1.59e-2)" "unprognostic (4.88e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.60e-4)" "unprognostic (2.77e-1)" "unprognostic (4.95e-2)" "unprognostic (4.78e-3)" "unprognostic (1.64e-2)" 0.2 0.1 0.0 2.4 0.2 1.2 0.1 0.0 0.0 0.2 0.0 0.7 0.8 0.0 0.1 0.3 0.1 0.5 0.3 0.0 0.0 0.1 0.2 0.4 8.2 0.2 0.0 0.0 11.6 0.0 0.0 0.0 0.2 0.2 1.0 0.7 0.5 0.0 0.2 0.3 1.1 0.0 0.0 2.2 1.0 0.2 0.0 22.1 0.2 0.0 8.1 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.3 0.0 0.0 0.5 0.0 0.2 0.2 0.0 1.3 0.1 2.1 0.0 49.7 26.7 0.0 0.1 62.8 36.4 1.0 0.1 0.1 0.1 115.7 18.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 TRBV5-5 "TCRBV5S3A2T, TCRBV5S5, TRBV55" ENSG00000211725 "T cell receptor beta variable 5-5" A0A597 7 142482548-142483019 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "lymphoid tissue: 18.6" "Cell type enriched" "Detected in single" 23 "T-cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 25 "memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.0;naive CD4 T-cell: 38.6;naive CD8 T-cell: 29.0;T-reg: 41.9" "Lineage enriched" "Detected in many" 30 "T-cells: 41.9" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (4.96e-5)" "unprognostic (4.74e-3)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.19e-1)" "unprognostic (1.98e-4)" "unprognostic (2.84e-3)" "unprognostic (9.58e-2)" "unprognostic (7.35e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (4.27e-4)" "unprognostic (7.42e-2)" "unprognostic (8.32e-3)" "unprognostic (9.06e-2)" 0.1 0.0 0.2 1.8 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.5 0.0 0.8 18.6 0.1 0.0 4.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.6 0.0 0.8 0.0 36.7 28.0 0.1 0.1 38.6 29.0 0.8 0.0 0.1 0.0 41.9 11.3 0.2 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TRBV5-6 "TCRBV5S2, TCRBV5S6, TRBV56" ENSG00000211728 "T cell receptor beta variable 5-6" A0A599 7 142500028-142500534 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 33.8" "Group enriched" "Detected in some" 21 "Early spermatids: 13.5;Late spermatids: 14.6;T-cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 40.2;memory CD8 T-cell: 22.9;naive CD4 T-cell: 35.9;naive CD8 T-cell: 45.2;T-reg: 66.0" "Lineage enriched" "Detected in many" 56 "T-cells: 66.0" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.27e-3)" "unprognostic (8.46e-3)" "unprognostic (1.20e-1)" "unprognostic (7.21e-2)" "unprognostic (5.25e-1)" "unprognostic (3.45e-4)" "unprognostic (5.72e-2)" "unprognostic (6.24e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-3)" "unprognostic (2.64e-2)" "unprognostic (2.39e-1)" "unprognostic (2.26e-7)" "unprognostic (7.62e-2)" "unprognostic (3.14e-2)" "unprognostic (2.41e-1)" "unprognostic (1.34e-1)" 0.2 0.0 0.0 2.1 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.6 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.1 0.8 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.2 1.1 0.1 0.0 1.9 0.4 1.7 0.0 33.8 0.1 0.1 5.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.0 3.0 0.1 40.2 22.9 0.1 0.1 35.9 45.2 1.1 0.0 0.1 0.2 66.0 17.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 TRBV6-2 "TCRBV13S2A1T, TCRBV6S2, TRBV62" ENSG00000283063 "T cell receptor beta variable 6-2" "A0A0J9YXY3, P0DPF7" 7 142349152-142349664 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 8.2" "Cell type enriched" "Detected in single" 10 "T-cells: 6.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 92.1" "Lineage enriched" "Detected in single" 175 "T-cells: 92.1" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" 0.2 0.0 0.0 2.4 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.5 8.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 2.3 0.2 0.0 0.0 4.6 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 92.1 0.2 24.0 26.4 0.0 0.0 21.7 17.5 0.5 0.0 0.1 0.1 40.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 TRBV6-6 "TCRBV13S6A2T, TCRBV6S6, TRBV66" ENSG00000211724 "T cell receptor beta variable 6-6" A0A0A6YYG2 7 142469537-142470013 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 14.7" "Cell type enriched" "Detected in single" 37 "T-cells: 3.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 81.4" "Lineage enriched" "Detected in single" 98 "T-cells: 81.4" "Cell line enriched" "Detected in some" 10 "HL-60: 10.4" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.69e-4)" "unprognostic (3.82e-4)" "unprognostic (3.66e-2)" "unprognostic (2.55e-2)" "unprognostic (8.55e-2)" "unprognostic (9.93e-5)" "unprognostic (4.36e-1)" "unprognostic (1.94e-2)" "unprognostic (1.09e-2)" "unprognostic (3.42e-2)" "unprognostic (5.90e-2)" "unprognostic (2.27e-1)" "unprognostic (1.78e-3)" "unprognostic (2.40e-1)" "unprognostic (2.22e-2)" "unprognostic (4.18e-2)" "unprognostic (2.01e-2)" 0.2 0.0 0.0 2.7 0.1 0.8 0.5 0.0 0.1 0.1 0.0 0.8 0.8 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.9 5.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.1 1.6 0.0 0.0 0.1 1.2 0.1 0.0 2.9 0.8 0.0 0.0 14.7 0.2 0.0 10.6 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.5 0.3 14.7 0.0 34.6 47.9 0.0 0.1 48.9 21.3 0.8 0.1 0.2 0.2 81.4 12.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRBV7-3 "TCRBV6S1A1N1, TCRBV7S3, TRBV73" ENSG00000211714 "T cell receptor beta variable 7-3" 7 142384329-142384841 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.9;testis: 2.7" "Group enriched" "Detected in some" 9 "Early spermatids: 32.5;Late spermatids: 39.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 31.9" "Lineage enriched" "Detected in single" 48 "T-cells: 31.9" "Cell line enhanced" "Detected in some" "ASC diff: 1.4;HBF TERT88: 2.3;HL-60: 1.6;RPTEC TERT1: 7.4;U-937: 3.8" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.78e-3)" "unprognostic (5.75e-4)" "unprognostic (1.76e-2)" "unprognostic (2.64e-3)" "unprognostic (3.07e-1)" "unprognostic (1.28e-4)" "unprognostic (4.17e-3)" "unprognostic (2.34e-2)" "unprognostic (2.06e-1)" "unprognostic (4.49e-3)" "unprognostic (8.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.57e-3)" "unprognostic (1.67e-1)" "unprognostic (1.21e-1)" "unprognostic (3.72e-1)" "unprognostic (3.10e-1)" 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.6 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.0 0.0 1.9 0.2 2.7 0.0 6.9 0.2 0.0 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.6 0.0 1.9 0.1 3.6 0.0 31.9 7.8 0.5 0.6 7.3 9.9 0.0 0.0 0.0 0.4 16.4 5.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 3.7 0.1 0.0 0.0 TRBV7-4 "TCRBV6S8A2T, TCRBV7S4, TRBV74" ENSG00000253409 "T cell receptor beta variable 7-4" A0A1B0GX95 7 142455174-142455635 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 17 "lymphoid tissue: 25.5;pancreas: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enriched" "Detected in some" 7 "HL-60: 90.9" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (8.71e-5)" "unprognostic (4.23e-3)" "unprognostic (7.05e-5)" "unprognostic (8.94e-4)" "unprognostic (2.75e-1)" "unprognostic (3.50e-3)" "unprognostic (4.40e-1)" "unprognostic (1.95e-3)" "unprognostic (4.97e-3)" "unprognostic (3.73e-2)" "unprognostic (9.93e-3)" 0.0 0.0 0.0 0.6 0.1 1.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 3.5 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 25.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 90.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 1.0 0.6 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 2.9 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TRBV7-6 "TCRBV6S3A1N1T, TCRBV7S6, TRBV76" ENSG00000211727 "T cell receptor beta variable 7-6" A0A1B0GX31 7 142492132-142492673 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 35.3" "Group enriched" "Detected in some" 15 "Gastric mucus-secreting cells: 5.1;T-cells: 7.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 22 "memory CD4 T-cell: 54.7;memory CD8 T-cell: 42.7;naive CD4 T-cell: 62.0;naive CD8 T-cell: 37.2;T-reg: 86.1" "Lineage enriched" "Detected in many" 52 "T-cells: 86.1" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (4.74e-2)" "unprognostic (1.21e-2)" "unprognostic (1.37e-2)" "unprognostic (4.25e-5)" "unprognostic (4.86e-3)" "unprognostic (4.06e-5)" "unprognostic (7.74e-2)" "unprognostic (3.83e-5)" "unprognostic (6.50e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (9.86e-5)" "unprognostic (1.83e-1)" "unprognostic (7.27e-2)" "unprognostic (5.90e-2)" "unprognostic (6.22e-3)" 0.1 0.0 0.5 3.7 0.3 1.3 0.2 0.2 0.4 0.1 0.1 0.6 0.0 0.1 5.3 1.7 0.1 1.4 0.0 0.5 0.2 0.1 0.4 0.8 6.9 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.4 0.3 0.0 0.3 1.1 0.0 0.4 3.7 1.1 0.5 1.0 35.3 0.2 0.0 7.6 2.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 2.5 0.1 54.7 42.7 0.1 0.3 62.0 37.2 1.6 0.1 0.1 0.1 86.1 17.1 0.5 0.3 0.2 0.4 0.5 0.2 0.5 0.3 0.3 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 TRBV9 "TCRBV1S1A1N1, TCRBV9S1" ENSG00000211716 "T cell receptor beta variable 9" A0A0B4J1U6 7 142391891-142392412 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.1;testis: 2.6" "Group enriched" "Detected in some" 11 "Early spermatids: 5.8;Late spermatids: 4.8;T-cells: 7.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 20.0;memory CD8 T-cell: 21.7;naive CD4 T-cell: 14.8;naive CD8 T-cell: 13.2;T-reg: 27.2" "Lineage enriched" "Detected in single" 31 "T-cells: 27.2" "Group enriched" "Detected in some" 16 "HL-60: 3.4;LHCN-M2: 6.0;U-937: 13.3" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (7.28e-3)" "unprognostic (1.34e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-3)" "unprognostic (3.00e-1)" "unprognostic (1.58e-4)" "unprognostic (8.88e-3)" "unprognostic (6.53e-2)" "unprognostic (1.20e-2)" "unprognostic (1.69e-3)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.60e-10)" "unprognostic (1.04e-1)" "unprognostic (7.94e-2)" "unprognostic (7.64e-3)" "unprognostic (1.46e-3)" 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.3 0.0 0.4 0.2 0.4 0.0 0.6 0.3 0.0 0.4 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.1 2.1 0.0 0.0 3.0 0.6 2.6 0.0 9.1 0.4 0.4 2.9 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 13.3 0.0 0.1 0.8 0.0 0.2 0.2 2.5 0.0 20.0 21.7 0.5 0.0 14.8 13.2 0.1 0.0 0.0 0.4 27.2 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 TRDC ENSG00000211829 "T cell receptor delta constant" 14 22462932-22465787 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 404.4" "Cell type enriched" "Detected in some" 4 "NK-cells: 746.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 87 "gdT-cell: 5873.4;NK-cell: 2243.9" "Group enriched" "Detected in all" 150 "NK-cells: 2243.9;T-cells: 5873.4" "Cell line enriched" "Detected in some" 38 "NB-4: 356.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.21e-3)" "unprognostic (8.15e-3)" "unprognostic (7.03e-2)" "prognostic favorable (8.25e-4)" "unprognostic (2.53e-1)" "unprognostic (2.42e-3)" "unprognostic (2.19e-1)" "prognostic favorable (6.13e-4)" "unprognostic (2.76e-2)" "unprognostic (2.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.67e-5)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (1.22e-2)" "unprognostic (1.99e-2)" 13.4 0.4 1.3 7.8 1.0 26.2 3.8 1.4 1.4 2.9 0.6 8.9 3.9 7.6 2.1 2.0 4.1 7.9 2.7 2.0 0.9 1.1 11.1 11.6 22.7 0.9 1.2 1.9 0.2 0.4 0.7 2.8 0.8 1.0 7.5 0.0 4.6 1.2 1.6 1.3 5.6 2.2 0.7 54.2 2.0 2.7 0.9 404.4 1.8 1.3 18.3 4.6 0.9 1.3 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 356.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 3.1 0.9 1.4 0.0 0.0 0.1 3.2 4.8 2.3 5873.4 7.9 3.8 5.7 16.7 31.7 9.2 1.9 16.2 46.6 27.0 2243.9 5.5 7.1 27.5 1292.0 1.3 1.0 1.4 1.4 2.0 0.9 0.9 1.2 0.8 0.7 0.9 1.3 1.1 3.2 5.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 165.7 0.3 0.0 0.5 0.0 0.9 0.8 0.7 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 4.2 0.5 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.9 0.0 0.0 5.7 0.0 746.6 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 123.5 0.0 0.0 0.0 TRGV3 "TCRGV3, V1S3" ENSG00000211699 "T cell receptor gamma variable 3" P03979 7 38358512-38359162 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 12.4" "Cell type enhanced" "Detected in some" "dendritic cells: 1.8;Plasma cells: 2.6;T-cells: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "gdT-cell: 59.0" "Lineage enriched" "Detected in many" 5 "T-cells: 59.0" "Cell line enhanced" "Detected in some" "HDLM-2: 7.0;JURKAT: 12.1;Karpas-707: 28.9;U-266/84: 5.9" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.87e-2)" "unprognostic (1.63e-3)" "unprognostic (4.58e-2)" "unprognostic (6.48e-3)" "unprognostic (4.66e-2)" "unprognostic (1.57e-3)" "unprognostic (2.28e-1)" "unprognostic (1.72e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-2)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (5.26e-3)" "unprognostic (2.28e-1)" "unprognostic (3.46e-2)" "unprognostic (3.71e-2)" "unprognostic (3.42e-2)" 0.6 0.3 0.1 1.3 0.1 2.8 0.5 0.1 0.2 0.7 0.1 1.8 1.0 0.6 0.0 0.5 0.6 3.9 0.3 0.1 0.3 0.4 0.7 1.4 12.4 0.7 1.3 0.1 0.2 0.3 0.2 1.0 0.4 1.3 1.9 0.0 1.1 0.4 0.1 0.3 3.1 0.7 0.5 7.6 1.3 0.5 0.5 9.3 0.4 0.0 8.9 2.0 0.3 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 3.8 12.1 0.7 28.9 0.0 0.2 0.0 1.4 0.2 0.0 0.0 1.5 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 3.1 0.8 0.0 0.0 0.0 0.1 3.0 5.9 0.4 0.1 1.6 0.0 0.1 1.6 0.0 59.0 0.7 50.1 3.4 11.0 34.0 5.7 1.8 9.4 27.6 0.1 11.4 2.2 11.1 6.3 8.0 0.1 0.1 0.1 0.2 0.1 0.3 0.7 1.3 0.4 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 TRGV4 "TCRGV4, V1S4" ENSG00000211698 "T cell receptor gamma variable 4" A0A0C4DH28 7 38353715-38354517 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.1" "Cell type enhanced" "Detected in some" "dendritic cells: 2.7;Plasma cells: 2.1;T-cells: 2.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "gdT-cell: 97.8" "Lineage enriched" "Detected in many" 15 "T-cells: 97.8" "Cell line enriched" "Detected in some" 4 "Karpas-707: 72.0" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (7.44e-3)" "unprognostic (7.26e-3)" "unprognostic (5.77e-2)" "unprognostic (1.90e-2)" "unprognostic (3.58e-1)" "unprognostic (6.75e-3)" "unprognostic (9.66e-2)" "unprognostic (8.83e-3)" "unprognostic (1.21e-1)" "unprognostic (2.63e-2)" "unprognostic (1.42e-2)" "unprognostic (1.58e-1)" "unprognostic (2.59e-3)" "unprognostic (2.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.47e-2)" "unprognostic (3.71e-3)" 0.4 0.4 0.2 0.4 0.2 3.0 0.4 0.3 0.2 0.3 0.8 1.6 0.4 0.4 0.2 0.4 0.5 2.2 0.2 0.2 0.2 0.4 1.4 1.7 11.1 0.8 1.2 0.1 0.1 0.1 0.2 0.4 0.5 1.9 1.4 0.0 0.9 0.3 0.1 0.5 3.5 0.3 0.4 9.0 1.6 0.7 0.9 7.1 0.4 0.0 4.9 0.8 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 13.9 0.1 8.3 0.0 0.0 0.0 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.1 8.3 4.6 72.0 0.1 0.2 0.0 16.8 0.4 0.0 0.1 0.6 0.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.2 0.0 0.0 0.0 2.7 1.9 0.0 1.1 14.5 0.0 0.2 1.5 0.1 97.8 0.3 30.1 1.0 4.4 26.8 1.7 0.6 2.0 23.8 0.6 6.5 0.1 5.8 1.4 7.2 0.2 0.2 0.3 0.2 0.2 0.2 0.8 1.2 0.5 0.4 0.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 TRGV8 "TCRGV8, V1S8" ENSG00000211696 "T cell receptor gamma variable 8" A0A0C4DH27 7 38330343-38330935 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.8;prostate: 4.9" "Cell type enriched" "Detected in some" 4 "T-cells: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.1" "Group enriched" "Detected in many" 6 "gdT-cell: 34.4;MAIT T-cell: 40.6;memory CD8 T-cell: 31.1;naive CD8 T-cell: 17.2" "Lineage enriched" "Detected in many" 7 "T-cells: 40.6" "Cell line enriched" "Detected in some" 4 "JURKAT: 44.9" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" 0.3 0.3 0.3 1.5 0.0 0.7 0.3 0.0 0.2 0.4 0.0 0.8 0.8 0.7 0.6 0.6 0.9 1.2 0.3 0.5 0.1 0.2 1.4 2.3 3.5 1.0 3.1 0.3 0.3 0.1 0.0 1.4 1.0 4.9 1.2 0.0 0.3 0.4 0.1 0.0 1.9 0.9 0.2 6.8 0.7 0.4 0.4 4.5 0.2 0.0 2.0 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 2.4 0.1 0.5 0.0 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 2.1 3.1 0.0 1.4 0.0 0.0 0.0 3.6 0.5 0.0 0.0 1.2 0.0 0.0 0.0 44.9 1.0 2.5 0.0 0.7 0.0 1.7 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.7 10.6 0.0 0.0 0.7 0.0 34.4 0.1 40.6 0.0 3.7 31.1 0.9 0.0 0.2 17.2 0.2 5.5 0.1 0.2 0.1 4.5 0.3 0.0 0.0 0.2 0.5 0.1 1.0 3.1 1.0 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689697-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 135.9;dendritic cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 54.0 21.3 13.1 101.3 18.8 90.3 50.7 16.3 23.7 42.7 25.5 36.0 25.2 50.6 70.2 37.1 49.3 78.6 22.6 14.7 16.5 21.2 72.5 83.4 139.0 17.9 16.7 60.3 17.2 8.0 12.6 21.5 16.7 43.3 53.4 11.0 65.4 52.6 13.4 18.1 53.4 52.1 17.7 143.1 39.5 15.4 12.8 101.2 21.7 40.6 120.7 61.6 22.6 29.3 2.8 1.2 13.9 2.4 88.6 174.6 5.0 53.3 93.9 89.8 209.9 1.7 8.6 111.9 13.0 80.2 20.6 10.5 34.0 56.4 10.7 2.0 0.0 6.4 5.6 1.4 107.8 18.2 11.4 190.6 54.3 18.7 9.6 124.5 128.7 1.0 2.3 4.7 111.6 1.5 54.1 16.9 40.3 0.5 4.9 62.6 3.4 2.3 51.1 14.9 1.4 2.7 4.5 4.5 2.1 56.8 4.5 17.9 153.6 56.4 29.8 2.5 2.4 4.9 4.4 11.2 67.7 28.9 7.2 108.7 118.5 79.6 109.0 143.3 145.9 149.4 118.4 117.2 138.7 158.2 106.5 102.7 103.1 61.3 181.1 177.0 197.9 181.9 13.1 18.8 16.3 23.7 14.7 16.5 17.9 16.7 16.7 17.7 12.8 29.3 54.4 67.3 57.7 2.0 135.9 12.6 17.0 42.5 56.3 0.5 17.7 14.0 6.0 7.2 60.5 29.5 0.0 1.5 113.9 4.7 5.9 11.2 0.3 16.1 27.0 40.5 4.2 16.8 4.9 8.0 4.7 36.2 20.9 23.8 17.7 5.4 33.5 4.3 18.7 1.7 0.3 9.0 30.5 87.1 46.6 2.0 36.1 67.8 5.4 52.5 59.0 6.4 83.4 1.0 0.5 5.4 6.3 30.1 18.8 9.9 4.4 3.3 52.5 1.0 13.1 35.1 24.4 0.6 0.3 14.1 8.7 2.3 89.3 13.0 5.0 18.8 TRIM46 "FLJ23229, TRIFIC" ENSG00000163462 "Tripartite motif containing 46" Q7Z4K8 1 155173787-155184971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055583 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 30: Mammary glandular cells - Lactation" "HPA055583: AB_2732599" "unprognostic (1.06e-1)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "prognostic unfavorable (2.61e-7)" "unprognostic (1.75e-1)" "unprognostic (7.26e-2)" "unprognostic (1.59e-2)" "unprognostic (4.65e-2)" "unprognostic (4.09e-1)" "unprognostic (2.88e-2)" "unprognostic (2.18e-3)" "unprognostic (1.24e-1)" "unprognostic (2.29e-12)" "unprognostic (8.58e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.72e-2)" 0.6 0.4 8.3 0.5 9.2 0.3 0.5 8.4 10.1 1.1 4.0 0.8 0.3 3.1 3.3 0.4 2.3 0.4 0.3 9.4 7.6 0.6 0.1 0.5 0.5 7.3 6.3 0.3 0.5 0.1 4.9 0.1 7.5 1.1 0.1 1.1 0.4 0.8 0.1 0.3 0.7 0.9 6.2 1.0 1.0 1.9 7.9 1.1 0.3 0.0 0.2 0.5 0.9 8.8 1.7 2.2 1.5 0.1 0.3 1.3 0.1 1.6 1.7 1.9 2.2 0.0 0.8 0.7 1.1 2.0 0.4 1.8 0.0 0.7 0.6 3.9 0.7 1.3 2.6 0.1 0.8 0.4 4.1 1.4 0.4 2.0 0.7 4.5 2.5 4.1 0.0 3.2 1.0 1.1 2.4 0.2 5.7 0.2 2.3 4.1 0.1 0.8 0.3 0.0 3.9 9.3 0.7 0.5 1.2 0.6 2.8 3.4 3.7 3.8 1.2 0.2 0.8 3.2 1.2 0.7 4.0 0.6 1.1 0.4 0.0 0.0 0.2 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.7 0.1 8.3 9.2 8.4 10.1 9.4 7.6 7.3 6.3 7.5 6.2 7.9 8.8 0.2 0.0 0.0 1.0 0.3 0.4 0.8 0.2 0.0 6.9 2.9 1.8 1.1 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.7 6.5 2.9 0.4 0.7 1.8 0.8 13.1 0.2 0.0 0.8 1.5 3.9 0.0 0.1 0.4 0.0 0.8 0.0 9.7 0.0 0.0 0.0 1.0 7.5 0.3 0.2 0.0 0.0 2.6 0.6 2.1 3.0 9.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.6 0.0 1.4 0.9 1.3 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.8 TTC16 FLJ32780 ENSG00000167094 "Tetratricopeptide repeat domain 16" Q8NEE8 9 127716079-127731590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "fallopian tube: 6.9;testis: 16.0" "Group enriched" "Detected in some" 4 "Early spermatids: 103.1;Late spermatids: 258.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.10e-3)" "unprognostic (1.63e-3)" "unprognostic (3.86e-3)" "unprognostic (2.02e-4)" "unprognostic (4.08e-3)" "unprognostic (2.25e-3)" "unprognostic (8.87e-4)" "unprognostic (2.91e-2)" "unprognostic (2.25e-2)" "unprognostic (2.36e-1)" "unprognostic (1.96e-3)" "unprognostic (7.32e-2)" "unprognostic (9.14e-3)" "unprognostic (6.35e-3)" "unprognostic (5.29e-2)" "unprognostic (1.17e-1)" "unprognostic (5.54e-3)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.0 6.9 0.1 0.0 0.1 0.1 0.1 0.0 0.7 0.4 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 1.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.2 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.4 0.1 0.1 1.0 0.0 0.0 0.2 0.1 0.8 1.5 5.7 0.0 0.0 0.0 13.7 0.0 0.0 0.0 103.1 6.0 0.1 0.5 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.3 0.0 258.3 1.2 0.3 1.8 0.0 0.3 0.2 9.2 4.5 0.1 0.0 0.0 3.8 2.6 0.0 0.0 0.4 41.8 0.5 0.0 0.1 0.4 17.9 1.6 0.0 0.0 0.0 7.4 3.8 0.0 0.1 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978322-48982620 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 4.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.1;Gastric mucus-secreting cells: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 4.5;cerebral cortex: 2.1" "Group enriched" "Detected in some" 8 "gdT-cell: 3.1;MAIT T-cell: 5.1;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 29 "T-cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Secreted to extracellular matrix" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.0 0.0 0.8 0.5 4.5 1.1 0.0 0.0 2.1 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.7 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.3 0.7 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.1 0.1 2.0 2.9 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.2 0.5 0.8 4.5 0.0 2.1 0.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 WNT10A ENSG00000135925 "Wnt family member 10A" Q9GZT5 2 218880852-218899581 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 7.0;skin 1: 8.9" "Cell type enhanced" "Detected in many" "B-cells: 12.2;Basal keratinocytes: 17.1;Basal respiratory cells: 15.5;Basal squamous epithelial cells: 30.1;Bipolar cells: 16.2;dendritic cells: 16.4;Plasma cells: 30.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.9" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 50.8;HaCaT: 140.1;HDLM-2: 58.7;RPTEC TERT1: 29.2;U-266/70: 69.0" "Region enhanced" "Detected in many" "cerebral cortex: 5.2" "Region enhanced" "Detected in single" "basal ganglia: 2.1" HPA013898 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "HPA013898: AB_1858847" "unprognostic (2.99e-4)" "unprognostic (4.31e-2)" "unprognostic (8.55e-2)" "unprognostic (1.17e-3)" "unprognostic (2.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.04e-1)" "unprognostic (6.34e-2)" "unprognostic (2.23e-3)" "unprognostic (9.52e-2)" "unprognostic (6.64e-9)" "unprognostic (1.22e-1)" "unprognostic (1.72e-1)" "unprognostic (4.89e-3)" "unprognostic (1.82e-1)" 0.7 0.2 0.7 1.0 1.6 0.5 0.5 0.2 1.3 1.5 0.2 1.6 3.7 0.0 0.4 7.0 1.2 0.3 0.1 1.2 0.5 2.4 0.2 0.7 2.5 0.4 0.6 0.2 0.1 0.0 4.3 3.4 0.5 1.7 1.0 1.4 2.5 1.0 0.0 8.9 2.1 0.0 0.3 2.0 2.5 0.4 0.7 1.1 0.2 0.0 1.9 2.7 2.9 0.7 15.8 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 50.8 2.8 10.4 0.0 3.8 140.1 0.0 0.1 0.0 58.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 10.5 29.2 0.4 0.0 0.4 0.3 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 69.0 1.1 1.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 6.2 1.0 0.0 0.7 1.6 0.2 1.3 1.2 0.5 0.4 0.6 0.5 0.3 0.7 0.7 0.2 0.0 0.0 0.3 12.2 17.1 8.2 15.5 30.1 16.2 0.5 1.3 1.4 0.0 1.1 9.2 2.1 1.2 16.4 0.0 0.0 0.3 1.2 0.3 0.1 0.2 0.0 0.4 1.3 0.0 0.4 1.9 0.5 0.2 0.0 0.0 0.0 0.2 0.1 0.0 1.9 0.0 2.0 0.0 1.3 0.1 0.6 1.0 7.2 0.0 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.0 30.4 2.5 0.0 0.3 0.6 1.5 0.0 0.1 0.8 0.9 0.6 5.2 4.7 0.1 9.8 0.0 0.2 3.2 XCL1 "ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1" ENSG00000143184 "X-C motif chemokine ligand 1" P47992 1 168576605-168582069 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.6" "Group enriched" "Detected in many" 4 "dendritic cells: 185.3;T-cells: 213.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 14 "NK-cell: 88.5" "Lineage enriched" "Detected in many" 14 "NK-cells: 88.5" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;Hep G2: 4.1;SCLC-21H: 3.3;SuSa: 6.1;U-266/70: 5.0;U-266/84: 1.9" "Not detected" "Not detected" HPA057725 Approved "Secreted to blood" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 63: NK-cells & T-cells - Immune response" "HPA057725: AB_2683511" "unprognostic (5.38e-3)" "unprognostic (5.72e-2)" "unprognostic (8.23e-3)" "unprognostic (4.19e-3)" "unprognostic (1.43e-1)" "unprognostic (6.10e-2)" "unprognostic (2.96e-1)" "unprognostic (4.27e-2)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (4.61e-1)" "unprognostic (8.85e-2)" "unprognostic (5.34e-10)" "unprognostic (1.96e-1)" "unprognostic (1.32e-1)" "unprognostic (5.47e-2)" "unprognostic (2.15e-2)" 0.5 0.1 0.1 1.0 0.1 3.5 1.0 0.0 0.2 1.0 0.0 0.7 1.0 2.2 0.8 0.2 0.6 1.1 0.5 0.1 0.2 0.5 2.6 1.8 2.3 0.1 0.1 0.2 0.5 0.0 0.1 2.2 0.2 0.4 1.0 0.0 1.5 0.3 0.1 0.1 1.5 0.3 0.1 4.6 1.2 0.2 0.6 4.1 0.3 0.0 1.6 0.9 0.4 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.3 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.0 1.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.2 0.0 0.2 0.0 1.0 5.9 0.0 0.0 0.3 4.0 0.3 88.5 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.6 0.1 2.3 3.2 5.5 0.0 1.5 4.0 0.5 0.0 2.2 0.0 1.3 1.5 2.0 1.5 0.0 0.0 0.0 1.4 185.3 0.7 0.0 0.0 1.3 2.0 1.9 1.9 0.0 8.4 0.0 0.2 1.2 1.9 8.2 2.9 2.5 0.0 1.4 0.9 0.4 0.0 0.1 0.8 0.0 1.9 10.6 0.0 0.0 3.1 39.2 0.0 0.1 0.0 42.2 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.1 0.0 0.0 0.0 0.3 1.7 0.2 0.2 1.8 4.3 0.8 213.4 0.0 0.4 0.1 XCL2 "SCM-1b, SCYC2" ENSG00000143185 "X-C motif chemokine ligand 2" Q9UBD3 1 168540768-168543997 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1;lymphoid tissue: 13.4" "Group enriched" "Detected in many" 10 "dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 8 "NK-cell: 423.5" "Lineage enriched" "Detected in many" 8 "NK-cells: 423.5" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;RT4: 1.1;SuSa: 1.1" HPA057725 Approved "Secreted to blood" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 39: CACO-2 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA057725: AB_2683511" "unprognostic (9.88e-3)" "unprognostic (7.89e-3)" "unprognostic (4.77e-2)" "unprognostic (9.32e-3)" "unprognostic (8.21e-2)" "unprognostic (6.79e-4)" "unprognostic (9.33e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.58e-3)" "unprognostic (6.26e-2)" "unprognostic (2.02e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (8.36e-9)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "unprognostic (3.02e-2)" "unprognostic (1.06e-1)" 1.1 0.8 0.3 3.2 0.3 14.1 0.9 0.3 0.5 1.0 0.4 1.9 3.2 3.6 0.9 0.6 1.8 1.9 0.7 0.3 0.4 0.4 5.6 3.3 5.6 0.5 0.3 0.4 0.6 0.3 0.2 1.4 0.4 0.5 1.5 0.0 1.9 1.0 0.3 0.1 2.0 1.4 0.4 13.4 2.9 0.3 0.6 3.8 0.6 0.5 3.6 2.0 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.4 47.2 0.2 2.7 0.3 3.6 50.1 0.3 0.1 2.1 37.1 1.9 423.5 0.3 0.1 0.0 17.1 0.3 0.3 0.3 0.5 0.3 0.4 0.5 0.3 0.4 0.4 0.6 0.4 2.9 0.0 1.1 0.0 3.3 2.4 0.0 0.0 1.8 0.0 1.6 1.4 0.8 0.0 0.0 0.0 0.0 0.1 513.6 0.3 0.0 0.1 0.0 2.4 2.0 1.0 0.0 19.2 0.0 0.0 0.0 1.1 8.2 2.2 1.3 0.0 1.4 0.6 0.4 0.0 0.0 0.7 0.0 5.0 4.0 0.0 0.0 3.7 33.8 0.0 0.8 0.0 277.1 0.0 0.0 0.0 1.1 0.0 13.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.9 1.1 0.0 240.6 0.0 0.1 0.1 Z82206.1 ENSG00000225528 "Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7" 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;lymphoid tissue: 4.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "K-562: 12.5" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.1 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.1 0.1 0.1 0.0 4.3 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 12.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.1 2.7 2.9 1.3 2.5 2.3 3.5 3.2 1.6 2.0 3.6 4.4 2.4 1.3 1.2 1.7 2.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 ZCCHC18 "PNMA7B, SIZN2" ENSG00000166707 "Zinc finger CCHC-type containing 18" P0CG32 X 104112131-104115842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;ovary: 4.2" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 4.2;NK-cells: 9.2;Oligodendrocyte precursor cells: 6.6;Sertoli cells: 6.6" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.5;Karpas-707: 4.6;SH-SY5Y: 3.1" "Low region specificity" "Detected in all" "HPA034940, HPA078516" Uncertain Approved Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA034940: AB_10671098, HPA078516: " "unprognostic (7.20e-2)" "unprognostic (7.71e-4)" "unprognostic (8.29e-2)" "unprognostic (4.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-3)" "unprognostic (2.20e-2)" "unprognostic (3.22e-2)" "unprognostic (7.59e-2)" "unprognostic (3.34e-1)" "unprognostic (4.44e-6)" "unprognostic (4.05e-2)" "unprognostic (1.02e-6)" "unprognostic (3.82e-2)" "unprognostic (4.02e-1)" "unprognostic (3.91e-2)" "unprognostic (4.14e-3)" 0.5 0.8 3.0 1.3 2.9 0.4 0.3 2.9 3.0 1.8 1.1 0.7 0.3 1.5 0.2 0.3 1.3 0.4 0.5 2.7 5.0 0.4 0.1 0.4 2.0 2.2 2.5 4.2 0.9 0.0 1.6 0.1 2.2 0.8 0.3 1.2 0.2 0.6 0.1 0.2 2.0 0.6 2.4 2.2 0.5 1.0 4.9 0.4 0.3 0.1 2.0 0.6 0.7 2.1 0.0 0.1 1.9 1.3 0.1 0.0 0.1 0.4 0.0 0.3 0.3 0.1 0.0 2.5 0.0 0.1 0.4 0.0 1.1 0.0 0.1 0.7 0.9 0.4 0.1 0.0 0.2 1.4 0.4 0.1 0.0 0.2 0.0 1.1 0.3 0.1 0.0 4.6 0.1 0.0 0.0 0.0 1.0 0.0 0.3 1.7 0.4 0.0 0.2 0.2 1.3 3.1 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.5 0.1 0.6 0.1 0.0 1.2 0.0 1.4 0.4 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.3 0.5 0.0 0.8 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.1 3.0 2.9 2.9 3.0 2.7 5.0 2.2 2.5 2.2 2.4 4.9 2.1 0.9 0.0 0.6 3.3 4.0 0.1 0.2 0.0 0.0 0.8 0.3 0.3 0.7 0.0 1.3 1.8 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.6 0.9 1.2 4.2 0.8 2.6 0.2 0.0 1.2 0.0 0.3 0.0 1.3 0.7 0.0 0.0 1.7 1.5 0.0 0.0 0.3 0.4 0.3 1.5 0.1 1.8 0.0 0.1 3.4 9.2 6.6 0.3 0.0 0.0 1.2 1.7 0.1 0.0 0.2 1.5 1.0 6.6 0.2 2.4 0.0 0.2 0.1 0.0 0.0 3.6 1.0 0.0 0.1 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4739833-4746119 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 28.3" "Cell type enriched" "Detected in many" 6 "Early spermatids: 191.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 1.8 1.3 1.6 2.4 1.6 1.0 1.7 1.6 2.5 0.9 1.7 0.8 4.0 0.6 0.5 0.9 1.1 2.8 0.6 1.6 1.8 1.9 3.1 4.6 1.7 2.4 2.0 0.7 1.2 5.5 1.4 1.2 2.0 1.7 0.7 0.3 3.1 0.8 0.4 1.4 3.0 0.7 2.0 5.5 1.9 28.3 2.4 0.8 1.1 0.1 0.4 1.8 0.7 2.6 2.1 0.3 0.0 0.9 0.0 0.1 0.1 0.0 0.5 0.5 1.1 0.9 1.9 0.0 0.0 0.0 0.2 1.6 0.4 0.1 0.0 0.2 0.7 0.0 0.2 0.5 0.3 0.0 0.6 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.6 0.6 0.9 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.6 1.6 1.6 2.5 1.6 1.8 2.4 2.0 2.0 2.0 2.4 2.6 0.8 0.0 2.0 1.3 0.6 0.9 8.0 1.8 0.6 0.3 4.4 3.7 0.7 2.8 3.1 1.8 0.0 0.1 0.2 3.3 0.0 1.6 191.4 2.8 0.3 1.4 1.2 0.0 0.0 3.9 0.0 0.7 4.6 2.7 0.0 0.3 3.9 0.6 5.2 0.0 0.1 2.9 0.0 11.9 7.3 30.9 0.6 12.9 1.8 1.9 21.9 2.0 0.0 1.0 0.5 3.5 1.4 2.2 0.1 6.7 3.8 0.8 3.7 0.3 0.0 0.2 1.0 24.3 2.0 0.5 0.9 0.0 0.2 0.3 1.3 8.5 ZNF683 "Hobit, MGC33414" ENSG00000176083 "Zinc finger protein 683" Q8IZ20 1 26361634-26374522 "Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 81.9" "Group enriched" "Detected in some" 12 "Early spermatids: 473.7;Late spermatids: 482.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "gdT-cell: 172.4;memory CD8 T-cell: 113.1" "Lineage enriched" "Detected in many" 15 "T-cells: 172.4" "Group enriched" "Detected in some" 8 "NB-4: 2.2;OE19: 4.8" "Not detected" "Not detected" HPA023865 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" "HPA023865: AB_2671333" "unprognostic (3.95e-3)" "unprognostic (5.58e-3)" "unprognostic (5.83e-2)" "prognostic favorable (2.90e-5)" "unprognostic (9.17e-2)" "unprognostic (8.98e-4)" "unprognostic (7.90e-2)" "unprognostic (5.05e-3)" "unprognostic (5.81e-3)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.30e-2)" "unprognostic (3.54e-8)" "unprognostic (5.90e-3)" "unprognostic (1.63e-1)" "unprognostic (1.14e-2)" "prognostic favorable (3.45e-5)" 0.2 0.4 0.3 0.6 0.6 1.9 0.8 0.3 0.3 0.9 0.1 0.3 0.3 0.6 0.1 0.7 1.7 1.7 0.8 0.8 0.3 0.3 0.6 4.7 1.9 1.1 0.3 1.0 0.3 0.2 0.3 0.4 0.5 0.9 0.5 0.0 10.1 0.8 0.1 0.5 0.6 0.3 0.5 2.2 3.4 81.9 0.5 2.9 1.1 0.0 0.4 0.9 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.2 0.1 172.4 0.1 0.4 0.2 35.4 113.1 0.0 0.0 13.4 63.2 0.9 11.8 3.8 0.3 1.1 24.2 0.3 0.6 0.3 0.3 0.8 0.3 1.1 0.3 0.5 0.5 0.5 0.6 0.9 3.2 0.6 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 473.7 0.2 0.5 0.8 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 482.4 1.8 1.8 0.0 0.0 0.3 0.0 6.2 0.0 0.1 0.0 0.0 1.2 1.7 0.1 0.0 0.2 0.7 0.0 0.0 0.4 0.7 3.3 2.2 0.2 0.0 0.0 39.8 0.0 0.0 0.0 ZNF831 "C20orf174, dJ492J12.1" ENSG00000124203 "Zinc finger protein 831" Q5JPB2 20 59123381-59259113 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 4 "dendritic cells: 20.5;Excitatory neurons: 19.5;NK-cells: 17.5;Plasma cells: 9.5;T-cells: 31.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 1.2;T-cells: 2.1" "Group enriched" "Detected in some" 6 "Daudi: 4.0;HMC-1: 1.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 25 "amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4" HPA016839 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA016839: AB_1859466" "unprognostic (2.90e-3)" "unprognostic (7.70e-6)" "unprognostic (9.71e-4)" "unprognostic (1.31e-3)" "unprognostic (7.00e-2)" "unprognostic (3.00e-5)" "unprognostic (3.08e-3)" "unprognostic (2.23e-2)" "unprognostic (2.89e-3)" "unprognostic (2.21e-3)" "unprognostic (2.80e-3)" "unprognostic (4.31e-1)" "unprognostic (3.40e-3)" "unprognostic (2.39e-1)" "unprognostic (3.42e-2)" "unprognostic (2.21e-1)" "unprognostic (1.93e-2)" 0.3 0.1 2.2 2.3 1.6 0.9 0.3 0.0 2.7 0.1 0.0 0.3 0.2 0.1 0.2 0.2 0.2 0.5 0.0 3.4 0.3 0.1 0.2 0.6 6.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.1 1.9 0.0 0.0 2.6 0.6 0.2 0.9 1.5 0.3 0.0 3.8 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.8 0.0 1.4 0.2 1.0 1.5 0.0 0.1 0.8 1.0 0.1 1.2 0.0 0.0 2.1 0.4 2.2 1.6 0.0 2.7 3.4 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.6 0.7 4.8 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.7 0.0 0.0 1.8 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 19.5 0.0 0.0 0.1 0.5 0.1 2.5 0.0 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 17.5 0.5 0.9 0.0 0.0 0.0 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 0.5 0.0 0.0 0.0 31.2 0.0 0.0 0.0